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Abstract
Abstract
This study has investigated the drug release mechanisms from
hydroxypropyl methylcellulose (HPMC) hydrophilic matrices. A
hypothesis was developed from interpretation of a previous study that
drug surface activity has an influence on drug liberation. The validity of
the hypothesis was tested by studying the interactions between HPMC and
the two non-steroidal anti-inflammatory drugs diclofenac Na and
meclofenamate Na, using tensiometry, rheology, NMR, neutron scattering
and turbimetry. Meclofenamate Na was found to interact with HPMC,
resulting in detectable changes in drug diffusion coefficients and polymer
structure in solution. There were increases in HPMC solution solubility
and changes in viscoelasticity, which suggested drug solubilisation of the
methoxyl-rich regions of the polymer chains. Diclofenac Na did not show
evidence of an interaction and exhibited changes consistent with a 'salting
out' of the polymer.
A confocal microscopy technique was used to image the drug effects on
early gel layer development. The presence of drugs affected gel layer
development, depending on the level of drug in the matrix and the
concentration of sodium chloride in the hydration medium. Diclofenac Na
matrices became increasingly susceptible to disintegration, while
meclofenamate Na matrices exhibited resistance to the effects of sodium
chloride. The influence of incorporated diluents on the gel layer was also
investigated and it was found that lactose had a disruptive effect, whereas
microcrystalline cellulose was relatively benign. When co-formulating
Abstract
drugs and diluents in the matrix, lactose acted to antagonise the effect of
medofenamate, but acted synergistically with diclofenac to reduce gel
layer integrity and accelerate matrix disintegration. In contrast, MCCwas
found to have a relatively neutral effect on drug-mediated effects.
HPMCparticle swelling and coalescence are critical processes in gel layer
formation extending drug release. Drug surface activity and capability of
interacting with HPMC appears to influence particle swelling processes,
affecting gel layer formation and provides a mechanistic explanation for
the differing release profiles of diclofenac and meclofenamate Na.
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Introduction
1.1 The principle of hydrophilic matrices
In recent years, significant interest has arisen in achieving extended
release of drugs from dosage forms. The aims of controlled drug release
include: (i) drug liberation at an appropriate time, at a specific rate and
site, (ii) maximising therapeutic effectiveness and (iii) reducing the
frequency and severity of side-effects. One method used to extend drug
release is the hydrophilic matrix, a technology that has been in use since
the first patents were filed in the 1960s (Alderman 1984, Melia 1991,
Colombo 1993, Li et al. 2005).
Hydrophilic matrices are mixtures of drugs and excipients typically
manufactured into tablets by compression (Melia 1991). There are a wide
range of polysaccharides and synthetic and semi-synthetic water-soluble
polymers used in such devices and include: (i) xanthan gum (Cox et al.
1999), (ii) sodium alginate (Sriamornsak et al. 2007), (iii) chitosan
(Phaechamud and Ritthidej, 2007), (iv) polyethylene oxide (PEO) (Wu et
al. 2005) and (v) the ether derivatives of cellulose, including
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hydroxypropyl methylcellulose (HPMC) and methylcellulose (MC)
(Alderman 1984, Liet al. 2005, Nair et al. 2007).
There are many reasons for the continued popularity of hydrophilic
matrices despite advances in other extended release technologies. These
include formulation simplicity, the ability to be manufactured using
conventional tabletting machinery, the ability to accommodate high drug
loadings and the relatively low cost and toxicity of the polymers used
which are generally regarded as safe (GRAS)excipients (Alderman 1984,
Melia 1991, Li et al. 2005).
HPMCand other cellulose ethers are the most common polymer carriers
used in hydrophilic matrices. HPMChydrates rapidly to form a gelatinous
layer on contact with aqueous fluids, is stable over a wide pH range (3.0 -
11.0) and is enzyme resistant (Alderman 1984, Dow Company Methocel
Information, Liet al. 2005). Asignificant amount of work has been carried
out in order to characterise HPMCwith respect to its performance as a
hydrophilic carrier material. This introduction will first consider the
chemical nature of HPMCand its properties in solution, before detailing its
use in extended release dosage forms. A particular focus will be on the
critical factors that affect drug release and a consideration of the
interactions between ions, molecules and HPMC. The aims of the
experimental programme will subsequently be outlined and discussed.
1.2 The structure and chemistry of cellulose
HPMC is a chemical derivative from the structural plant cell polymer
cellulose. Cellulose is the most abundant polymer in the biomass,
functioning as the key structural component of green plants (Klemm et al.
2005). It represents approximately 1.5 X1012 tonnes of the annual
biomass production and, as consumer demand increases for
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biocompatible products, is considered an almost inexhaustible source of
raw material (Klemm et al. 2005). Chemically, cellulose is a linear
carbohydrate composed of 1:4 linked glucose units (figure 1.1). These
constituent glucose units have the empirical formula C6H1206,and adopt a
cyclic structure, designated as ~-D-glucopyranose. The monomer units
are covalently linked through acetal functions between the equatorial OH
group of C4and the Cl carbon atom W-l, 4-glucan).
o
o o
n
Figure 1.1 - The molecular structure of cellulose
ResultantIy, cellulose is an extensive, linear chained polymer with three
hydroxyl groups per anhydroglucose unit (AGU) present in the
thermodynamically preferred 4C1 conformation. This material is
insoluble, with chemical substitutions conducted under heterogenous
conditions required to produce polymers, including the cellulose ethers,
that possess suitable water soluble functionality (Klemm et al. 2005).
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1.2.1 Types and usesof cellulose ethers
The cellulose ethers possess a range of properties with respect to
solubility, viscosity and surface activity depending on the various alkoxy
species used in their manufacture. These properties are exploited in a
number of different applications in industry and are summarised in table
1.1.
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Table 1.llndustrial Applications of Cellulose ethers (adapted from Donges 1990)
Abbreviations: methy1cellulose (MC), ethyIcellulose (EC), hydroxyethy1cellulose (HEC),
hydroxypropylcellulose (HPC), carboxymethy1cellulose (CMC),
hydroxypropylmethyIceIlulose (HPMC),hydroxyethylmethyl cellulose (HEMC),sodium
carboxymethy1cellulose (NaCMC)
Application Cellulose derivative function
Construction materials (plasters, MC, HEMC, HPMC, CMC, HEMCMC Water retention capacity, stability
filler, pastes) CMC, HEC, HEMC, HPMC, HEMCMC under load, adhesive strength
Stability of suspension, thickening,
Paints film formation, wetting
Paper manufacture CMC, HEC, HEMC, HPMC Agents for binding and suspending,
sizing aids and stabilisers
Textile industry (sizes, textile CMC, MC, HPMC, CMSEC Adhesive and film-forming
printing dyes) properties, thickening and soil
release
Polymerisation HEC, HPMC, HPMC Protective colloid, surface activity
Drilling industry, mining (drilling CMC, CMSEC, HEC, HPC, HPMC Water retention, flow
fluids)
characteristics, surface activity
Detergents CMC, HEMC, HPMC Anti-redeposition power, wetting
ability, suspending and emulsifying
agents
Engineering (extrusion, electrode MC, HPC, HPMC Friction reduction, water retention,
construction, ceramic sintering) enhanced ignition processes
Cosmetics (creams, lotions, CMC, MC, HEC, HEMC, HPMC Thickeners, binding, emulsifying
shampoos) and stabilising agents
Pharmaceuticals (ointments, gels, CMC, MC, HEC, HEMC, HPMC Thickeners, binding, emulsifying
tablets, coated tablets) and stabilising agents, film
formation, tablet disintegrants
Foodstuffs (sauces, milks bakes, CMC, HPMC, MC Thickeners, binding agents,
bakery products) stabilisers and emulsifiers
5
Chapter 1
1.3 The solution properties of HPMC
The principal solution properties of cellulose ethers will now be
discussed.
1.3.1. Solubility
The solubility of cellulose ethers occurs as a result of the introduction of
substituent groups along the polymeric backbone. The resulting steric
hindrance reduces hydrogen bonding between the native cellulose chains
causing reduced crystallinity, exposed hydroxyl groups and consequently
an increase in water solubility (Donges 1990). In general. an increase in
the degree of substitution, through greater etherification of the
anhydroglucose units, is accompanied by a progressive increase in
solubility in comparison with insoluble cellulose. The larger the
substituent group used in etherification, the lower the degree of
substitution necessary to impart aqueous solubility (Greminger 1980).
1.3.2 Surface activity
Amongst the many cellulose ethers, HPMCpossesses surface activity. This
manifests itself as the ability to reduce the interfacial tension of aqueous
systems (Grover 1993, Sarkar 1984, Yasueda et al. 2004). The surface
activity of cellulose ethers has been ascribed to non-homogenous
substitution of the cellulose backbone during manufacture, leading to the
simultaneous presence of hydrophobic (alkyl) and hydrophilic (hydroxyl)
groups (Doelker 1987). The degree of surface activity is dependent on the
distribution of these groups along the cellulose backbone (Sarkar 1984).
For example, HPMCUSP 2910 and 2906 have surface tensions of 44-50
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mN/m, whereas HPMCUSP 2208 with a different substitution ratio has a
surface tension of 50-56 mN/m (Doelker 1987).
Further insights into the surface activity of HPMC have been recently
provided by Perez et al. (2006). Surface pressure isotherms and
structural and surface dilatational properties at the air-water interface of
three grades of HPMC(Methocel E4M,E50LV,and F4M) were determined.
The three grades formed very elastic films at the air-water interface, even
at low surface pressures. E4M showed the highest surface activity, mainly
at low bulk concentrations. The differences observed in surface activity
may be attributed both to differential hydroxypropyl molar substitution
and molecular weight of different HPMCs. All grades formed films of
similar viscoelasticity and elastic dilatational modulus, which the authors
suggested was a result of their similar degree of methyl substitution.
1.3.3 Viscosity
Cellulose ether solution viscosity, in common with other polymer
solutions, is dependent primarily on molecular weight. This is controlled
by cleavage of the glycosidic bonds of polymer chains during manufacture,
which is achieved through control of exposure to air during processing.
Thuresson and Lindman (1999) have suggested that the viscosity of
cellulose ether solutions may be attributable to short term to polymer
entanglements and, in the longer term, strong associations between
unsubstituted regions of the native cellulose. These interactions are
thought to arise from strong hydrogen bonds between unsubstituted
hydroxyl groups in a manner similar to that which makes native cellulose
insoluble.
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1.4 Thermogelation and the sol:gel transition
Alkyl substituted cellulose ethers, including HPMC undergo the
phenomenon of thermo-reversible gelation. This occurs on heating of a
solution above a critical temperature (so-called "reversible thermal
gelation") and the influence of this transition on solution viscosity is
shown in figure 1.2. Initially, an increase in temperature results in a
decrease in the solution viscosity. However, as the solution temperature
continues to increase, polymer solution viscosity undergoes a marked
increase at reaching the incipient gelation temperature. Above this
temperature polymer chains associate through hydrophobic interactions
between regions highly substituted with methoxyl groups (Grover 1993).
This is thought to be as a result of dehydration of the hydration sheath
around the hydrophobic, methoxyl-rich regions of the cellulose backbone,
in comparison with regions relatively low methoxyl substitution (Haque et
al. 1993). These sites of intermolecular hydrophobic bonding form
"junction zones" resulting in the formation of a three dimensional gel
network of polymer chains (Sarkar 1979; Carlsson 1990).
This gelation phenomenon often results in phase separation, which is
thermo-reversible on cooling. Repeating the heating and cooling cycle has
no significant effect on gel or solution properties (Haque and Morris 1993;
Haque et al. 1993). Each grade of cellulose ether has a characteristic
thermal gelation temperature range as a result of the relative balance of
hydrophobic and hydrophilic substituents. Cellulose ethers with a high
content of hydroxyalkyl groups tend to have higher gel temperatures
whereas higher methoxyl substitution levels result in lower gel
temperatures (Sarkar 1979).
8
Chapter 1
'b 120
e
.v;
8
VI
s
200
160
80
40
o
Rate of Shear = 86 sec"
i
Incipient Gelation
Temperature
o 10 20 30 40 50 60 70
Ternperature.vc
Figure 1.2 Gelation behaviour of a 2%w /w aqueous solution of HPMC on heating
and cooling (Methocel E4M)
Adapted from Sarkar 1979.
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Recent spectroscopy advances have permitted further insights into the
gelation process. Banks et al. (2005) have used attenuated total reflection
Fourier transform infrared (ATR-FTIR) spectroscopy to probe the
behaviour of aqueous solutions of HPMC during the thermal gelation
transition. The relative intensities of bands associated with the methoxyl
groups and hydrogen-bond-forming secondary alcohol groups were found
to change during the gelation process, indicating the involvement of
hydrophobic polymer chain interactions. The dominance of inter-
molecular H bonding over intra-molecular H bonding within the cellulose
ether in solution was also observed.
1.4.1 Factors that affect the thermal gelation phenomenon
1.4.1.1 Molecular weight
There appears to be no relationship between the molecular weight of
HPMC and the thermal gelation temperature (Sarkar 1979). It has been
suggested (Sarkar 1979) that this may be a consequence of the purity of
HPMC samples with regard to their molecular weight. Variations in
molecular weight of HPMC samples are usually high and so a definitive
pattern of gelation temperatures may be difficult to detect.
1.4.1.2 Substitution
The degree and type of substitution has a significant role in thermal
gelation. In hydroxyethyl methylcellulose (HEMC), a high degree of
methoxyl substitution is necessary for gel formation to occur (Sarkar
1979). It is believed that methoxyl groups are responsible for gel
formation in HPMC with hydroxypropyl substitution significantly
modifying gel properties (Sarkar 1979). Increasing the degree of HPMC
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substitution leads to a decrease in gelation temperature, owing to an
increase in hydrophobic interactions at any given temperature (Sarkar
1995, Sarkar 1979). Increasing molar substitution of HPMC with
hydroxypropyl groups is thought to increase the gelation temperature as a
result of stabilising the interaction with water and making polymer chain
dehydration less favourable. Consequently, a greater heat input is
required to dehydrate the polymer and so bring about gelation (Haque et
al.1993).
1.4.1.3 Electrolytes and Sugars
When in solution, HPMC is a hydrated colloid and as such is susceptible to
"salting out" from solution above certain limits of electrolyte and sugar
concentrations (Heyman 1935; Sarkar 1979; Harsh 1991; Nakano et al.
1999). The process of "salting out" occurs as a result of competition for
water between the polymer and the other solutes present (Sarkar 1979).
The propensity of various ions to "salt out" cellulose ethers follows the
Hofmeister or lyotrophic series (Touitou and Donbrow 1982), although
for anions the trend is more complex (Mitchell et al. 1990; Melia 1991;
Nakano et al. 1999). More detailed consideration of the incompatibilities
between electrolytes and HPMC is provided in section 1.9.
1.4.1.4Surfactants
There is considerable evidence that surfactants interact with cellulose
ethers such as HPMC. The addition of sodium dodecyl sulphate (SDS) has
been shown to increase the cloud point of HPMC solutions, an effect that
equates to an increase in solubility of the polymer (Nilsson 1995). The
mechanism for this is thought to result from the solubilisation of the
methoxy rich "junction zones" that occur upon gel formation and precede
precipitation of the polymer on heating.
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Evertsson and Nilsson (1998) have studied the microviscosity of solutions
containing mixed micelles of SOS and cellulose ethers. A microviscosity
maximum generally corresponded to a low SOSadsorption and resultantly
high polymer content mixed micelles. The hydrophobicity of the cellulose
derivatives (EHEC,MC,HECand HPMC)was found to correlate with the
amplitude of the overall microviscosity pattern for the mixed micelles.
This is evidence that an increased polymer hydrophobicity produced
polymer-surfactant aggregates with increased rigidity. All
polymer/surfactant combinations investigated gave aggregates with a
higher rigidity than the micelles formed from SOS alone, attributed to
closer packing of the aggregate structures.
The nature of the counter-ion on the interaction between anionic
surfactants and cellulose ethers has been studied by Ridell et al. (2002).
They used fluorescence probes, microcalorimetry and dye solubilisation
to study the interaction between hydroxypropyl methyl cellulose (HPMC)
or ethyl hydroxyethyl cellulose (EHEC) and potassium, sodium, and
lithium dodecyl sulphates (KOS, NaOS, LiDS). It was found that the
counter-ion influenced the concentration at which the interaction began
as well as the nature of the mixed aggregates formed. The rank order was
found to be KOS < NaOS < LiDS for both HPMC and EHEC.
Microcalorimetry measurements confirmed surfactant adsorption onto
the polymer is initially endothermic and entropy driven and at a critical
level of cluster formation on the polymer chains the process converts to
an exothermic reaction, driven by both enthalpy and entropy.
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1.5 The application of HPMC in extended release drug
delivery
To provide a context for this research, HPMC application in extending
drug delivery will now be discussed.
1.5.1 Hydration of HPMC matrices and the mechanism of
controlling drug release
When exposed to an aqueous medium, HPMC hydrophilic matrices
undergo rapid hydration and chain relaxation (Colombo 1993) to form a
viscous gelatinous layer at the matrix surface. This is commonly termed
the 'gel layer'. This layer acts as a diffusion barrier, slowing water
penetration into the dry core of the matrix and thus preventing
disintegration (figure 1.3). Drug present on the surface of the tablet is
released as a burst as the gel layer is forming (Ford et al. 1985a) but it is
the physical characteristics of this 'gel layer' that control the subsequent
water uptake and drug release kinetics. If a properly functioning gel layer
is formed, drug release is reduced and the rate of release is dependent
either on the rate of diffusion through the gel (if the drug is freely soluble)
or the rate of mechanical removal and disentanglement of the external
surface of the gel layer if drug solubility is low.
Such is the crucial role that it has in understanding the mechanism of
controlled release from HPMC hydrophilic matrices, many studies have
investigated the formation and nature of the gel layer. It has been
suggested by several workers (Melia et al. 1992. [u et al. 1995) that three
distinct regions exist within the HPMCgel layer. These are: (i) a uniformly
hydrated gel/core interface, (ii) a non-uniformly hydrated region in the
13
Chapter 1
centre of the gel layer and finally (iii) the outer most edge of the gel layer
that consists of highly hydrated polymer. These theories on the gel layer
composition are supported by earlier studies by Melia et al. (1990) which
studied internal structure and relative levels of polymer hydration within
the gel layer using cryogenic scanning electron microscopy coupled with
energy dispersive x-ray microanalysis.
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1.6 Imaging the behaviour and gel layer of hydrophilic
matrix tablets
The formation and growth of the gel layer plays a significant role in the
overall process of prolonging drug release in hydrophilic matrix tablets.
Hence, an understanding achieved through imaging the formation of the
gel layer and dosage form swelling kinetics is of crucial importance in
producing an insight into the mechanisms underlying dosage form
performance. To achieve this, several different methods have been
employed to observe the behaviour of hydrophilic matrices during the
process of gel layer formation, erosion and dissolution.
Some of the earliest work in this area was carried out by Melia et al.
(1990). Using a combination of cryogenic SEMand energy dispersive X-
ray microanalysis, observation of a hydrated alginate-based hydrophilic
matrix tablet elucidated structural details and drug distribution within the
dosage form. Cryogenic SEMwas used to image the hydrated region of a
tablet section, while energy dispersive X-ray microanalysis was used to
locate the distribution of the model drug diclofenac within the gel layer.
The presence of undissolved particles and the observation of a drug
concentration gradient through the gel layer suggest a combined drug
release mechanism of diffusion and polymer relaxation (erosion).
In a different investigation (Mitchell et al.. 1993a), two methods were used
to measure the expansion of hydrating HPMC tablets: (a) a
thermo mechanical probe and (b) the position of a projected laser beam
either side of the matrix. Despite no difference in the release of the model
drug propranolol from matrices composed of different HPMC grades, it
was observed that the amount of axial swelling was dependent on the
HPMCgrade and that axial swelling was greater than radial swelling.
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Other workers have used penetrometers. The first work in this area was
carried out by Conte and Maggi (1996), who used a penetrometer
attached to a texture analyser and video microscope to analyse the gel
layer thickness of hydrating Geomatrix tablets. It was found that results
obtained using each technique were similar and that the effect of a rate
controlling barrier on one or two surfaces of the tablet could be
demonstrated. A disadvantage of the technique was a destructive
sectioning procedure that was required prior to data acquistion,
preventing an in situ gel layer analysis.
A penetrometer has been used alongside backscattered ultrasound by
Konrad et al. (1998) to measure the position of the gel layer/hydrating
media interface, the so-called 'erosion front'. Although both methods
produced similar results, the non-destructive nature of the ultrasound
technique makes it preferable. There were a number of limitations with
this method. The swelling of the tablet could only occur in one plane
owing to the special cylinder the tablets were held in and it was not
possible to measure the glassy core/rubbery gel interface.
Colombo et al. (1993) have calculated releasing surface areas of hydrating
matrices by taking photographs at various time points during dissolution.
By modifying the swelling behaviour and drug release by coating the
tablet surfaces with an impermeable polymer it was shown that drug
release was directly dependent on the available surface area. Further
work in this area was carried out by Bettini et al. (1994) who imaged
HPMC tablets held in position between two Plexiglas discs in order to
analyse drug release and surface area with respect to time. Investigation
into the movement of internal fronts was carried out within the same
group using the apparatus (Colombo et al. 1995; 1996; 1999a, b). This
involved the use of a model drug, buflomendil pyridoxalphosphate (BPP),
which is a yellow solid and produces an orange solution. The use of this
model drug allowed the observation of three distinct fronts during the
17
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swelling process. These were interpreted by Colombo as: (i) the swelling
front, which is the boundary between the glassy polymer and the rubbery
gel state, (ii) the diffusion front, which is the interface between the solid
drug in the core and the dissolved drug in the gel layer and finally (iii) the
erosion front, which is the outermost radial front and forms the boundary
between the gel layer and the outside hydrating medium. Figure 1.4
shows a series of images of the matrices containing different percentages
of BPP (w/w). They were taken after 120 minutes of swelling.
18
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Figure 1.4 Images of HPMC matrices containing different percentages of
buflomendil pyridoxalphosphate BPP (wjw) taken after 120 minutes of swelling
(from Colombo et al. 1999)
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Gel layer growth in hydrating HPMCtablets has been examined by nuclear
magnetic resonance (NMR)microscopy by Rajabi-Siahboorni et al. (1994).
NMRmicroscopy does not require physical sectioning of the tablet, so is
non-destructive like some other imaging techniques. One of the key
findings from this work was the observation that gel layer growth is
similar in both the axial and radial directions and the greater overall tablet
growth is in the axial direction, caused by axial expansion of the dry core.
NMR microscopy has also been used to image the disruption of the gel
layer caused by incompatibilities with the model drug diclofenac and the
observation of insoluble excipient particles in the gel layer (Bowtell et al.
1994). Figure 1.5 shows a vertical section through a hydrating Methocel
K4M hydroxypropylmethylcellulose matrix that reveals the unusual
concave development of gel growth in the axial direction. Water mobility
has also been measured using NMRmicroscopy (Rajabi-Siahboomi et al.
1996). It has been shown that a water concentration gradient exists
across the gel layer, with the highest level of hydration at the outer
regions of the gel.
Another paper by Fyfe and Blazek-Welsh (2000) has exploited one
dimensional 19F NMR imaging to follow the release of two model drugs
containing fluorine: triflupromazine and S-fluorouracil. It was shown that
the two compounds diffused through the gel layer at different rates and
that this was the reason for variation in the dissolution rates.
Matrix tablets were physically sectioned using a two blade knife by
Moussa and Cartilier (1996). This destructive technique was able to
elucidate the causes of observed differences in drug-release rates from
cross-linked amylase matrices by demonstrating that rate of water
penetration was dependent on the degree of cross-linking.
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Figure 1.5 Vertical section through a hydrating Methocel K4M hydroxypropyl
methylcellulose matrix
The image reveals the unusual concave development of gel growth in the axial direction.
[a] 10 min, [b] 30min exposure to distilled water. From Bowtell et al. 1994.
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Confocal laser scanning microscopy (CLSM)has also been utilised in the
study of gel layer formation and growth. Adler et al. (1999) produced a
tablet hydration cell that held either an intact tablet flat to enable imaging
of radial swelling or a halved tablet to image axial and radial swelling. By
using fluorescent microspheres as non-diffusing makers and tracking their
movement through a time series of CLSM images, it was possible to
quantitatively map the pattern of internal swelling within the gel layer.
Melia et al. (1997) in an early study showed how CLSMalong with a
fluorescent marker Congo red could be used to observe the expansion of
the gel layer in tablet formulations containing HPMC. Only radial swelling
was observed through the limitations of the cell geometry.
These studies have been advanced by the development of a real-time
confocal fluorescence imaging method which allows the critical early
stages of gel layer formation in HPMCmatrices to be examined (Bajwa et
al. 2006). Congo Red, a fluorophore whose fluorescence is selectively
intensified when bound to beta-D-glucopyranosyl sequences, allows
mapping of hydrated polymer regions within the emerging gel layer, and
revealed, the microstructural sequence of polymer hydration during
development of the early gel layer. The earliest images revealed an initial
phase of liquid ingress into the matrix pore network, followed by the
progressive formation of a coherent gel layer by outward columnar
swelling and coalescence of hydrated HPMC particles (figure 1.6). Gel
layer growth in 0.1-0.5 MNaClwas progressively suppressed until at 0.75
M, particles clearly failed to coalesce into a gel layer, although with
considerable polymer swelling. The failure to form a limiting diffusion
barrier resulted in enhanced liquid penetration of the core, and the
swelling of particles that did not coalesce culminated in surface
disintegration.
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Figure 1.6 Time series of fluorescence images in situ of a hydrating HPMCmatrix in
aqueous 0.008% w [v Congo Red.
The images are coded for fluorescence intensity from white (highest) to black (lowest) as
indicated by the wedge. The bright regions indicate areas of high fluorescence,
highlighting regions of polymer hydration where the fluorophore has penetrated.
Hydration medium maintained at 37°C. Ex 488/E >510 nm. Scale bar =750 11m.(from
8ajwa et al. "Microstructural imaging of early gel layer formation in HPMC matrices."
(2006)
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Studies of the front movement have been undertaken by Vlachou et al.
(2005) using an optical analysis technique. The measurements made of
tablets comprising of HPMC alone and with the addition of two model
drugs, furosemide and diclofenac, allowed investigation of the progress of
the swelling/release processes. It was observed that diclofenac, with
twice the solubility of furosemide, caused twice the increase in the
dimension of the gel layer and twice the percentage of drug release.
Furthermore, with the drug of lower solubility the diffusion front
converges with the erosion front, increasing the dimension of the diffusion
layer. It was suggested by the authors that diclofenac was released by a
combination of diffusion and matrix erosion, whereas furosemide was
released by erosion alone.
Kowalczuk et al. (2004) have used magnetic resonance imaging (MRI) to
study the behaviour of the gel layer thickness in HPMC matrices with
different loadings of a soluble drug tetracycline hydrochloride. The
swelling properties were described in terms of the solvent penetration
front. It appeared that tetracycline hydrochloride decreases the
resistance to movement of solvent molecules through the gel network
structure and that swelling of the matrix increased with the amount of
drug present.
Baumgartner et al. (2005) have used MRI in combination with NMR
spectroscopy to investigate the in situ swelling behaviour of cellulose
ether matrix tablets and to quantify the polymer concentration across the
gel layer. Combining the proton NMR relaxation parameters of the
polymer solutions with the MRI data facilitated a quantitative description
of the swelling process on the basis of the concentrations and mobility of
water and polymer as functions of time and distance. The different
concentration profiles observed after determined swelling times were
found to be the consequence of the different polymer characteristics.
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Using a similar rationale of combining spectroscopy and imaging,
Dahlberg et al. (2007) have investigated the swelling characteristics of an
HPMCmatrix containing the hydrophilic drug antipyrine. MRI revealed
the swelling behaviour of matrices when exposed to water whilst NMR
spectroscopy provided the concentration of the drug released into the
aqueous phase. In agreement with other studies, the authors concluded
both swelling and drug release are diffusion controlled.
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1.7 Physicochemical factors affecting drug release
The principal factors that have been proposed to affect the release of
drugs from HPMChydrophilic matrices will now be discussed.
1.7.1 Polymer factors affecting drug release
1.7.1.1 Polymer hydration rate
It has been suggested that gel layer formation must occur more rapidly
than the dissolution rate of both the drug and other excipients in order for
sustained release to be achieved (Alderman 1984). Investigating the
effect of substitution type on drug release, Alderman also found that in
tablets containing 85% spray dried lactose. 10% HPMCpolymer and 5%
Riboflavin, only the "fastest-hydrating" polymers such as HPMC 2208
(Methocel™ type K) provided sustained release. The relative rate of
hydration of HPMCpolymers was thought to be related to the amount of
hydrophilic hydroxyl (and hydroxypropoxy) substituents on the cellulose
backbone (Alderman 1984). Alderman's matrices however, contained an
unusually low content of HPMC and this may have exaggerated the
observed effects.
At higher HPMC levels, Mitchell et al. (1993a) found no relationship
between proposed hydration rates of HPMCgrades. and the release rate of
drugs from matrix tablets. The authors attributed the different release
rates described by Alderman to the differing tablet formulations. Rajabi-
Siahboomi et al. (1993) investigated the swelling and hydration rate of
different HPMCgrades using lH-NMRmicroscopy and like Mitchell et al.
(1993) found no relationship between Methocel" grade and hydration
rate.
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1.7.1.2 Polymer substitution levels
The release rate of a drug from a matrix tablet has been shown to increase
with increasing hydroypropyl content (Dahl et al. 1990). The authors
attributed this to HPMC particle domains becoming more amorphous.
Polymers possessing greater amorphous than crystalline regions are likely
to exhibit enhanced dissolution rates (Dahl et al. 1990). Haque and Morris
(1993b) reported that as the hydroxypropyl content of HPMC was
increased, a weaker gel was formed and as a result, the gel layer may
become more susceptible to erosion leading to faster drug release
kinetics.
1.7.1.3 Polymer concentration
Many reports have shown that as the concentration of polymer in a matrix
increases, a reduction in drug release rate is observed (Alderman 1984,
Dabbagh et al. 1999, Gao et al. 1996) and some have proposed that the
drug:polymer ratio is the most influential variable controlling drug release
(Ford et al. 1985, Ford et al. 1987). This reduction in drug release rate has
been attributed to reduced erosion of the gel layer and an increase in the
drug diffusion path length and the tortuosity of the molecular
environment (Alderman 1984, Mitchell et al. 1993b, Velasco et al. 1999).
However, Gao et al. (1995a, b) have attributed the reduction in drug
release to an exponential reduction in the diffusion coefficient of drugs as
the concentration of HPMCincreased, measured by 1H-NMRspectroscopy.
It is probable that the reduction in drug release rate is the result of a
combination of these factors.
In contrast to these findings, Campos-Aldrete and Villafuerte-Robles
(1997) found that the relationship between viscosity grade of HPMCand
drug release rate only occurred in matrices containing 10% HPMC. At
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HPMCcontents of 20 and 30% no significant relationship was found. Wan
et al. (1993) reported that as the HPMCcontent of matrices was increased
from 5% to 10%, ibuprofen release changed from zero order drug release
kinetics to a Higuchi release mechanism. Increasing the polymer content
further lead to a reduction in the release rate, however the release
mechanism did not change.
1.7.1.4 Polymer viscosity
The molecular weight of the HPMCpolymer, and therefore the apparent
polymer viscosity, is an important factor in determining drug-release
properties (Alderman 1984, Li et al. 2005). It is generally accepted that
drug dissolution is slower from matrices comprising of a higher molecular
weight HPMC, which would produce a gel layer with greater viscosity,
resultantly more tortuous and with greater resistance to the forces of
erosion (Alderman 1984, Sung et al. 1996 and Velasco et al. 1999).
Mitchell and Balawinski (2008) have investigated the drug release rate
variability from typical controlled release formulations over several HPMC
viscosity ranges. Using pentoxifylline, theophylline, and
hydrochlorothiazide as model drugs they predicted that drug release
variability over the viscosity ranges would be greatest for the lower
viscosity grades, such as ESO and KlOO LV. It was proposed that drug
release variability due to viscosity variations would be expected to be
larger when there is substantial erosion contribution to drug release. and
smaller for formulations with a predominantly diffusion controlled drug
release mechanism.
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1.7.1.5 Polymer particle size
HPMC particle size has been found to have a considerable influence on
extended release rates. It has been demonstrated [Campos-Aldrete and
Villafuere-Robles 1997) that, at low polymer content «30%), drug release
rate increased when HPMCparticle size increased. The HPMCcontent at
which particle size is less important varies between 30% and 45% in the
literature.
Heng et al. (2001) have studied the effects of different HPMCparticle size
ranges on the release behaviour of aspirin from a matrix tablet. A critical
threshold was identified at a mean HPMCparticle size of 113 urn as the
release mechanism deviated from first order kinetics above this mean
particle size. Polymer fractions with similar mean particle size but
differing size distribution were also observed to influence drug release
rate but not release mechanism. The first order release constant Kt was
found to be related to the reciprocal of the cube root of both mean
polymer particle size and number of matrix polymer particles.
Mitchell and Balwinski (2007) have investigated the influence of particle
size by selecting combinations of six model drugs and four HPMC (USP
2208) viscosity grades. HPMC samples with different particle size
distributions (coarse, fine, narrow, bimodal) were generated by sieving.
For some formulations, the impact of HPMC particle size changes was
characterized by faster drug release and an apparent shift in drug release
mechanism when less than 50% of the HPMCpassed through a 230 mesh
(63 urn) screen. Within the ranges studied, drug release from other
formulations appeared to be unaffected by HPMCparticle size changes.
The effect of particle size ratios of HPMCand API has been investigated
with respect to percolation thresholds (Fuertes et al. 2006, Miranda et al.
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2006, Miranda et al. 2006). In one study (Fuertes et al. 2006) matrices
were prepared using acyclovir and HPMC Methocel K4M using five
different excipient/drug ratios. According to percolation theory, the
critical points observed in dissolution and water uptake studies can be
attributed to the percolation threshold of the excipients. It was found that
this threshold was between 20.76% and 26.41% v/v of excipient plus
initial porosity. This conclusion was supported by investigations of
different matrix systems containing potassium chloride (Miranda et al.
2006a) and lobenzarit disodium (Miranda et al. 2006b) respectively.
1.7.1.6 Polymer surface properties
Sasa et al. (2006) have investigated the correlation between the surface
properties of cellulose ethers and the mechanisms of water-soluble drug
release from hydrophilic matrices. Using inverse gas chromatography
(IGC), it was found that the differences in the surface free energy of HPC,
HEC or HPMC were relatively small. However, there were significant
differences in relative polarity in the order HEC > HPMC > HPC. This
correlated with water sorption and the degree of polymer matrix swelling.
It was concluded that the surface properties of the cellulose ethers may
influence their interaction with water and subsequently the release
mechanisms of the drug from matrix devices.
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1.7.2 Non-polymer factors affecting drug release
1.7.2.1 Drug factors
Drug release from HPMChydrophilic matrices may also be influenced by
the physical properties of the drugs included in the formulations. Several
reports have investigated the effect of drug particle size on release rates.
Ford and co-workers (Ford et al. 1985a,b,c) have found that the effect of
particle size of water-soluble drugs (promethazine hydrochloride,
propranolol hydrochloride and aminophylline) on the release rate from
HPMC tablets was only evident at low HPMC contents and when the
particle size was large. However, for a poorly soluble drug such as
indomethacin, a particle size increase resulted in a decrease in the release
rate. It was proposed that the reduced release rate was simply the result
of slower dissolution of large particles as the drug surface area to volume
ratio decreased.
In contrast, Velasco et al. (1999) found that the particle size of diclofenac
Na had no effect on the drug release rate at low HPMCcontents, whereas
at higher HPMCcontent an increase in the release rate was noted as the
particle size was increased. No rationale for these findings was offered.
Drug solubility is an important factor affecting drug release from HPMC
matrices. The mechanism by which soluble drugs are released from HPMC
matrices is considered to be Fickian diffusion, whereas poorly soluble
drugs are released mainly by gel layer erosion. Using the optical method
first described by Colombo et al. (1995), Bettini et al. (2001) studied the
effect of drug solubility on release rates using drugs with a range of
aqueous solubility. The rate and amount of drug released from K100M
was found to be dependant on drug solubility. A shift of undissolved drug
particles from the swelling front of the matrices to the eroding front of the
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gel layer was observed and the process was termed "drug particle
translocation". It was proposed that drug particle translocation occurred
as a result of the spring-like action of macromolecular chains upon
transition from the glassy to the rubbery state. Similar observations were
reported by Adler et al. (1999) for insoluble beads in swellable polymers.
The rate of poorly soluble drug release has been shown to increase on
complete hydration of the matrix core (Bettini et al. 2001). This was
thought to be the result of drug particles reducing the entanglement of the
polymer chains, increasing gel layer erosion rate. This was manifested in
dissolution profiles as an inflection and was more pronounced as drug
solubility decreased. Jayan et al. (1999) noted an increase in release rate
of hydrochlorothiazide from mixed HPMC: PEO matrices upon complete
hydration of the core.
Gafourian et al. (2007) have characterised the effect of chemical structure
on the release of drugs from HPMC 2910 and 2208 matrices using a
quantitative-structure-property relationship (QSPR) technique. Structural
descriptors including molecular mechanical, quantum mechanical and
graph-theoretical parameters, as well as the partition coefficient and the
aqueous solubility of the drugs were used to establish relationships with
release parameters. The aqueous solubility and molecular size of the
drugs were found to be the most important factors for both HPMC2208
and 2910 matrices.
1.7.2.2 Lubricants
Magnesium stearate is commonly used as a lubricant for formulations.
The hydrophobic nature of magnesium stearate may have implications for
tablet wetting and tensile strength and as a result may affect drug release.
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Investigations by Rekhi et al. (1999) found that magnesium stearate
content up to 2% w/w had no effect on drug release rates.
Sheskey et al. (1995) also found that the effect of magnesium stearate
content between 0.2 and 2% had no effect on drug release. It is probable
that at higher concentrations, magnesium stearate would cause a
reduction in tablet tensile strength and drug release may be increased.
1.7.2.3 Drug-release modifiers
1.7.2.3.a pH modifying excipients
Drug solubility is a key determinant of release in these dosage forms and,
when drug solubility is pH-dependent, the changing pH environment
along the gastro-intestinal tract may give rise to poor drug solubility and a
change in release mechanism (Badawy and Hussain, 2007). The most
common examples are weakly basic drugs, which have high solubility in
the stomach but are poorly soluble at the neutral pH of the duodenum. A
common approach is to maintain the drug in its soluble form by
incorporating pH-modifying excipients in the matrix with the release of
weakly basic drugs commonly improved by the inclusion of weak acids or
acidic polymers [Gabr, 1992, Thoma and Ziegler, 1992, Streubel et al,
2000, Espinoza et aI, 2000, Varma et al. 2005, Kranz et al. 2005, Siepe et al.
2006).
Streubel et al. (2000) have investigated the release of verapamil
hydrochloride from HPMCmatrix tablets. They evaluated the effect of
incorporating various acids into the matrix system. All three acids tested
(fumaric, sorbic and adipic) resulted in Significant increases in drug
release in pH 6.8 and 7.4 phosphate buffers. Fumaric acid was more
effective than the other acids in enhancing drug release and exhibited a
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release profile that almost overlapped those in pH 1.2. The lower pKa of
fumaric acid was proposed to provide a lower pH within the matrix.
Release profiles were also shown to be independent of the amount of
fumaric acid in the formulation.
Citric acid has been used to modify the release of pelanserin, a weakly
basic drug with a short half-life, from an HPMCformulation (Espinoza et
al. 2000). Dissolution studies were carried out in pH 1.2 for the first 3 h,
and phosphate buffer pH 7.4, h 3-8. Increasing concentrations of citric
acid produced increasing values of the kinetic constants, in a cubic
relationship. Higher HPMCproportions produced slower dissolution rates
but with a citric acid compensating more clearly a decreased solubility of
pelanserin at pH 7.4.
1.7.2.3.b. Other polymers
A number of workers have investigated tailoring release profiles from
HPMC matrices by incorporating other polymers into the hydrophilic
matrix. Examples have included anionic polymers, other natural based
polymers and synthetic polymers.
Anionic polymers such as Eudragit S, Eudragit L 100-55 and sodium
carboxymethylcellulose have been incorporated into HPMC K100M
matrices to modify the drug release (Takka et al. 2001). The effects of
changing the ratio of HPMC to the anionic polymers were examined in
water and different pH media. The interaction between propranolol
hydrochloride and anionic polymers was confirmed by UV spectral
subtraction. Drug release was controlled with the type of anionic polymer
and the interaction between propranolol hydrochloride and anionic
polymers. The HPMC-anionic polymer ratio was also found to influence
the drug release.
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Hardy et al. (2007) have investigated the effect of the binder polyvinyl
pyrrolidone (PVP) incorporation on the release of the water soluble drug
caffeine from HPMC matrices. Mechanistic studies using gel rheology.
excipient dissolution and near-infrared (NIR) microscopy were used to
investigate the underlying drug release mechanism. It was shown that
drug release was modulated by a HPMC viscosity reduction which
occurred at a critical concentration of PVP. This resulted in a break-up of
the extended release tablet.
Feely and Davis (1988) investigated the effects of the ionic polymers
diethylaminoethyl dextran (cationic) and sodium carboxymethylcellulose
(NaCMC) (anionic). and the non-ionic polymer polyethylene glycol (PEG)
6000 and the hydrophobic polymer ethylcellulose, on HPMC matrices.
They reported that non-ionic polymers were no more effective than HPMC
itself. whilst ionic polymers had a slight effect in retarding the release of
oppositely charged drugs.
Conti et al. (2007) have used HPMC and NaCMC in combination as
polymeric carriers. In vitro release studies demonstrated how the mixture
enabled a better control of the drug release profiles at pH 4.5 and at 6.8
both in term of rate and mechanism. The results suggested that the two
cellulose ethers used in combination form a gel. which is less susceptible
to erosion and chain disentanglement and the drug release mechanism is
mainly governed by diffusion.
1.7.2.3.c Cyclodextrins
The effect of cyclodextrin (CD) incorporation into HPMCdosage forms has
been investigated by a number of authors.
A study by Savolainen et al. (1998) investigated the effect of various CDs
on the bioavailability of glibenclamide when formulated with HPMC in
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solution. It was found that the incorporation of HPMC in the solution
enhanced the solubilising effects of the CDs, reducing the levels required.
No mechanism for this effect was offered.
Koester et al. (2004) have evaluated the effect of ~-cyclodextrin
incorporation by mixing or complexation in a hydrophilic matrix
containing carbamazepine and HPMC. It was found that the rate of drug
release was increased when the drug was complexed with the CD rather
than simply mixed. The methods of drying the complex; spray drying and
freeze drying, had no effect when 30% HPMCwas used in the formulation
but there was significant impairment of gelling and matrix formation at
15% HPMCwhen complexes were spray dried.
Pose-Vilarnovo et al. (2004) have explored the effects of ~-cyclodextrin
and hydroxypropyl-~-cyclodextrin on the diffusion and release behaviour
of dicIofenac sodium and sulphamethizole from HPMC gels and matrix
tablets. Gels of concentration 0.5-2.0% polymer containing different
drug/Cl) mole ratios showed no effect on cloud point while diffusivity
from the gels appeared to be increased, owing to a reduction in
polymer/drug hydrophobic interactions.
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1.8 Interactions between non-ionic cellulose ethers and
pharmaceutical and other additives
During the development of a successful hydrophilic matrix extended
release formulation, interactions between individual formulation
components and those in dissolution media need to be determined, and
where they cause a problem, overcome. This section considers literature
pertaining to the interactions and incompatibilities of cellulose ethers
with drugs, electrolytes, surface active materials and other excipients.
Often, a precise mechanism by which these interactions occur is poorly
understood and in the absence of conclusive experimental evidence the
theories are speculative.
1.8.1Incompatibilities with electrolytes
Originally, it was thought that electrolytes depress the solubility of
cellulose ether solutions due to their greater affinity for water, and the
order of potency follows that of the Hofmeister lyotropic series. Touitou
and Donbrow (1982) proposed that the mechanism by which ions reduce
the sol:gel phase transition temperature is by removing water from the
hydration sheath surrounding the hydrophobic groups of the polymer and
hence lowering the temperature by which hydrophobic interactions of the
gel state become favourable. However, recent advances in our
understanding of Hofmeister effects and how these relate to the
interactions between ions and macromolecules have suggested that ions
do not affect bulk water properties but may directly interact with the
hydration sheath macromolecule (Zhang and Cremer 2006). This is based
on the experimental observations that (i) anions have no effect on
hydrogen bonding network outside their immediate vicinity (Omta et al.
2003), [ii] no thermodynamic changes in bulk water surrounding species
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were observed using pressure perturbation calorimetry (Batchelor et al.
2004) and (iii) physical behaviour in Langmuir monolayers is only
disrupted by direct penetration of ions rather than changes in the
properties of the bulk water (Gurau et al. 2003).
It is well established that certain phenolic preservatives including
chlorocresol, p-hydroxybenzoic acid, p-aminobenzoic acid and
chlorophenol are incompatible with MC (Martindale 1996). This
incompatibility was investigated by Tillman and Kuramoto (1957) who
reported that the phenolic compounds formed an insoluble complex with
methylcellulose and that their effect was associated with a decrease in
solution viscosity. It was proposed that the complex was formed by
hydrogen bonding between the hydroxyl groups of phenol and MC.
However, it was noted that the viscosity of MCsolution was not affected
by the presence of other preservatives such as sodium phenoate, sodium
benzoate, benzoic acid, pyridine or aniline hydrochloride.
Mitchell et al. (1990) found that the ability of salts to lower the cloud point
of HPMCgels followed their order in the lyotropic series, i.e. chloride <
tartrate < phosphates and potassium < sodium. They also found that
anions had greater influence than cations in lowering the cloud point.
Phosphate and chloride salts were found to influence the dissolution of
propranolol hydrochloride from HPMCmatrices with an increase in ionic
strength decreasing dissolution rates to a minimum before the occurrence
of a 'burst' (immediate) release. Disintegration times of HPMCmatrices
without API also varied with respect to the ionic strength of the
disintegration medium.
Kajiyama et al. (2008) have studied the effects of inorganic salts on
disintegration of HPMCmatrices. The disintegration time was reduced by
the addition of NaHC03, KHP04. K2S04. KCI, or NaCI. Conversely. the
38 •
Chapter 1
addition of Na2C03or Na2S04had no effect on disintegration. It was found
that there was a reduction in disintegration time when the heat of
dissolution of inorganic salts was endothermic whereas no effect was
observed when it was exothermic. These results suggested that the
thermal environment and ionic strength inside the tablet might affect the
disintegration of HPMCmatrix tablets.
Liu et al. (2008) have used micro-differential scanning calorimetry (m-
DSC)and rheological measurements to study the effects of inorganic salts
on the thermal gelation behaviour of HPMC. The salts included
monovalent (NaCt KCI.NaBr. and NaI). divalent (Na2HP04. K2HP04.and
Na2S04). and trivalent (Na3P04) species. It was found that the
effectiveness of anionic species in changing the maximum heat capacity
(T) of the HPMCsolutions followed the Hofmeister series.
Organic ions such as amino acids have been found to influence HPMC
gelation temperatures. Richardson and co-workers (2006) have studied
the effect of an L-amino acid series on the phase transition temperature of
1% w/w HPMC solutions. The ability to raise or lower the transition
temperature was critically related to amino acid hydrophobicity. Smaller
and more hydrophilic amino acids reduced the phase transition
temperature, whereas large hydrophobic aromatic amino acids increased
it. It was proposed that the effects of amino acids are a balance between
the ability of their hydrophilic regions to dehydrate and disrupt the
polymer hydration sheath, and the ability of their hydrophobic regions to
associate with and solubilise methoxyl-dorninated regions of the polymer
in a manner analogous to that of surfactant systems.
1.8.2 Interactions with surfactants
Interactions between surface active agents and various polymeric
materials have been the focus of a wide-range of research within many
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different industries, including the cosmetic, oil recovery, food and
pharmaceutical areas. This is a result of the possibility of interactions
significantly affecting the properties of polymer in solutions.
The addition of a surfactant to an aqueous solution of a hydrophobically
modified polymer usually leads to a viscosification of the solution at a
moderate level of surfactant addition. In a pharmaceutical context, this
may have significant impact on the behaviour of dosage forms containing
hydrophobically modified polymers such as HPMC
Nilsson (1995) studied the interactions between HPMCand SDS in water
using viscometry, equilibrium dialysis, cloud point determinations, dye
solubilization, and fluorescence spectroscopy. He proposed that SDS
adsorbs in a cooperative manner as molecular clusters, forming small
micelles which solublise the hydrophobic regions of the HPMC polymer
chain. This increases the polymer solubility and raises the cloud point
temperature. Important rheological effects such as high viscosity are
observed over a fairly limited composition range beginning at the onset of
adsorption and ending long before adsorption saturation is reached. The
maximum capacity of adsorption in HPMCwas found to be of the order of
one adsorbed amphiphile molecule per polymer monomer unit.
Kulicke et al. (1998) have investigated the behaviour of aqueous solutions
of three highly substituted, hydrophobic HPMCin mixtures containing the
anionic surfactant sodium lauryl sulfate (SLS). In the absence of anionic
surfactant, the aqueous HPMC solutions showed predictable polymer
solutions flow behaviour. The most hydrophobic HPMCdisplayed clearly
the effects of an SLS-dependent viscosity increase and the appearance of
dilatant flow. At constant HPMCconcentration (0.5% w/w), a fifteen-fold
increase in viscosity was observed in the critical micelle concentration
range for SLS.
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Wittgren et al. (2005) have used size exclusion chromatography (SEC)
with online multi-angle light scattering (MALS) and refractometric index
(RI) detection to characterise the surfactant-polymer interaction between
various cellulose derivatives including HPC, HPMC and HEC and the
surfactant sodium dodecyl sulphate (SOS). The more hydrophobic HPC
and HPMC adsorbed surfactant to a significantly greater extent than HEC.
The inter-chain interactions at compositions close to the critical
aggregation concentration (CAC) were clearly seen for HPC and HPMC as
an almost two-fold average increase in the apparent molecular mass of the
complex.
Sovilk and Petrovic (2006) have used conductivity, viscosity and
rheological measurements to study the interaction of HPMC with the
anionic surfactant SOS in aqueous solutions. The concentration of SOS at
which interaction starts (the critical aggregation concentration (CAC)) and
at which it ends (polymer saturation point (PSP)), were determined, and
an interaction mechanism was proposed. The linear relationship was
found between the PSP and HPMC concentrations, while CAC remained
constant. In addition, it was found that stability of the emulsions was
influenced by the HPMC-SOS interaction.
1.8.3 Interactions with drugs
There have been several reports of drugs influencing the physiochemical
properties of non-ionic cellulose ether solutions. Generally, the studies
have lacked a detailed mechanistic explanation.
The effects of nicotinamide on the properties of aqueous HPMC solutions
were studied by Hino and Ford (2001). Nicotinamide exhibited a 'salting
in' effect on the HPMC solutions resulting in an increase in gelation
temperature and cloud point temperature (CPT). Hino and Ford (2001)
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proposed that these effects were due to the hydrogen-bonding of
nicotinamide to the HPMC,which was suggested by a shift to a longer
wavelength of the UVspectra of nicotinamide solutions on the addition of
HPMC.
The aqueous interaction of ibuprofen sodium with the cellulose ethers
ethyl hydroxyethyl cellulose (EHEC) and HPMC,has been investigated by
cloud point, capillary viscometry, equilibrium dialysis, and fluorescence
probe techniques (Ridell et al. 1999). Fluorescence and microviscosity
measurements showed that ibuprofen is an amphiphilic drug which
formed micelles in pure water. At the critical micelle concentration (CMC)
of the drug, a marked increase in the CPT of the cellulose ethers was
reported. It was postulated, that above the CMC,micelles of ibuprofen
solubilise the hydrophobic parts of the polymer, and therefore increase
the polymer hydration and the CPT(Ridell et al. 1999).
Mitchell and co-workers (Mitchell et al. 1990, Mitchell et al. 1991) have
examined the effect of drugs on the thermal properties of HPMCsolutions.
Propranolol hydrochloride and promethazine hydrochloride increased the
CPT of HPMC with this effect more prominent at higher drug
concentrations. Promethazine is amphiphilic and forms micelles at
concentrations greater than 0.5% w[v, Propranolol hydrochloride is
weakly surface active, therefore the response of HPMCin the presence of
these drugs may be associated with the surface activity of this drug.
Aminophylline and tetracycline gave straight line relationships between
their concentration in solution and the observed CPT. Quinine bisulphate
and theophylline did not affect the CPT. It was suggested that the
hydrating effect of the quinine molecule was counteracted by the
dehydrating effect of the sulphate ions.
Touitou and Donbrow (1982) utilised the viscosity-temperature curve to
examine the effect of drugs on the sol:gel transition temperature of MC.
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Potassium phenoxypenicillin and chlorpheniramine maleate raised the
sol:gel transition temperature and this effect was explained on the basis
that the drugs are adsorbed onto the macromolecule, carrying with them
water molecules and raising the degree of hydration of the polymer. The
failure of compressed matrices of MCcontaining these drugs to undergo
attrition or disintegration, unlike the matrices from which these agents
were absent, suggests that these drugs stabilised the gel layer of these
matrices. Reduction of the gel point by salicylic acid may be as a result of
formation of a low solubility complex with the macromolecule (Touitou
and Donbrow 1982).
Katzhendler et al. (1998 and 2000) have investigated the interactions of
HPMC with naproxen sodium and carbamazepine. Using differential
scanning calorimetry (DSC), it was found that addition of naproxen
sodium increased the fraction of bound water in HPMC 2208 solutions
from 1.5 water hydration layers to 2.2. This was explained by water
ordering as a result of naproxen sodium adsorbing onto the polymer
backbone. In the same study, the viscosity of HPMC 2208 solutions
containing naproxen sodium was found to be lower than solutions
containing the free acid or no drug.
McCrystal and co-workers (McCrystal et al. 1999a, McCrystal et al. 1999b)
have also used DSCto investigate the effect of propranolol hydrochloride
and diclofenac sodium on the distribution of water in HPMCgels. The
moles of bound water per polymer repeating unit increased with
diclofenac sodium, whereas propranolol hydrochloride had no effect.
They suggested that diclofenac sodium 'salted-out' the polymer, reducing
its solubility.
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1.9 Aims and objectives of this PhD thesis
As has been presented and discussed in this introduction, there is
considerable evidence in the literature that the physicochemical
properties of HPMCand its performance in extended release hydrophilic
matrices can be modified by additives, including salts, surfactants and
commercial drugs. To facilitate formulation development, it is essential to
achieve a level of understanding of the fundamental interactions between
polymer, drugs and incorporated diluents and the macroscopic
manifestation of these effects with regard to the morphology, structure
and functionality of hydrophilic matrix gel layer.
1.9.1 Principal Aim
The purpose of this thesis is to identify and probe critical processes in
drug release from HPMChydrophilic matrices, primarily by studying the
interactions of drugs with HPMCin the context of colloidal science and the
macroscopic pharmaceutical consequences of these interactions using a
suite of experimental and imaging techniques. Subsequent efforts will
attempt to reconcile effects of the former to changes in the latter.
1.9.2 Approach
To accomplish the above principal aim, the work will be divided into the
following key areas:
Chapter 2: A critical analysis of a previous study into the release of drugs
from hydrophilic matrices with an interpretation with respect to possible
molecular interactions.
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Chapter 4: An investigation into the effect of non-steroidal anti-
inflammatory drugs on HPMC solution properties and probing of the
molecular basis of the interactions.
Chapter 5: The effect of drugs on early gel layer formation and the
subsequent properties of a hydrophilic matrix comprising of HPMC.
Chapter 6: The effect of soluble and insoluble diluents on the early gel
microstructure and the subsequent properties of hydrophilic matrices
Chapter 7: The interactive effects of incorporated drugs and diluents on
the morphology and functionality of the nascent HPMCgel layer.
The specific aims and objectives in each of these chapters may facilitate
insight into some of the critical processes that are involved in drug release
from HPMChydrophilic matrices.
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1.9.3 Thesis organisation
The following diagram shows the organisation of the experimental
chapters with respect to achieving the principal aim.
Developing a
hypothesis
Investigating
interactions
Chapter 2
Interpretation of
a previous drug
release study
from HPMC
matrices
Chapter4
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between non-
steroidal anti-
inflammatory
drugs and
HPMC
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Chapter 2
Interpretation of a previous drug release
study from HPMC matrices
2.1 Aims of this chapter
Several studies in the literature have reported how the performance of
HPMCas an extended release carrier may be affected by incompatibilities
with drugs, electrolytes and other small molecules. Some of these effects
alter the drug release kinetics, whilst others may lead in extreme cases to
failure of gel layer formation and immediate drug release (Mitchell et al.
1990, Ford 1999, Li et al. 2005, 8ajwa et al. 2006).
To date there have been no studies that directly relate the molecular
interactions between drugs and HPMCto the drug release performance of
hydrophilic matrices. This opening chapter is an interpretation and
rationalisation of the work carried out in a previous PhD study by Simon
Banks (Banks 2003) who investigated the release profiles of two non-
steroidal anti-inflammatory drugs (NSAIDs) containing similar chemical
moieties (diclofenac sodium and mecJofenamate sodium) (figure 3.1).
These drugs have also been used as the model drugs in the current thesis.
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CaONa
Cl
Diclofenac sodium (pKa 4.0, Log P 4.5)
Cl
Meclofenamate sodium (pKa 3.7, Log P 6.0)
Figure 2.1 The molecular structure of NSAlDsused by Banks (2003) and
subsequently used as model drugs in this thesis
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2.2 Introduction
In this chapter, the release studies performed by Banks of diclofenac Na
and meclofenamate Na from HPMC hydrophilic matrices are presented
with an interpretation of the potential molecular mechanisms underlying
the release process. The aim of Banks' study was to investigate the two
drugs as examples of chemical species containing substituted aromatic
moieties which may possess incompatibility with HPMC. However, as will
become apparent as the data is presented, there was evidence of other
phenomena occurring within the dosage forms. The investigation of these
is the basis of the experimental work carried out in this thesis.
2.2.1Identifying a series of model drugs
The original aim of Bank's investigation (Banks 2003) was to identify key
chemical moieties within drug structures that were responsible for
incompatibilities with HPMC. The incompatibility of HPMCwith phenols
is well known (Martindale 2005) and Banks (2003) showed that many
aromatic molecules including substituted phenol and aniline derivatives
can reduce the cloud point temperature (CPT) of aqueous HPMCsolutions.
Banks' hypothesis was that drug molecules containing these structures
may also alter the CPTof HPMCsolutions and subsequently influence the
drug release characteristics. A range of potential model drug candidates
containing phenol or aniline molecules were subsequently identified by
searching the Merck Index 1999 (Merck & Co Inc, N),USA).
NSAIDspossess a simple molecular structure with the absence of complex
side chains and incompatibilities between NSAIDSwith cellulose ethers
have been reported in the literature [Rajabi-Siahboomi 1993, Ridell et al.
1999, Touitou and Donbrow 1982). For this reason Banks explored their
effect on release from HPMCmatrices.
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2.3 Summary of Banks' results
2.3.1 Banks' formulations and matrix preparations
Banks prepared hydrophilic matrices from a 63-90 urn sieve cut of a single
batch E4M HPMC (HPMC USP 2910), anhydrous direct compression
lactose and the model drugs. The tablets weighed 300 ± 5 mg and had a
diameter of 9.35 mm. The drug content was varied from 10% w/w to
50%, and HPMCcontent varied from 20% to 60% w/w using lactose (qs)
to complete the formulation as required. All formulations contained 2.5%
magnesium stearate as lubricant and 0.5% silicon dioxide.
2.3.2. The release of diclofenac Na and meclofenamate Na from
HPMC hydrophilic matrices
Figure 2.2 shows the release profiles of matrices containing 10%, 25% and
50% w/w diclofenac Na. In the formulations containing 10% w/w
diclofenac Na, only matrices containing 60% w/w HPMC afforded
extended release and below this HPMC content drug release was
immediate. When the drug content was increased to 25% w/w and 50%
w[v«, all matrices exhibited immediate release profiles.
Figure 2.3 show the drug release profiles for meclofenamate Na matrices
with different levels of HPMC content. In contrast with diclofenac Na
formulations, drug release rates became increasingly extended as the drug
content was increased. Formulations containing 50% w/w
meclofenamate Na released drug over 10 hours, whereas at lower drug
contents, all drug was released within 60 minutes.
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Figure 2.2 Drug release from matrices containing (A) 10% (B) 25% and (C) 50%
w/w diclofenac Na at different HPMClevels
Matrices weighed 300 ± 5 mg. Dissolution tests carried out in 0.9% NaCIusing the USP I
apparatus at 100 rpm. 37 ± 0.5 "C, Mean [n=B] ± 1
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2.3.3 Banks' disintegration study of diclofenac Na and
meclofenamate Na matrices
Table 2.1 shows the disintegration times obtained by Banks (2003) for
HPMCmatrices containing diclofenac Na and meclofenamate sodium Na.
Critical differences were apparent between the two drugs. Both
increasing the drug content and decreasing the HPMCcontent resulted in
more rapid disintegration of diclofenac Na matrices. In contrast
mecIofenamate Na matrices disintegrated more slowly with decreasing
HPMC content and increasing drug content. At the highest levels of
mecIofenamate Na, the matrices did not disintegrate during the
experimental period.
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DnII Content "', HPMC Dlsinteantion TImes (minutes,
Content ('"
DidofenKHa MecIofenamMe Ha
10 20 15 14
30 15 19
40 20 10
60 20 8
25 20 9 120i
30 10 45
40 10 20
60 10 8
SO 20 15i >120
30 12i >120
40 8 >120
Table 2.1 Disintegration times for HPMCmatrices containing the model drugs
included in the investigation
Disintegration data obtained in 900ml 0.9% saline at 37 ± 1 ·C. observations made from
4 tablets and taken to the nearest minute. :j: indicates that matrices stuck to the Perspex
disc.
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2.4 Interpretation of the work of Banks
2.4.1 The role of drug properties
Banks discovered that there were fundamental differences in the manner
in which diclofenac Na and meclofenamate Na were released from HPMC
hydrophilic matrices despite possessing similar solubility and almost
identical chemical structures (figure 3.1). In the case of diclofenac Na,
increasing the level drug led to matrix failure and loss of extended release
properties whereas in meclofenamate Na- matrices increases in drug
levels improved the extended release properties of the formulations. A
review of literature describing studies of the interactions between drugs
and HPMC has been presented in section 1.9.
Many factors affect the drug release mechanism from HPMC hydrophilic
matrices with several drug-related factors being cited as having a critical
influence. Particle size has an effect (Ford et al. 1985 a, b. c) but only in
the case of poorly water soluble drugs when there is a low HPMC content
in the matrix. Drug solubility has been highlighted as a key influence on
drug release (e.g. Bettini et al. 2001, Gafourian et al. 2007) but the
solubility difference between the two model drugs examined in Banks'
work (10 vs 50 mg/rnl for diclofenac Na and meclofenamate Na
respectively at 25°C) would not explain the disparity in drug release
profiles.
An overlooked physico-chemical factor may be the potential surface
activity of these drug molecules and their potential to interact with HPMC
in the hydrated state. Surface activity is not unique to soap and detergent
solutions: many drugs are also surface active and can self-aggregate to
form micelles or micelle-like structures above a critical concentration
(Attwood 1995, Schreier et al. 2000). These include antihistamines,
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antidepressants, anticholinergics and tranquillisers as well as NSAIDs
(Fini et al. 1995). Fini et al. analysed the surface active properties of ten
NSAlDs of the acetic and propionic classes with respect to their
solubilisation of a lipid probe, the azo-orange dye Orange ~T. It was found
that solubilisation was related to the self-aggregation of the drug anion
above a critical concentration, which differed for each drug. Although in
this case, the solubilisation capacity of meclofenamate Na and diclofenac
Na was not compared, the surface activity of these two drugs will differ as
they have different structures, pI<..and solubility.
Polymer association with complementary additives can strengthen or
induce connections between polymeric chains and can result in
considerable increases in the viscosity of polymer dispersions. In several
studies, surfactants have been used to induce changes in the conformation
of polysaccharides, and to promote the formation of aggregates. This has
been proposed as a way to obtain homogenous aqueous dispersions and
to modulate rheological behaviour. For example, in Carbopol 1342 gels,
the beta-blocker alprenolol has been found to form micelle-like aggregates
with polymer lipophilic residues, increasing the elastic and viscous moduli
of Carbopol hydrogels (Paulsson and Edsman, 2002). However, as the
drug concentration was increased, the gel collapsed and, when alprenolol
amino groups fully neutralised the carboxylic acid groups of the acrylic
polymer, precipitation occurred. The changes then observed in alprenolol
diffusion rate were concluded to be a consequence of both the interactions
with the polymer and the changes induced in the viscosity of the systems.
In another study, the interaction of various phenothiazines
(chlorpromazine, trifluoromazine, promazine and promethazine) with
hyaluronate caused the gels made of this anionic polymer to shrink with
the minimum drug concentration required being proportional to the CMC
(Yomota and Okada, 2003). The potential for periodontal drug delivery of
non-ionic cellulose ethers with surface active anaesthetic drugs was
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highlighted by Scherlund et al. (2000). Lidocaine and prilocaine did not
interact with EHEC or hydrophobically modified EHEC but strongly
affected polymer interactions with sodium dodecyl sulphate and
myristoyJcholine bromide. As a consequence, the drug loaded systems
differed notably from polymer-surfactant dispersions in their viscoelastic
behaviour
The addition of surfactants to hydrophilic matrices has also been noted in
the literature. An HPMCmatrix including sodium dodecyl sulphate (SOS)
was shown to release chlorpheniramine maleate more slowly than
without surfactant probably as a result of surfactant/drug ionic
interactions (Feely and Davis 1988). Surfactants have also been found to
induce modifications in the degree of swelling of the gel layer, by
establishing interactions with the polymer, which may also alter the drug-
release process. Nokhodchi et al. (2002) have evaluated the influence of
nature and concentration of several surfactants or their mixtures on the
release of propranolol from HPMC-Eudragit matrices. Matrices were
prepared by direct compression of drug/HPMC/Eudragit exhibited a
progressive decrease in drug release rate in both pH 1.2 and pH 6.8 when
the SOS proportion was increased up to 20 mg. These results were
explained by both drug/surfactant interactions, which decrease drug
solubility, and polymer/surfactant interactions, which increase the
viscosity of the gel layer.
Hence, a mechanism by which these surface active drugs interact with
HPMCand cause viscosification in the case of meclofenamate Na or a drug-
mediated 'salting out' with diclofenac Na may be proposed. This would
provide an explanation for the differing drug release profiles observed for
diclofenac Na and meclofenamate Na.
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2.4.2 The influence of lactose content
The choice of diluent and its influence on drug release should also be
considered when interpreting Banks' drug release profiles. Lactose is a
soluble sugar and its level of incorporation within the matrices in Banks'
work was varied to allow alteration of the drug: HPMCratio. However, the
effects of lactose on drug release processes can not be readily discounted.
Lactose has been implicated in the literature as affecting the mechanism
and release kinetics of drugs from HPMC hydrophilic matrices. For
example, Rekhi et al. (1999) have investigated the effect of lactose
incorporation on the release of metoprolol tartrate. It was found that
increasing the lactose content of matrices from 25 to 61% w/w led to an
increase in the drug release rate. When the soluble excipient content
exceeded 50% of the matrix weight, rapid dissolution of the excipients led
to a fragile and highly porous gel and as a result, there is an increase in
both drug diffusion and the rate of gel layer erosion.
An additional factor when considering the potential influence of lactose on
hydrophilic matrix performance is the propensity of saccharides to
influence the phase transitions of thermally sensitive polymers (Kawasaki
et al. 1996, Kim et al. 1995, Kato et al. 2001, Williams et al. 2008). These
effects may also apply to the modulation of HPMCsol:gel glass transition
temperature by simple sugars. Several examples are highlighted in the
literature. For example, Kim et al. (1995) showed how maltose and
glucose reduced the lower critical solution temperature (LCST)of thermo-
sensitive polymers such as Pluronics, poly(N-isopropylacrylamide), and N-
isopropylacrylamide copolymers. As the polymer concentration was
increased, the saccharide effects became more pronounced. It was found
that glucose was more effective than the disaccharide maltose in lowering
the LCST,especially in Pluronic solutions. Kawasaki et al. (1996) have
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investigated saccharide-induced volume phase transition of poly(N-
isopropylacrylamide) (NIPA) gels. The temperature-induced volume
phase transition was decreased by glucose, galactose, and sucrose. The
effect of the diluent is therefore investigated in a concentration dependent
manner in this thesis.
2.4.3 The choice of dissolution medium
The influence of media chosen for Banks dissolution experiments was not
trivial. The swelling of HPMC,in common with other macromolecules, is
sensitive to the presence of electrolytes in solution (Bajwa et al. 2006 Liu
et al. 2008). Rajabi-Siahboomi (1993) found that when phosphate buffer
was used as a test medium, matrices containing diclofenac Na failed and
rapid drug release resulted. Similar observations were made by Fagan et
al (1989) and Mitchell et al (1990) when investigating the effect of
electrolytes on the disintegration of HPC and HPMC Methocel K1SM
matrices respectively. Mitchell et a/ (1990) employed a dissolution
medium of distilled water to eliminate the effect of an ionic dissolution
medium. However the rapid swelling of HPMCin the absence of an ionic
environment is unrealistic, hence the studies of drug release presented in
the work of Banks were performed in 0.9% w/w NaCI. This in itself
presents problems, since it is not representative of the conditions with the
gastro-intestinal tract. In addition, it may affect the proposed interactions
between drugs and HPMC,since solubility and self-aggregation behaviour
will be strongly dependent on the ionic environment. Therefore the
influence of sodium chloride on drug-HPMC interactions will also be
investigated in this thesis.
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2.5 Conclusions
Banks' work shows considerable disparities in the drug release profiles
between diclofenac Na and meclofenamate Na from HPMC hydrophilic
matrices. Despite the structural similarities between the two drugs,
meclofenamate Na showed progressively extended release as drug
content increased and only when the level of drug incorporation was
above 50% w/w. In contrast, extended release of diclofenac Na was only
achieved at low drug levels with corresponding high levels of HPMC
within the matrix.
2.5.1Interaction hypothesis
A hypothesis has been developed that proposes that below certain ratios
with HPMC,meclofenamate Na acts to dehydrate HPMCand compromise
the formation of the gel layer. This is rationalised by the immediate
release observed in Banks' matrices containing less than 50% w/w drug.
Above this threshold, the drug promotes gel layer formation and increases
its viscosity, resulting in the extended drug release. Diclofenac Na may not
possess this capability and correspondingly extended drug release is not
achieved as drug content was increased. The mechanism may be related
to drug surface activity, and interactions with the HPMC, modifying the
solution properties, externalising as changes to the gel layer.
The validity of this hypothesis will be determined in this thesis by
investigating drug-polymer interactions and their effect on the gel layer.
These drug effects may also be influenced by the diluent within the matrix,
particularly the effect of lactose. Hence, the influence of incorporated
diluents and drugs will also be investigated.
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Chapter 3
Materials and methods
3.1 Materials
Details of the materials used in this study are included in appendix 1.
3.2 Methods
This chapter contains the general experimental methods used throughout
this thesis. Techniques used in individual investigations are described in
the appropriate chapters, along with any method development.
3.2.1 Manufacture of 1%w/w HPMC solutions
100 ml solutions of 1% wjw HPMC were prepared by the addition of
accurately weighed polymer powder to the water in a glass flask sufficient
to make one tenth of the final weight. The dispersion was agitated
vigorously using a bench top magnetic stirrer until the powder aggregates
were visually dispersed. They were then stored in a refrigerator at 2-8°C
for 48 hours to allow complete hydration of the polymer (Ford and
Mitchell 1995) and for air bubbles to dissipate. The remaining 90% of
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water required to make the solution was then added and stirred in a
closed container for a further 24 hours at room temperature prior to use.
HPMC solutions containing drugs, diluents and/or other additives were
prepared in a similar manner with the additive dissolved in the additional
90% of water prior to mixing. This incorporation method limited the
maximum concentration of additive to 90% w/w of the saturated
solubility but minimised interactions between additive and polymer prior
to dissolution.
3.2.2 Turbimetric determination of HPMC cloud point
temperature (CPT)
Turbimetric measurements were undertaken on 1% w/w HPMCsolutions
(prepared by the method detailed in section 3.2.1) using a white-light
temperature ramped Cloud Point Apparatus (Medical Physics, QMC,
Nottingham) (figure 3.1). The solutions were placed in 10 mm path-length
quartz cuvettes (Optiglass, Essex) with a magnetic cuvette flea. The
cuvettes were placed in the cuvette holder in the heating block, which also
contained a magnetic stirrer. The sample was heated at a rate of 2 °C.min-
A Tungsten light source was passed through the HPMC solution and
detected by a photodiode positioned behind the sample. The diode signal
was converted to an absorbance reading by software within the PC. The
temperature was monitored by a TC-08 channel silicone coated
thermocouple (Pico Technology Ltd, Cambridge, UK) which was inserted
into the cuvette to record the sample temperature. The probe was placed
in the sample so that it did not interfere with light transmission or come
into contact with the side of the cuvette.
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Figure 3.1 Schematic diagram of the cloud point temperature apparatus
HPMC solutions undergo a sol:gel phase transition upon increasing
temperature which induces cloudiness in the sample. The temperature at
which light transmittance falls to 50% of the original is known as the
cloud point temperature (Sarkar 1979, Sarkar and Walker 1995).
Absorbance is related to light transmission by the following equation:
A = logTo/T Equation 3.1
Where A is absorbance, To is the initial percentage light transmission and
T is the percentage light transmission at any given time. Thus the
absorbance at the cloud point temperature (CPT) is log 100/50= 0.301.
The solutions were visually observed to confirm gelation since a turbid
solution can be achieved before polymer precipitation, which can make
the determination of a cloud point subjective (Mitchell et al. 1990, Ford,
1999).
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3.2.3 Continuous shear viscosity measurements
Continuous shear viscosity measurements were undertaken on 1% w/w
HPMCsolutions containing additives using a Physica MCR301 rheometer
(Anton Paar, Germany). All samples were studied at 20°Cusing a stainless
steel 2°/50 mm cone and plate geometry. A new sample which had not
been subject to any other testing was used for each experiment.
The sample was placed onto the Peltier temperature-controlled plate at 20
± O.l°C. To minimise shear effects before testing, the sample was loaded
carefully using a plastic spoon. The cone was lowered into the sample to a
predetermined point to provide a gap of 49 urn, Excess sample was
removed from the edges of the plate prior to testing. The viscosity profiles
of each sample were determined at shear rate values between 0.01 and
100 S-l, increased incrementally on a log scale with an equilibrium period
at each shear rate of 30 seconds. This facilitated reproducibility by
allowing the sample to reach steady state prior to measurement. Sample
testing was performed in triplicate.
3.2.4 The theory of dynamic oscillatory rheology
Viscoelasticity measurements are based on the mechanical properties of
materials exhibiting both the viscous flow properties of liquids and the
elastic properties of solids. An ideal fluid flows when stressed and ceases
upon stress removal. In contrast, an ideal solid recovers its original state
as soon as the stress is removed. Some materials exhibit viscoelastic
characteristics and show both solid and liquid features.
The viscoelastic characteristics of HPMCsolutions were determined using
a small amplitude oscillatory shear experiment. A brief synopsis of the
mathematical principles behind the technique is now provided.
64
Chapter 3
During an oscillatory shear experiment, the sample is exposed to a
continuously changing sinousoidal stress, at a given frequency (Rao 1999).
The sample strain will also follow a sinusoidal pattern, provided the stress
is within the linear viscoelastic region (LVR)of the material. A controlled
stress apparatus is used to achieve a response in the LVR.
For an ideal solid, shear stress is proportional to shear strain, and the
amplitude of the strain will follow exactly the amplitude of the stress, as
shown in Figure 3.2 (a). For an ideal liquid, shear stress is proportional to
the strain rate and the resultant strain will be 90° out of phase with the
applied stress as shown in Figure 3.2 (b). It is likely that the samples in
this study be viscoelastic showing an intermediate response and a phase
angle greater than 0°, but less than 90°, as illustrated in Figure 3.2 (c).
The rheological behaviour was characterised as the dynamic moduli G'
and G" as a function of frequency, where G' is the storage (elastic)
modulus and G" the loss (viscous) modulus. The storage modulus (a
measure of the energy stored and recovered per cycle of deformation)
reflects solid-like component of viscoelastic behaviour of the material,
while the loss modulus (a measure of the energy lost per cycle) reflects
the liquid-like component. In addition to the dynamic moduli, the
viscoelastic nature of the test sample was further evaluated using the loss
tangent, tan S. Tan S is an indicator of the overall viscoelasticity of the
sample being a measure of the energy loss to the energy stored per cycle
(Gil /G'). Tan S < 1 indicates a solid (gelj-llke response, whereas tan S > 1
reflects a liquid like response. Thus, as tan 0 becomes smaller, the
elasticity of the material increases, whilst the viscous behaviour is
reduced.
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Figure 3.2 Idealised stress and strain response. of (a) an ideal solid. (b) an ideal
liquid. and (c) a viscoelastic material
Adapted fromRao (1999).
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3.2.5 Dynamic oscillatory rheology - Methods
Dynamic oscillatory rheology was undertaken on a Physica MCR 301
rheometer (Anton Paar, Germany) using a stainless steel 2°/50 mm
parallel plate geometry. Plate temperature was controlled at 20°C by the
use of a circulating water bath. The sample was carefully loaded onto the
plate using a spoon spatula and any trapped air bubbles were removed
using a plastic pipette. The parallel plate was lowered to a predetermined
point to provide a gap of 1000 urn between the plates. Excess sample was
removed from the edges of the plate. To minimise water loss, a thin layer
of low viscosity silicone oil (Sigma-Aldrich, Dorset, UK)was placed on the
sample periphery.
3.2.5.1 Dynamic oscillatory rheology - amplitude sweep
Oscillatory rheological studies are performed within the linear viscoelastic
region (LVR)of the sample in order for measurements to be independent
of stress and strain (Ross-Murphy 1988). Viscoelastic changes outside the
LVRmay result from the destruction of the sample by the rheometer (e.g.
shear thinning), and this will significantly affect data accuracy.
An amplitude sweep was performed to establish the LVR. A typical
amplitude sweep is shown in figure 3.3. Experiments were performed at
strain values ranging from 0.005 to 10 Pa, at a constant frequency of 0.5
Hz. Amplitude sweeps were performed for all the samples studied at the
experimental temperature of 20°C.
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Figure 3.3 A representation of a typical amplitude sweep
Shear strain is compared against both storage (G') and loss (G") moduli. The linear
viscoelastic region (LVR) is the region where deformation is considered not to damage
internal structure. The graph shows a typical amplitude sweep for 1% w/w HPMC (20
0c).
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3.2.6 HPMC hydrophilic matrix manufacture
3.2.6.1 Sieving of HPMCpowder
Several studies have shown how HPMC particle size has an important
influence on the drug release kinetics of hydrophilic matrices (Alderman
1984, Campos-Aldrete and Villafuerte-Robles 1997). To reduce this
influence, matrices were prepared using a sieve fraction of 63-90 urn,
The fractionation of HPMCwas undertaken as follows: 20 cm diameter,
stainless steel sieves (Endecotts Laboratory Test Sieves Ltd., London, UK)
were arranged in descending order from 125 urn to 63 urn mesh size with
a collecting tray on the bottom. Approximately 40 g of powder was placed
onto the top sieve in accordance with the manufacturers guidelines. The
sieves were mounted onto an automated sieve shaker (Copley Scientific,
Nottingham, UK) and agitated for 30 minutes. Each sieve was weighed
and sieved for a further 10 minutes. Sieving was stopped when sieve
weight differences between agitations were less than 5%.
3.2.6.2 Formulation preparation
All formulations were prepared in 50 g quantities to allow for manual
tablet compression. Sieved HPMC and other tablet excipients, in
appropriate quantities for each formulation, were mixed using a Turbula
2TF mixer (Glen Creston Ltd, Middlesex, UK) in a glass container for 15
min. Where a lubricant (magnesium stearate) was included in the
formulation this was added afterward and mixed for a further 3 minutes.
After mixing, the blends were stored in air tight amber bottles prior to
tabletting.
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3.2.6.3 Matrix tablet manufacture
Matrix tablets weighing 200 ± 5 mg were prepared on a Manesty F3 single
punch tablet press (Manesty, Liverpool, UK) at a compression pressure of
180 MPa, using 8 mm flat-faced punches (I Holland, Nottingham, UK)..
Powder blends were placed in the filling shoe and the tabletting machine
was manually taken through the compression cycle. The press was
instrumented with a tablet compression monitor TCM1 (Copley
Instruments Ltd, Nottingham, UK) to allow measurement of the upper
punch compression pressure applied during matrix preparation.
Matrix tablets were periodically sampled and tested for weight uniformity
(Mettler Toledo balance) and crushing strength using a CT40 hardness
tester (Engineering Systems, Nottingham, UK).
3.2.6.4 Matrix tablet storage
All batches of matrix tablets were assigned a date of manufacture and a
batch number for reference and stored in amber glass, air-tight jars. A
minimum storage time of 24 hours was allowed prior to further testing, to
allow any post-compression relaxation to occur.
3.2.7 Disintegration testing of matrix tablets
The disintegration time of HPMCmatrix tablets was measured using a four
station Erweka disintegration testing apparatus (Copley Scientific,
Nottingham, UK) conforming to the official USP monograph for
disintegration testing. Tests were conducted at 37 ± 1DCin 900 ml of test
medium, degassed by helium sparging. Perspex discs were used to
prevent the matrices floating. Matrices were monitored at 1 minute
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intervals for the first 10 minutes and every 5 minutes thereafter up to 120
minutes. After 120 minutes the tests were terminated.
3.2.8 Routine monitoring of HPMC powder moisture content
It is well known that powdered HPMCabsorbs moisture and can contain
an equilibrium moisture content that varies between 2-10% w/w
(Doelker 1993). The moisture content of the HPMC batch used
throughout the study was monitored periodically at 3 month intervals
using a MB45 Moisture Analyser (Ohaus Corporation, Leicester, UK).
Samples (-500 mg) were heated on disposable aluminium pans from
ambient to 105°C using a linear temperature ramp over 3 minutes and
held at this temperature until there was less than 1 mg change over 2
minutes. The endpoint was automatically determined by the apparatus.
The moisture content was found to be maintained in the range 3.5-4.5%
w/w throughout the study (see appendix 2).
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Chapter 4
Interactions between non-steroidal anti-
inflammatory drugs and HPMC
4.1lntroduction
In chapter 2, the release profiles of diclofenac Na and meclofenamate Na
from HPMCmatrices were presented and interpreted with respect to the
HPMChydrophilic matrix literature. It was proposed that the drug release
was a consequence of drug surface activity and different modes of
interaction with HPMCin aqueous solution. The aim of this chapter was to
investigate the interactions between these drugs and HPMCin solution, to
confirm or disprove this hypothesis.
Previously, it has been reported that incompatibilities between drugs and
HPMCmay have critical effects on the performance of extended release
hydrophilic matrix dosage forms (Li et al. 2005) and examples from the
literature suggest that certain drugs have the potential to interact with
HPMC. These include: (i) ibuprofen (Ridell et al. 1999), (ii) nicotinamide
(Hino and Ford 2001), (iii) propranolol (Mitchell et al. 1993), and (iv)
aminophylline (Ford et al. 1985). Although the relatively simple concepts
of 'salting-out' and 'salting-in' have been proposed as the principal
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underlying mechanism for the drug-polymer interaction (Mitchell et al.
1993, Hino and Ford 2001), there has been little attention paid to the
potential for drug interaction with HPMC through the drug molecule
surface activity and the consequences for polymer solution properties and
drug release performance in HPMCmatrices.
4.1.1 Surface activity of drugs
In many pharmaceutical dosage forms, polymers are concomitantly
formulated with amphiphilic drugs and excipients (Florence and Attwood
1998). Interaction between these components has the potential to
influence the physicochemical properties of the dosage form, for example
by altering chemical stability or affecting the drug release kinetics
(Puttipipatkhachorn et al. 2001, De la Torre 2003, Tang and Singh 2008).
Pharmaceutical excipients such as emulsifiers, solubilising agents and
wetting agents are surface active. In addition, a significant number of
drugs possess an amphiphilic molecular structure. Resultantly, these
drugs are surface active and are capable of forming self-assembled
structures such as micelles when in aqueous solution at a concentration
higher than their critical micelle concentration (CMC)and at temperatures
exceeding their Krafft temperature (Attwood 1995). Examples of surface
active, micelle forming drugs can be found in the phenothiazines (Barbosa
et aJ. 2008, Cheema et al. 2008), tricyclic and tetra cyclic antidepressants
(Kumar et al. 2006), antihistamines (Attwood and Udeala 1975), local
anaesthetics (Strugala et al. 2000), anticholinergics (Wu et al. 1998) and
non-steroidal anti-inflammatory drugs (Fini et al. 1995). As with more
well-known surfactants, surface activity is dependent on the chemical
nature and position of the hydrophobic and hydrophilic portions of the
drug molecule (Attwood 1995).
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4.1.1.1 The surface activity of NSAIDs
The surface activity of several non-steroidal anti-inflammatory drugs
(NSAlDs) has been described in the literature by Fini et al. (1995). Surface
activity was investigated with respect to drug self-aggregation and the
subsequent solubilisation of a lipid probe, the azo-dye Orange OT. It was
found that the sodium salts of indomethacin and fenclofenac exhibited dye
solubilisation activity in pure water at concentrations of 30 and 40 mM
respectively, with these values decreasing with increasing ionic strength
as sodium chloride was added. Diclofenac sodium was found to possess
insufficient solubility to solubilise the dye and a higher solubility salt
prepared with an organic base counterion was necessary. Naproxen,
sulindac, ketoprofen, indoprofen sodium salts had to be dissolved at high
concentrations (100-160 mM) in order to solubilise the dye in the
presence of a high total ionic strength.
4.1.2Interactions between NSAIDs and polymers
Rades and Mueller-Goymann (1998) have investigated the interaction
between fenoprofen sodium and high molecular weight poly (ethylene
oxide) (PEO). A wide variety of techniques were used including: surface
tension measurements, viscometry, cloud point temperature
measurements, proton NMR, polarised light microscopy, transmission
electron microscopy, and differential scanning calorimetry. These
investigations suggested that polymer: drug interaction began below the
CMCof the drug as evidenced by: (i) an upheld shift of the PEO proton
signal for fenoprofen sodium concentrations below the CMCof the drug,
(H) the absence of a critical association concentration in the surface
tension measurements and (iii) cloud point temperature determinations.
The surfactant did not appear to bind quantitatively to the PEO, as a
higher fenoprofen concentration was needed to cause the same upheld
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shift of the PEO proton signal than for more lipophilic surfactants, and no
plateau phase in the surface tension reduction isotherm could be
determined. Interactions were found to be independent of the PEO chain
length.
The interaction of ibuprofen Na with EHEC and HPMC has been
investigated (Ridell et al. 1999). Fluorescence and microviscosity
measurements showed that ibuprofen was an amphiphilic drug which
formed micelles in water. At the CMC of the drug, a marked increase in
cloud point was reported. It was postulated that above the CMC micelles
of ibuprofen may solubilise the hydrophobic methoxyl-rich regions of the
polymer, and thereby increase polymer hydration.
4.1.3 Methods for investigating surfactant-polymer interactions
In this chapter, we propose to study the potential interaction of diclofenac
Na and meclofenamate Na with HPMC. Therefore, it presents a logical
starting point to first assess the surface activity of the drugs before
progressing to an investigation of their potential interactions with the
polymeric carrier material. A brief review of common methodologies used
to investigate surfactant-polymer interactions is necessary and this is
provided below.
4.1.3.1 Surface tension
Surface active molecules, including drugs, either adsorb at the surface or
form complexes in the bulk, leading to variations in the surface tension
(Florence and Attwood 1998). Figure 4.1 depicts a well-established
schematic representation of the current understanding of how surface
tension (y) varies with respect to bulk surfactant concentration [Ss].
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At low surfactant concentrations, there is preferential adsorption of
surfactant molecules at the surface which disrupts the hydrogen bonding
between water molecules and as a result, lowers the surface tension
progressively as the surfactant concentration is increased. However, at a
certain concentration of surfactant (known as the critical micelle
concentration or CMC) the surface becomes saturated with amphiphile
and it becomes energetically more favourable for the surfactant to form
micelles in solution. As a result there is little change in surface tension as
the surfactant concentration is further increased.
The use of surface tension measurements to explore the interactions
between surfactants and non-ionic polymers was first described by Jones
(Jones 1967), who investigated the interaction between sodium dodecyl
sulphate and poly(ethylene oxide). Jones first proposed the concept of
transition points to describe the interactions and these critical concepts
have been further developed by Bell et al. (Bell et al. 2007). A schematic
diagram showing the key concepts is shown in figure 4.2.
Two regions illustrate the clear differences between the surfactant (figure
4.1) and surfactant/polymer systems (figure 4.2). These are: (i) the
concentration of the CMC and (ii) a point of lower surfactant
concentration known as the critical aggregation concentration (CAC). The
CACrepresents the point at which the polymer and the surfactant begin to
interact in the bulk solution (Bell et al. 2007). At concentrations below the
CACthere is a monotonic decrease in surface tension. The surface tension
is lower in the polymer/surfactant system than in the surfactant-only
system at the same bulk surfactant concentration as there is some
cooperative disruption by polymer and surfactant. At concentrations
above the CAC,there is no significant change in the surface tension with
increasing surfactant concentration. Once a certain concentration of
surfactant is reached, the surface tension begins to reduce again. This is
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the point at which surfactant micellar aggregates have saturated the
polymer. The reduction in surface tension then continues until the CMCis
reached and once again micelles form in the bulk. As in the surfactant-
only system, there is little change in surfactant adsorption at the surface
beyond the CMC. It has been found that the length of this 'plateau' in
surface tension isotherm from CAe to CMC is dependent upon the
concentration of polymer added to the system (Purcell et al. 1998).
There are numerous examples in the literature in which measurement of
surface tension has been used to characterise the interactions between
surfactants and polymers (Nilsson et al. 1995. Onesippe and Lagerge
2002, Ridell et al. 2002. Peron et al. 2007). A recent example is Claro et al.
(2008) who used surface tension measurements to determine the
formation of a complex between hydroxypropyl cellulose-methyl
methacrylate and a polyoxyethylene nonylphenyl ether non-ionic
surfactant with a high hydrophilic-lipophilic balance (HLB).
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Figure 4.1 Schematic diagram showing how surface tension varies with log(bulk
surfactant concentration) (Sb) for an aqueous solution containing an ionic
surfactant
(Adapted from Bell et al. 2007).
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Figure 4.2 Schematic diagram showing how surface tension varies in a surfactant-
polymer system in the presence (dashed line) and absence (solid line) of
complexation
(Adapted from Bell et al. 2007).
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4.1.3.2 Rheological techniques
Rheological techniques are commonly used to characterise the association
between surface active agents and polymers since these interactions
strongly influence polymer conformation and as a result the phase
behaviour in solution (Thuresson and Lindman 1997). Rheological
behaviour of surfactant-polymer solutions can be described in terms of
change in the dynamic moduli G' and G" as a function of frequency, where
G' is the storage (elastic) modulus and G" the loss (viscous) modulus.
Rheological analysis can provide insights into the gelation properties of
polymer solutions by characterizing swelling and connectivity between
polymer chains and the influence of surfactant addition. For example,
Zhao and Chen (2007) have investigated the effect of nonionic surfactant
addition on the rheology of aqueous solutions of hydrophobically
modified hydroxyethyl cellulose and found that surfactant addition
altered the rheology of aqueous solutions of the polymer. In addition, the
rheology of aqueous solutions of hydrophobically modified
polyacrylamides and surfactants has been investigated by Penott-Chang et
al. (2007).
4.1.3.3 Small-angle neutron scattering (SANS)
Small-angle neutron scattering (SANS) is a useful tool with which to
investigate molecular structures ranging in size from 5 A to several
hundred angstroms and often polymeric materials, surfactants and their
complexes fall into this range. An advantage of using neutrons to study
these systems is the ability to suppress selectively the scattering of either
component by adjusting their scattering length densities relative to the
solvent (8u et al. 2005). Several papers have described the use of SANSto
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study the structure of polymer-surfactant complexes (Griffiths et al. 2004,
Griffiths et al. 2007, Bu et al. 2007).
4.1.3.4 Turbidimetry
The determination of solution turbidity is a bulk method that detects the
effect of surfactant-polymer interactions on the macroscopic behaviour of
the polymer in a solution. Recent examples in which turbimetric
measurements has been applied to characterize surfactant polymer
interactions include (i) chitosan and SDS (Lundin et al. 2008, Onesippe
and Lagerge 2008), (ii) casein and dodecyltrimethylammonium bromide
(DTAB) (Liu and Guo, 2007) and (iii) various surfactants with
hydrophobically modified alginate (Bu et al. 2007).
4.1.3.5 Isothermal Titration Calorimetry (ITC)
The thermodynamics of surfactant-polymer interactions can be
characterised using isothermal titration calorimetry (ITC). Such data can
provide detailed information about the binding process of surfactants in
the absence and presence of a polymer (Wang et al. 1997). The
measurement principle of ITe is based on both titration and power
compensation techniques. Titration calorimetry measures the enthalpy
change of a chemically reacting system as a function of the amount of
added reactant (Tam and Wyn-Jones 2006). Recent applications of
calorimetry in the study of surfactant-polymer interactions include the
interactions between (i) sodium alginate and SDS (Yang et al. 2008), (ii)
chitosan and SOS (Onesippe and Lagerge, 2008), and (iii) hydrophobically
modified cationic polysaccharides with surfactants (Bai et al. 2007).
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4.1.3.6 Pulse-gradient spin echo nuclear magnetic resonance (PGSE-NMR)
Owing to its non-invasive nature and wide applicability, pulsed gradient
spin-echo (PGSE) NMR has become the method of choice for measuring
self-diffusion coefficients of species in the solution state. PGSE-NMRhas
been used to quantify surfactant-polymer interactions as an association
between the two species (Griffiths et al. 2002, Davies and Griffiths 2003).
Polymers have far lower self-diffusion values compared to low molecular
weight species such as drugs, and as such, changes in the self-diffusion
behaviour of small molecular weight species can be attributed to
interactions between the species and the polymer (Davies and Griffiths
2003).
4.1.3.7 Other techniques
Other significant recent techniques used in the characterisation of
surfactant-polymer systems include (i) fluorescence correlation
spectroscopy (Bosco et al. 2006), (ii) neutron relectometry (Taylor et al.
2007) and (iii) x-ray reflectivity (Stubenrauch et al. 2000).
4.1.3.8 Choice of techniques to study drug-polymer interactions
The choice of technique to study drug-polymer interactions is dependent
on the type and level of experimental evidence required to develop a
theory and the availability of equipment. Ideally, complementary
techniques should be used to provide a detailed insight that encompasses
both the microscopic and macroscopic aspects of potential interactions
between drugs and HPMC. Tensiometry, rheological and turbimetric
analytical facilities were available within the Schools of Pharmacy and
Biosciences at University of Nottingham. Collaboration with Dr P C
81
Chapter4
Griffiths at the School of Chemistry (Cardiff) allowed access to PGSE-NMR
and SANS methodologies. ITC was considered as an experimental
methodology but was not used as a result of time constraints.
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4.2 Aims and objectives
The overall aim of this chapter was to test the hypothesis that the
underlying mechanism for the different drug release profiles is a result of
differing interaction modalities between diclofenac Na or meclofenamate
Na with HPMC. Specifically, the objectives of this chapter are:
To investigate the potential for diclofenac Na and meclofenamate
Na to influence HPMC solution properties, using cloud point,
rheology and surface tension measurements.
To interpret the experimental findings with respect to the
literature pertaining to the interactions of surfactants with
macromolecules, and to confirm or disprove the hypothesis that
surface activity is significant in drug-HPMC interactions and
subsequent drug release.
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4.3 Materials and Methods
4.3.1 Materials
4.3.1.1 HPMC
HPMC(Methocel E4M CRPremium) was used a supplied. Full details are
listed in appendix 1.
4.3.1.2 Drugs
DicIofenac Na and meclofenamate Na were of analytical grade and used as
supplied. Full details are listed in appendix 1.
4.3.1.3 Water
Solutions were prepared using Maxima HPLCgrade water except in the
case of the pulsed-gradient spin-echo NMR (PGSE-NMR)and small-angle
neutron scattering (SANS) experiments where deuterium oxide
[Fluorochern, Derbyshire) was used for all solution preparation. Full
details are listed in appendix 1.
4.3.2 Manufacture of HPMC solutions
0.1% and 1% w/w solutions of HPMC were prepared by the method
described in section 3.2.1.
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4.3.3 Turbimetric determination of the sol:gel phase transition
temperature
Turbimetric determinations of the sol:gel transition temperature of HPMC
solutions were undertaken using the method described in section 3.2.2.
4.3.4 Density Measurements
Density measurements of 0.1 % w/w HPMC solutions containing the
model drugs were made using a DMA 5000 oscillating Il-tube Density
Meter (Anton Paar, Graz, Austria). The density determination is based on
measuring the period of oscillation of a vibrating U-shaped tube that is
filled with sample and using the relationship between the period of
oscillation and the density. This relation holds as long as the sample is not
too viscous. The density was obtained at 20°C and mean values (n=3)
were used subsequently in the surface tension measurements.
4.3.5 Interfacial tension measurements of NSAID and HPMC
solutions
Surface tension measurements were carried out at 20 ± 1 °C using a
Profile Analysis Tensiometer (Sinterface tensiometer PATl, Berlin,
Germany) using the pendant drop method. Solutions of 0.1 % w/w HPMC
containing the model drugs were prepared by mixing appropriate
quantities of drug and HPMC in solutions and allowing equilibration for 24
hours prior to measurement. Samples were prepared in triplicate.
Replicate measurements were automatically determined 100 times. The
relative standard deviations of the 100 measurements were smaller than
0.05%.
85
Chapter4
4.3.6 Pulsed-gradient spin-echo NMR
As an experimental technique, PGSE-NMR permits probing of self-
diffusion coefficients within complex colloidal systems since the
characteristic structural dimensions in such systems (10 nm-lO urn) are
comparable to the displacements on the NMR time-scale (10 ms-LO s)
(Griffiths et al. 2002).
The strength of the association between drugs and HPMCwas quantified
using a pulsed-gradient spin-echo NMR (PGSE-NMR)method described
previously (Davies and Griffiths 2003). The self-diffusion measurements
on 0.1% w/w HPMC solutions containing a range of concentrations of
diclofenac Na or meclofenamate Na and the corresponding drug solutions
in the absence of polymer were performed on a Bruker AMX360 high-
resolution NMR spectrometer (Bruker, Coventry, UK) employing a
stimulated echo sequence (figure 4.3).
rf
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Figure 4.3 Timing diagram for the PGSE-NMRpulse sequence for determining self-
diffusion coefficients
(taken from Antalak 2007)
Briefly, a constant current gradient amplifier (Bruker) delivers pairs of
read and write gradients matched to better than 10 ppm. These gradients
were ramped up to the maximum value and down again over a time o,
typically 250 us, which in conjunction with three pre-pulses before every
scan minimizes distortions due to coil heating and eddy currents.
86
Chapter4
The self-diffusion coefficient, Ds, was extracted by fitting the data to
equation 4.1 the measured peak integral, A(G, 0), as a function of field
gradient duration 0 ramp time a intensity G,and separation ~:
Equation 4.1
and where y is the magnetogyric ratio of the nucleus under observation, in
this case protons. The Ao term is determined by the number of protons in
the sample. All experiments were performed at 20 ±1°C.
4.3.7 Small-Angle Neutron Scattering (SANS)
SANSis used for studying the structures of a material on a length scale of
10-1000 A. In particular, it is used to study the size of particles (including
macromolecules) in a homogenous medium. SANSis a diffraction based
technique which involves the scattering of a monochromatic neutron
beam from a sample and measurement of the scattered neutron intensity
as a function of scattering angle (figure 4.4). The wave vector transfer
Q(=41tsin9jA, where A is the incident neutron wavelength and 29 is the
scattering angle in these experiments is small, typically in the range of 10-3
to 1.0 kl, the wavelength of neutrons used for these experiments usually
being 4-10 A. Since the smallest Q values occur at small scattering and
angles (_1°) the technique is known as small angle neutron scattering.
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Figure 4.4 Schematic diagram of experimental set-up in SANSexperiments
(taken from Goyal and Aswa12001)
Small-angle neutron scattering (SANS)measurements were performed on
60 mM drug solutions in the presence and absence of 0.1% HPMCusing a
fixed-geometry, time-of-flight LOQdiffractometer (ISISSpallation Neutron
Source, Oxfordshire, UK). This concentration was chosen to maximise the
possibility of interaction between the species. By using neutron
wavelengths spanning 2.2-10 A, a Q = 4n sin(9/2)/A range of
approximately 0.008-0.25 A-l (25 Hz) is accessible, with a fixed sample-
detector distance of 4.1 m. The samples were contained in 2 mm path
length, UV-spectrophotometer grade, quartz cuvettes (Hellma, Essex, UK)
and mounted in aluminium holders on top of an enclosed, computer-
controlled, sample chamber. Sample volumes were approximately 0.4
ern", Temperature control was achieved through the use of a
thermostatted circulating bath pumping fluid through the base of the
sample chamber. Under these conditions, a temperature stability of better
than ±0.5 °C can be achieved. Experimental measuring times were
approximately 40 min.
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All scattering data were (a) normalized for the sample transmission, (b)
background corrected using a quartz cell filled with 020 (this also
removed the inherent instrumental background arising from vacuum
windows, etc.), and (c) corrected for the linearity and efficiency of the
detector response using the instrument-specific software package. The
data were put onto an absolute scale by reference to the scattering from a
partially deuterated polystyrene blend.
4.3.8 Continuous shear viscosity measurements
Continuous shear viscosity measurements on 1% wjw HPMC solutions
containing diclofenac Na and meclofenamate were carried out in triplicate
on a Physica MCR 301 rheometer (Anton Paar, Germany) using the
method described in section 3.2.3.
4.3.9 Dynamic viscoelastic rheology
Viscoelastic moduli were determined in triplicate on a Physica MeR 301
rheometer (Anton Paar, Germany) with a stainless steel2°jSO mm parallel
plate geometry using the methods described in section 3.2.5.
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4.4 Results
4.4.1Interactions between meclofenamate sodium or diclofenac
sodium with HPMC in solution
4.4.1.1 Surface tension measurements
Figures 4.5 and 4.6 show the surface tension concentration behaviours of
diclofenac Na and meclofenamate Na, with and without the addition of
0.1% wjw HPMCand these resemble partly the generalised case given in
figure 4.2. Both drugs were found to be surface active; i.e. when added to
aqueous solution there was a decrease in the surface tension. A critical
concentration at which drug addition led to no further reduction in
surface tension was identifiable for mecIofenamate Na(- 45 mM) but not
for diclofenac Na. In the case of both drugs, the slope of the isotherm in
the presence of polymer was very different to the drug solution alone. The
lower initial values for these curves are indicative of the surface activity of
HPMC. The phenomenon of HPMC surface activity has been given
considerable attention in the literature (Perez et al. 2006, Martinez et al.
2007) and it has been suggested that it is a result of unequal distribution
of hydrophobic and hydrophilic substituents along the polymer chain.
90
Chapter4
70
.
oOi~oOoo
.
.._
60
E
--
::!;
..s
c
0
.;;; 50c
~
~
..
't:
:::J
VI
40
Meclofenamate Na
Meclolenamate Na + 01% w/w HPMC
30+--------------T---------- __
1 10
Drug concentration (mM)
100
Figure 4.5 The effect of increasing meclofenamate Na addition on the surface
tension of water and 0.1% w/v HPMC solution at 20°C. Surface tension
measurements were made using the pendant drop method. Mean (n=5) ± SD
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Figure 4.6 The effect of increasing diclofenac Na addition on the surface tension of
water and 0.1% w/v HPMC solution at 20°C. Surface tension measurements were
made using the pendant drop method. Mean (n=5) ± SD
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These results provide evidence for an interaction occurring
between the drugs and HPMC. However, the nature of this interaction
differs for each drug. In figure 4.5 there is evidence that meclofenamate
Na is associated with the polymer even at low concentrations but the
onset of drug association with the polymer was not detectable. Evidence
for binding is shown by the absence of a surface tension decrease with
respect to drug addition (the so-called 'plateau' phase described in the
model proposed by Bell et al. 2007) as the drug is unable to lower surface
tension as it may be associated with the polymer in the bulk solution. A
key feature is that above 25 mM drug, the surface tension for the
drug/polymer solution was higher than the drug-alone solution, indicating
that the surface was either less heavily populated by surface active
complex or that the complex is less surface active. Both of these
interpretations are consistent with a drug/polymer interaction leading to
the formation of complexes within the bulk solution.
As shown in figure 4.6, diclofenac Na was also found to be surface active in
aqueous solution. In contrast with meclofenamate Na, it did not
demonstrate a critical concentration in aqueous solution, which may be
related to its solubility (-10 mg/rnl at 20°C) and/or pKa. (4.5). Unlike
meclofenamate Na, a possible onset of binding was identified between 3
and 5 mM. This was followed by a plateau phase between 5 and 25 mM
and at concentrations above this point, the isotherm decreased in surface
tension in a manner analogous to the free drug. This plateau phase
suggested diclofenac Na associated with the HPMC. This was followed by
saturation of the potential association sites on the polymer and the
lowering of the surface tension above a critical concentration as free drug
becomes available once again. This is where the drug is free to exert a
'salting out' effect.
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4.4.1.2 Pulsed-gradient Spin Echo NMR investigations
PGSE-NMRwas used to determine the self-diffusion coefficients of the two
drugs in the presence and absence of 0.1% w/w HPMC. PGSE-NMRhas
been used in previous work to investigate surfactant-polymer interactions
and determine the association between the two species (Griffiths et al.
2002, Davies and Griffiths 2003). Polymers have significantly lower self-
diffusion values than low molecular weight drugs, and as such, changes in
the self diffusion behaviour of the drugs can be attributed to interactions
between the drug and the polymer (Davies and Griffiths 2003).
Figures 4.7 and 4.8 show self-diffusion coefficient values determined for
dicIofenac Na and mecIofenamate Na in the presence and absence of
HPMC. It can be seen that there was a pronounced reduction in the
diffusion coefficient of meclofenamate Na in the presence of 0.1% w/w
HPMCcompared to mecIofenamate Na alone. In the case of dicIofenac Na,
there was little change in the diffusion coefficients of either free drug or
drug in the presence of polymer.
Clearly, the presence of polymer affected the self-diffusivity of
meclofenamate Na. This is suggestive of association between the drug and
polymer in the case of meclofenamate Na, with an increasing association
with the polymer with respect to increasing concentration. The onset of
this association appeared at around 20 mM, since at concentrations above
this the self-diffusion coefficients were seen to reduce dramatically.
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Figure 4.7 The effect of HPMC on the meclofenamate Na self-diffusion coefficient in
solution as a function of drug concentration. Determined using PGSE-NMR at 20°C
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solution as a function of drug concentration. Determined using PGSE-NMR at 20°C.
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4.4.1.3 Small-angle Neutron Scattering (SANS)
Neutron scattering curves result from interferences between neutrons
scattered by different nuclei in the sample. The interferences are
determined by the scalar product Q r, where Q is the scattering vector and
r is the vector separating points. For isotropic samples, only the
magnitude Q of the scattering vector matters. Then the scattering pattern
may be reduced to a scattering curve I( Q). From this scattering curve,
geometrical parameters characterising the distribution of scattering
length in the sample may be determined (Goyal and AnsweI2001).
The results of SANSanalysis of 60 mM drug solutions in the presence and
absence of 0.1% wjw polymer are presented in figures 4.9 and 4.10.
Diclofenac Na clearly showed no measurable scattering (figure 4.9)
suggesting the absence of self-associated structures were present,
whereas the scattering from meclofenamate Na was also very weak, but
perhaps discernible, consistent with the apparent blue tinge of these
samples. Clearly aggregates are present, but their concentration is too low
to give a measureable signal.
The HPMC scattering was also weak and unaffected by the presence of
diclofenac Na, indicating no measurable change in polymer conformation.
The situation with meclofenamate Na was quite different however. It can
be seen that there was an increase in intensity and above the polymer
alone in the presence of meclofenamate Na but not diclofenac Na. There
was some evidence of a structure peak (figure 4.10) in meclofenamate Na-
containing polymer solutions located at approximately 0.04 A-l, which is
absent in the diclofenac Na solutions. This supports the findings of
association between medofenamate Na and HPMCdetermined by surface
tension and PGSE-NMRstudies.
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Figure 4.9 SANSscattering curves at 20°C from 60 mM diclofenac Na and 0.1% w/w
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4.4.2 The effect of drugs on HPMC solution cloud point (CPT)
Figure 4.11 shows the effect of diclofenac Na and meclofenamate Na on
the CPT value up to the limit of aqueous drug solubility. The CPT of 1%
w/w HPMCsolution in the absence of drugs was found to be 57.1 ±0.2 °C
(n=3). Cloud point temperature (CPT) was reduced in a progressive
manner as diclofenac Na concentration was increased. A maximum
reduction of approximately 12°C was achieved at 60 mM. In contrast,
meclofenamate Na was more potent than diclofenac Na at reducing the
CPT values at low concentrations but beyond a maximum reduction in
CPT of around 15°C (-33°C), the CPT increased markedly with increasing
drug concentration. This minimum CPT for HPMC solutions containing
meclofenamate Na occurred at a concentration of 40 mM which
approximated to the concentration at which apparent association of drug
with the polymer began in the tensiometry studies. At concentrations
approximating to the saturated solubility (-60 mM), meclofenamate Na
had increased the CPTfrom this minimum value to 49.7 ±0.45 (n=3).
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Figure 4.11 The effect of diclofenac Na and meclofenamate Na on the cloud point
temperature of 1% w/w HPMCsolutions
Cloud point temperature (CPT) measured turbimetrically as a reduction 50% in light
transmission (Sarkar 1979). Mean (n=3) ± SD
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4.4.3 The effect of drugs on the continuous shear viscosity of
HPMC solutions
The continuous shear viscosity of 1% w jw HPMC solutions at 20°C was
measured as a function of shear rate over the range 0.01-100 ljs at drug
concentrations ranging from 0 to 60 mM.
Figure 4.12 shows the viscosity profiles of 1% HPMC solutions containing
increasing concentrations of diclofenac Na and meclofenamate Na. The
shear viscosity as a function of meclofenamate Na and diclofenac Na
concentration are shown in figures 4.13 and 4.14 respectively. The
viscosity profile of 1% HPMC without drugs showed a clear Newtonian
plateau at low shear rates, and a tendency to shear thin at high shear
rates. This solution can therefore be described as non-Newtonian. The
corresponding viscosity profiles for HPMC solutions containing increasing
concentrations of meclofenamate Na are shown in figure 4.12a.
Meclofenamate Na addition increased the solution viscosity and there
were dramatic increases at drug concentrations of 40 mM and above.
These solutions also exhibited a profound shear thinning at the higher
shear rates. The 40 mM threshold corresponded to the earlier inflexion
point seen in the cloud point studies (figure 4.11) and approximated to the
concentration at which self-association of drug molecules appeared in the
surface tension studies(figures 4.5 and 4.6). This point is illustrated more
clearly in figure 4.12, where a clear increase in continuous shear viscosity
occurs above 20 mM at both low and high shear.
In contrast to the behaviour of HPMC solutions containing mecJofenamate
the progressive addition of dicIofenac Na to the solution increased the
solution viscosity only slightly and the shape of the viscosity profile
remained the same (figure 4.12b).
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Figure 4.12 The effect of (A) meclofenamate Na and (B) diclofenac Na on
continuous shear viscosity of 1%w/w HPMCsolution
Geometry = CP 2°/50 mm. Temperature = 20 ± O.loC. Mean (n =3) ± lSD
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Figure 4.13 The continuous shear viscosity of 1%w/w HPMCand containing
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Geometry = CP 2°/50 mm. Temperature = 20 ± O.l°C. Mean (n =3) ± ISD
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Figure 4.14 The continuous shear viscosity of 1% w/w HPMCsolutions containing
various concentrations of diclofenac Na at (A) low (0.1 S·l and (B) high (100 S·l)
shear rate
Geometry = ep 2°/50 mm. Temperature = 20 ± O.I°C. Mean (n =3) ± ISD
102
Chapter4
4.4.4 The effect of drugs on the oscillatory rheology of HPMC
solutions
Dynamic oscillatory shear rheology can provide information about how
energy from small oscillations applied to a sample is recovered or
dissipated, and hence provide information on the internal structure of
samples.
In order to carry out satisfactory oscillatory rheology, the linear
viscoelastic region (LVR)was first determined. This was determined at
the temperature at which subsequent frequency sweeps were undertaken
to determine the effect of drugs on the storage and loss moduli of the
HPMCsolutions.
4.4.4.1 The effect of incorporated drugson the complex viscosity
of HPMC solutions
Initially, the frequency dependence of the complex viscosity was
investigated to gain an insight into the viscoelastic response of the drug-
polymer mixtures. It is generally found that this behaviour can be
described in terms of a power law where m assumes values of 0 and 1 for
a liquid and a solid, respectively (Larson 2005). Figure 4.15 shows the
frequency dependencies of complex viscosity, as measured in small-
amplitude oscillatory shear experiments, for 1% w/w solutions of HPMC
containing mecIofenamate Na and dicIofenac Na. HPMC solutions
containing diclofenac exhibited a liquid-like behaviour at all
concentrations of drug. This is shown by gradients close to 0 which is
indicative of only weak polymer-surfactant interactions. In contrast, for
HPMC solutions containing meclofenamate Na, the elastic (solid-like)
response becomes more pronounced with increasing meclofenamate Na
concentration and the highest values of m are observed for the system (60
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mM meclofenamate Na) that exhibited the most marked viscosity
enhancement. This strong elastic response is typical for systems with
well-developed association networks (Larson 2005).
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Figure 4.15 Frequency dependence of complex viscosity for 1% w jw HPMC
solution containing various concentrations of (A)meclofenamate Na and (B)
diclofenac Na at the drug concentrations indicated.
Geometry = pp 2°/50 mm. Temperature = 20 ± O.l°C. Mean (n =3) ± lSD
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4.4.4.2 The effect of drugs on the storage and loss moduli of HPMC solutions
Figures 4.16 and 4.17 show the mechanical spectra obtained for HPMC
solutions containing various concentrations of dicIofenac Na and
meclofenamate Na. For clarity, the loss and storage moduli with respect
to drug concentration are shown separately in figures 4.18 and 4.19. Little
or no change was seen in the mechanical moduli of HPMC solutions in the
presence of dicIofenac Na (figures 4.16 and 17). However, with
meclofenamate Na, there were pronounced increases in mechanical
moduli as a result of mixing this drug with HPMC, with large increases in
both G' (figure 4.16) and Gil (figure 4.17), suggesting that both the elastic
and viscous properties of the HPMC are enhanced by the addition of the
drug.
The magnitude of G' is directly related to the gel strength of the sample. In
a strongly cross-linked gel. G' would be much larger than Gil and not
influenced by the oscillation frequency, while a physically entangled gel
network would have a Gil exceeding G' at some point in the frequency
range with a substantial decline in G' and to a less extent Gil at low
frequencies. In a physically entangled system, polymer chains entangle
and move past each other at low frequencies so that the material behaves
more like a viscous liquid. At higher frequencies there is insufficient time
for network rearrangements to occur within one oscillation, and as a
result the response of the sample is a predominately elastic deformation.
Figure 4.19 shows that diclofenac Na had little effect on the storage and
loss moduli of 1% HPMC solutions. The slopes of the G' and Gil frequency
relationship showed a small concentration dependent increase with
respect to 1% HPMC alone. In contrast, meclofenamate Na increased the
elastic modulus of 1% HPMC solutions significantly with a corresponding
lesser effect on Gil.
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Figure 4.18 The loss (G") and storage (GO)moduli of mixtures containing 1% w[w
HPMCand varying amounts ofmeclofenamate Naat 0.1 and 10 Hz
Measurements taken in the linear viscoelastic region (LVR). Geometry = pp 2°/50 mm.
Temperature = 20 ± 0.1°C. Mean (n =3) ± 1S0
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Figure 4.19 The loss (G") and storage (G') moduli of mixtures containing 1% wjw
HPMCand varying amounts of diclofenac Na at 0.1 and 10 Hz
Measurements taken in the linear viscoelastic region (LVR). Geometry = pp 2° ISO mm.
Temperature = 20 ± 0.1°C. Mean (n =3) ± ISO
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4.4.4.3 The effect of drugs on the tan 6 values of HPMC solutions
Tan 6 values provide further evidence of the changes in viscoelascity. The
tan 6 is the ratio of G" to G' and indicates the potential of the sample to
move towards a gel-like behaviour from liquid characteristics. The point
at which tan 6 is equal to 1 (G'=G") was used as a parameter for the
interaction of a range of drug concentrations with HPMC.
Figure 4.20 shows the effect of drugs on the tan 6 of 1% w/w HPMC
solutions. It can be seen that when converting the dynamic moduli to a
tan 6 an order of magnitude shift in viscoelastic profiles caused by
mecJofenamate Na in comparison with dicJofenac Na became readily
apparent The extent to which the dynamic moduli (and tan 6) is changed
is dependent on the interaction between the drug and polymer, where a
shift in viscoelastic properties to a much more pronounced elastic
behaviour (tan 6 <1) indicates a high degree of interaction between the
drug and the polymer.
110
Chapter4
100
• OmM
A • 10mM• 20mM
• 30mM
•
'"
.. 40mM
'" •
'"10 '" • SOmM• .... .. ....,..
..... • 60mM
~ •
Qi • • • •
• • • • •
.. . ........ - ..-
•• • • •
"0 .. .. ..
...
..:. ~ I
c: .. • • • • • •ro .. ..
• •t- .. .. • • • • •.. ..
.. ..
• ... .. ..1 .. .. .. ..• •
.. .. ..
• •
._
• • •• •• ... ,.
•
0.1 +-------~~r_---~-~-....,....,
0.1 1
Frequency (Hz)
10
1000 • OmM
B • lOmM• 20mM
• 30mM
100 .. 40mM
• SOmM
·1• •y- • 60mM
ro • • •...,
• • • • • •Qi 10 i"0 • • : • * • ,.c •• •
",I .··.··(i ( Iro • • •t- .. ,
1
0.1 1
Frequency UHz)
10
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4.4.5 The effect of sodium chloride on the interaction between
drugs and HPMC
The influence of ionic species on surfactant-polymer interactions has been
studied in the literature (e.g. Masuda et al. 2002, Thongngam and
McClements 2005). As highlighted in the interpretation of the studies in
chapter 2 dissolution tests were carried out in 0.9% w]» (0.154 M) NaCI
to represent a more realistic swelling medium for the HPMChydrophilic
matrices, hence the effect of NaCl on the drug-HPMC interactions was
worthy of investigation.
4.4.5.1 The influence of sodium chloride on drug effects on HPMCsolution
cloud paint temperature (CPT)
Figure 4.21 shows the effect of 0.154 Msodium chloride (NaCI) addition to
1% w/w HPMCsolutions containing the model drugs. The effect of drugs
without the addition of sodium chloride is included within the figure for
reference. In the case of didofenac Na, the addition of NaCI to HPMC
solutions led to a decrease in the CPTat all concentrations of diclofenac Na
when compared with drug addition alone. The propensity of NaCI to
decrease the thermogelation temperature of HPMChas been noted in the
literature (8ajwa et al. 2006, Liu et al. 2008). Therefore, NaCI and
diclofenac Na addition appeared to synergistically 'salt-out' HPMC in
solution.
In the case of meclofenamate Na, the influence of NaCImanifested as two
key changes. At lower concentrations of drug, the CPT of HPMCsolutions
was lowered to a greater extent by the combination of drug and sodium
chloride, in a manner analogous to diclofenac Na and NaCl. In addition,
the meclofenamate Na concentration at which the HPMCsolutions became
'salted in' as opposed to 'salted out' was shifted to between 20 mM and 30
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mM compared with between 30 to 40 mM in the absence of NaCI. Beyond
this concentration, the CPT values increased in a similar manner
irrespective of the presence or absence of NaCI.
4.4.5.2 The influence of sodium chloride on the effect of drugs on HPMC
solution viscoelastic properties
Figures 4.22 and 4.23 show the changes in loss and storage modulus in 1%
w/w HPMC solutions containing 0.154 M NaCI at 0.1 and 10 Hz with
respect to increasing drug concentrations of meclofenamate Na and
diclofenac Na.
It can be seen that the most profound effect is the shifting of the
concentration of meclofenamate Na that resulted in the large increase in
the storage modulus. This occurred at around 30 mM in the case of drug
alone (figure 4.18) and is shifted to between 10 and 20 mM when NaCI is
present in the system (figure 4.22). There is also evidence of a plateau in
the storage modulus with respect to drug concentration. In contrast, there
was little change in the loss or storage modulus in solutions containing
diclofenac Na (figure 4.23) which is comparable to the effects of drug in
the absence of NaCI(4.19).
These results are in agreement with findings in the literature with respect
to ionic influences on surfactant-polymer interactions. For example,
Evertsson and Holmberg (1997) have shown using steady-state
fluorescence measurements that the presence of NaCI led to sos
interacting with EHEC at lower concentrations. Also, Wangsakan et al.
(2006) have shown that NaCIinfluenced the interaction between sos and
maltodextrin by reducing the onset of interactions concentration of sos.
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Figure 4.21 Modulation of the effect of diclofenac Na and meclofenamate Na on the
cloud point temperature of 1% w/w HPMCsolutions by 0.154 MNaCI
Cloud point temperature (CPT) measured turbimetrically as reduction of 50% in light
transmission (Sarker 1979). Mean (n=3) ± ISD
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Figure 4.22 The loss (G") and storage (G') moduli of mixtures containing 1% w/w
HPMC and varying amounts of meclofenamate Na and 0.154 M NaCI at 0.1 and 10
Hz
Measurements taken in the LVR. Geometry = pp 2°/50 mm. Temperature = 20 ± 0.1°C.
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Figure 4.23 The loss (G") and storage (G') moduli of mixtures containing 1% w/w
HPMC and varying amounts of diclofenac Na with 0.154 M NaCI at 0.1 and 10 Hz
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4.5 Discussion
4.5.1 The mechanism of interaction between the model drugs
and HPMC
Figure 4.24 depicts a hypothetical scheme describing how diclofenac Na
and meclofenamate Na molecules might interact with HPMC. Evidence
from the cloud point studies suggested that both drugs exert a 'salting-out'
effect This may be a result of substituted aromatic moieties within the
chemical structure (Banks 2003). The propensity to 'salt-out' the polymer
is evidenced by the suppression of HPMCsolution cloud point on addition
of low drug concentrations «30 mM). Tensiometry and PGSE-NMR
results suggested a limited association between drug and polymer at these
low concentrations and the rheological investigations confirmed there
was little change in polymer chain mobility and connectivity (figure
4.24a). However, it was seen that the different drugs exerted divergent
effects on HPMCsolution properties as their concentration was increased.
In the case of diclofenac Na (figure 4.24b). the surface tension studies
show that the drug was able to associate with the HPMC. However. the
results from tensiometry also suggested saturation of binding sites. no
formation of a drug-polymer complex as determined by SANS and
rheological analysis suggesting insufficient associated drug in order to
change polymer conformation in solution. Free drug effects predominated
and the polymer was increasingly dehydrated with respect to drug
concentration as demonstrated by the turbimetric studies.
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Figure 4.24 Proposed theory for the interaction between NSAIDs and HPMC
(A) Low polymer and drug concentration, (B) Low polymer and high diclofenac Na
concentrations and (C) low polymer and high meclofenamate Na concentrations
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The influence of meclofenamate Na contrasted with diclofenac Na (figure
4.24c). Tensiometry showed evidence of drug binding, but failed to
demonstrate a saturation concentration. This suggested that the drug
forms associative structures and co-operatively bound to HPMC,resulting
in the formation of drug-polymer aggregates detectable by SANS. These
complexes were more soluble than 'salted out' polymer, demonstrated by
an increase in cloud point temperature with respect to meclofenamate Ma
concentrations above 30 mM. Rheological analysis showed increases in
shear and complex viscosity resulting from the increased chain-chain
interactions as determined by profound changes in the mechanical moduli
of the solutions.
It is proposed that there is a dynamic balance between the associative and
the free drug effects on the properties of HPMCin solution. One effect,
mediated by free drug in solution, reduces polymer solubility and had
little or no effect on polymer viscoelastic properties. The other effect,
resulting from association of drug with polymer, led to the formation of a
drug-polymer complex with significant increases in chain-chain
interactions, resulting in large viscosity increases. In the presence of low
drug concentrations, the 'salting-out' mechanism predominates. Above a
critical concentration for meclofenamate Na but not diclofenac Na, the
drug-polymer complex predominated over free drug effects. This drug-
polymer complex possesses poly(electrolyte) characteristics of increased
viscoelastic properties, greater solubility and strong susceptibility to
modulation by ionic species.
4.5.2 Pharmaceutical Consequences
The potential pharmaceutical consequences of these interactions can be
conjectured. In other pharmaceutical systems, the interactions between
surface active drugs and polymers have been noted as being potentially
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useful in order to achieve an efficient control of release processes from
aqueous dispersions (Paulsson and Edsman, 2001, [imenez-Kairuz et al.
2002) or chemically cross-linked hydrogels (Gonzalez-Rodriguez et al.
2002, Rodriguez et al. 2003a). In our systems, polymer association with
complementary additives might be used to rapidly strengthen or induce
connections between polymeric chains and may be a useful way to obtain
considerable increases in the viscosity of dispersions.
In the case of hydrophilic matrix dosage forms, the establishment of an
adequate surface gel diffusion barrier has been proposed as being a
critical process in achieving extended release (Alderman 1984, Melia et al.
1991, Li et al. 2005). From the work in this chapter, we can speculate that
the association of drug with the polymer would affect the viscosity and gel
strength within the gel layer. This may manifest as changes in the
morphology and functionality of the gel layer and result in improved
extended release characteristics of medofenamate Na matrices over
diclofenac Na matrices by providing a more efficient barrier to drug
release. The dissolution data presented in chapter 3 suggests that this is
the case. Subsequent investigations will consider the effects of these
drugs on early gel layer development and the potential role of
incorporated diluents using a recently developed confocal microscopy
methodology.
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4.6 Conclusions
In the literature, there is strong evidence that many NSAIDsare surface
active (Attwood 1995, Fini et al. 1995) and as a consequence, surface
tension experiments were performed on aqueous solutions of diclofenac
Na and meclofenamate Na in the presence and absence of polymer. These
studies demonstrated surface activity and drug association with the
polymer. It was found that diclofenac Na saturated the HPMCwhereas
meclofenamate Na did not show a saturation concentration up to the limit
of its aqueous solubility.
Evidence of association between meclofenamate Na and HPMC (but not
diclofenac Na and HPMC) was provided by PGSE-NMRand SANS data
which suggested that this phenomenon may be responsible for the
changes in polymer solution properties containing these two drugs.
Turbidimetric studies showed that the effect of these drugs was complex,
and that the increased solubility of HPMCseen with higher concentrations
of meclofenamate Na (but not diclofenac Na) may be the result of binding
of drug molecules in sufficient numbers to form polar drug-polymer
poly( electrolyte) complexes that could overcome the inherent 'salting-out'
of the free drug molecules.
Rheological investigations showed that at whilst low concentrations, the
drugs caused only small increases in HPMCsolution viscosity. At higher
concentrations, meclofenamate Na caused a dramatic increase in solution
viscosity to a value two orders of magnitude greater than that of 1%
HPMC alone. This would suggest that a fundamental change in
microstructure has taken place as a result of drug association with
meclofenarnate Na and suggests that this drug induces considerable inter-
chain bonding.
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Chapter 5
The effect of drugs and ionic media on the
morphology and functionality of the gel layer
in HPMC hydrophilic matrices
5.1lntroduction
In the preceding chapter, a theory describing the interaction between
HPMC with dicJofenac Na and meclofenamate Na was developed from
evidence of drug effects on HPMCsolution solubility and viscoelasticity.
This interaction and its influence on HPMCparticle swelling and early gel
layer formation may provide an insight into the drug release mechanism
and an explanation for the release profiles presented in chapter 2. The
next stage is to obtain experimental evidence to confirm or disprove the
hypothesis that interactions between the drugs and HPMC influence the
formation and functionality of the early gel layer in hydrophilic matrices.
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S.l.l The importance of particle swelling in HPMC hydrophilic
matrix dosage forms
Essentially the HPMChydrophilic matrix is a compressed particle bed of
an active pharmaceutical ingredient (API), HPMC and other tabletting
excipients (Hogan 1989, Melia 1991). It can be anticipated that HPMC
particle swelling and coalescence during gel layer development will
greatly impact on the capability to form an adequate diffusion barrier.
This rationale is supported by the recognition that a major influence on
the extended release properties of many polymers is the ability to hydrate,
swell and coalesce (Alderman 1984, Melia 1991, Ford 1999).
S.1.2 Selection of a technique to characterise the swelling
properties of HPMC particles
Several techniques are described in the literature to investigate the effect
of dissolved material on polymer swelling. These have included:
(i) gravimetric measurements (Mortazavi and Smart 1993, Pini et
al.2008),
(ii) volumetric measurements (Bencherif et al. 2008),
(iii) direct visualisation (Wan and Prasad, 1990, Degim and
Kellaway 1998),
(iv) ion beam analysis (Riggs et al. 1999),
(v) nuclear magnetic resonance (NMR)microscopy (Katzhendler et
al. 2000, Marshall eta!. 2001),
(vi) electron spin resonance (ESR) (Katzhendler et al. 2000)
(vii) thermomechanical analysis (TMA)(Nakamura et al. 2000).
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The method chosen for this thesis was originally described by Wan and
Prasad (1990) who used video microscopy to study the swelling
characteristics of individual tablet disintegrant particles in water (figure
5.1). The swelling of excipients was measured by placing a particle on a
microscope slide and covering it with a cover slip. The particle was
hydrated by water, introduced using a micro-syringe. The swelling was
recorded using video microscopy and the change in area of the swelling
particle measured using image analysis. This method was selected for use
in this chapter as it is high-throughput and simple with respect to the
experimental procedure and equipment
5.1.3 Selection of a technique to characterise the gel layer
development in HPMC hydrophilic matrices
The formation and growth of the gel layer plays a significant role in
extending drug release (Alderman 1984, Melia 1991, Ford 1999, Li et al.
2005). Several methods have been employed to observe hydrophilic
matrices during the processes of gel layer formation, erosion and
dissolution. These include (i) photography and video imaging (Gao and
Meury 1996, Colombo 1999), (ii) ultrasound (Konrad et al. 1998), (iii)
cryogenic SEM (Melia et al. 1993), (iv) thermomechanical or texture
analysis probes (Pillay and Fassihi 2000), tv) laser positioning (Mitchell et
al. 1993), (vi) NMR microscopy (Bowtell et al. 1994) and (vii) confocal
microscopy (Bajwa et al. 2006). A review of the use of these different
techniques has been provided in section 1.7.
Each of these techniques possesses their own advantages and
disadvantages but few are capable of the spatial and temporal resolution
required to follow the processes of early gel layer development.
Fluorescence imaging offers good spatial resolution, sensitivity and time
resolution (Gumbleton and Stephens 2005, White and Errington 2005)
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and confocal microscopy provides fluorescent images that are free from
out-of-focus flare.
5.2 Confocal Laser Scanning Microscopy (CLSM)
CLSM has become increasingly used in the characterisation of
pharmaceutical systems (Pygall et al. 2007) including topical dosage
forms, pellets and hydrophilic matrices. The use of CLSMto explore the
early development of the HPMC gel layer microstructure has been
described by 8ajwa (8ajwa et al 2006). The technique exploits the
temporal and spatial capabilities of CLSMto provide imaging of the rapid
structural developments within the emerging gel layer of hydrophilic
matrix tablets on hydration in liquids. The following sections provide the
reader with brief details of the theory of confocal microscopy.
5.2.1 Theory of Confocal Laser Scanning Microscopy
CLSM offers several advantages over conventional optical microscopy.
The most important is that out-of-focus blur is essentially absent from the
image, giving the capability for direct non-invasive serial optical
sectioning of intact and living specimens (Sheppard and Shotton 1997).
The confocal microscope was first conceived by Minsky in 1955 (Minsky
1988) who determined that in order to observe individual nerve cells
within a packed central nervous system, a microscopic technique was
required to prevent interference of scattered light from cells adjacent to
the cell of interest. To achieve this, he designed a simple instrument in
which a pinhole was placed in front of an objective and condensing lens.
The pinholes (now termed confocal apertures) discriminated out-of-focus
light contributions from the specimen. In 1961 Minsky patented designs
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in two geometries: the first used transmitted illumination, with a separate
objective lens and condensing lens on either side of the specimen, whilst
the second used epi-illumination, where the same lens was used as both
an objective and a condenser. This simple concept formed the basis for all
future confocal microscopes (Sheppard and Shotton 1997).
Figure 5.1 shows a schematic illustration of the principal components and
light paths in a confocal microscope. Excitatory laser light from the
illuminating aperture passes through an excitation filter (not shown) and
is reflected by the dichroic mirror. It is then focused by the microscope
objective lens to a diffraction limited spot at the focal plane within the
fluorescent specimen. The emitted fluorescent light is captured by the
same objective lens and is focused onto a photomultiplier. Only 'in focus'
signals are aligned with the aperture and so pass through to the detector
Any signal emanating from above or below the focal plane is stopped by
the confocal aperture and so not collected, therefore 'blurring' of the
image is avoided as the 'out-of-focus' signal does not contribute to the
image. The system shown in figure 5.1 is an epi-illumination system as the
same lens is used as both objective and condenser. The signal detected by
the photomultiplier is converted to a digital signal and displayed on a
computer monitor, with the intensity of the fluorescent emission
corresponding to the relative intensity of the pixel in the image. To build a
complete image, the beam is scanned over the sample using controlled
galvanometer driven mirrors. A more detailed review of confocal
microscopy is given elsewhere (Sheppard and Shotton 1997).
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Photomultiplier (PMT)
Illuminating Aperture
Point Source Dichroic Mirror
In-focus rays
Out-of-focus rays
Figure 5.1 Schematic illustration showing the principal components and light paths
in a confocal laser scanning microscope
Adapted from Sheppard and Shotton (1997).
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5.2.2 Characterisation of the fluorophore Congo red
Congo red (figure 5.2) is used as a histo-pathological and botanical stain
for cellulose and in textile dyeing (Horobin 2002). It has been shown to
have a high binding affinity with (1-4)-I3-linked D-glucopyranosyl native
cellulose sequences (Wood 1980).
+
Na
Figure 5.2 Chemical structure of Congo red
Yamaki et al. (2005) have shown that Congo red appears to interact with
cellulose through a combination of electrostatic and hydrophobic
interactions and hydrogen bonding between its azo and amino groups
with the native cellulose fibres. There is an increase in the dye sorption
when cellulose fibres are hydrated and molecular access of the dye is
enhanced (Mirza et al. 1996). In the first paper to describe the use of
confocal microscopy to investigate early gel layer formation, Bajwa et al.
(2006) have shown how the use of Congo red at a concentration of
0.008% wIv allowed determination of various regions within a swelling
matrix tablet of HPMC,without being at a high enough concentration to
affect gel formation and matrix swelling.
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5.3 Aims and Objectives
Chapter 4 investigated the interaction between HPMC and the model
drugs diclofenac Na and meclofenamate Na. This chapter presents
investigations to determine the pharmaceutical consequences of these
interactions with respect to HPMCparticle swelling and early gel layer
formation.
Specifically, the aims of this chapter are:
• To investigate the effect of increasing diclofenac Na and
meclofenamate Na matrix content on HPMC particle swelling
and early gel layer development
• To relate the influence of drugs on HPMC solution
properties to particle swelling and gel layer formation.
• To investigate the influence of sodium chloride on drug
effects on early gel layer formation.
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5.4 Materials and Methods
5.4.1 Materials
5.4.1.1 HPMC
Asieve fraction of 63-90 11mHPMC(Methocel E4MCRPremium) was used
in matrix manufacture. Details of the source and batch number are
presented in appendix 1.
5.4.1.2 Drugs
Diclofenac Na and meclofenamate Nawere used as supplied. Details of the
source and batch number are presented in appendix 1.
5.4.1.3 Silicon dioxide
Silicon dioxide was used as supplied. Details of the source and batch
number are presented in appendix 1.
5.4.1.4 Water
Solutions were prepared using Maxima HPLCgrade water (source details
in appendix 1).
5.4.2 Measurement of singleHPMC particle swelling
The method described by Wan and Prasad has been developed within the
Formulation Insights Group (Richardson 2002). In the developed method.
a haemocytometer counting chamber is used instead of a microscope slide
as the distance between the cover slip and chamber surface is precision
engineered to 75 11mand an HPMCparticle from the sieve fraction 63-90
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urn placed in the chamber would be trapped by the weighted cover slip.
Trapping the particle in this manner restricts axial swelling and ensures a
fixed volume of swelling (figure 5.3). As a consequence, only radial
swelling occurs and the extent of swelling can be calculated from a 20
image using image analysis.
Microscope 20
field of view
Weight of
jBluTack®\
•/1 0
Haemocytometer counting chamber
with a chamber depth of lOOl-Lm
/swelling. •
,~ - [a,~
~~===::;:._Jt
Radial
Injection of
artificial
saliva
Cover Slip Haemocytometer
counting chamber
particle
swelling
Figure 5.3 The experimental geometry used to visualise single particle swelling
(adapted from Richardson 2002)
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5.4.3 Method used for the visualisation of single particle swelling
A single HPMCparticle was randomly selected from the 63-90 urn HPMC
sieve fraction used for matrix manufacture and placed onto the centre of a
haemocytometer counting chamber (Thoma, Hawksley, UK). The particle
was covered by a cover slip and the cover slip weighted on either side by
Blu-Tack® (Bostick Ltd, Leicester, UK). 15 ~L of hydration fluid (either
water or additive solution) was injected at the front of the chamber, close
to the cover slip, using a micropipette. Capillary forces between the
chamber surface and cover slip sucked fluid between the interface and
immersed the single particle. Using an optical microscope (Nikon
Labophot, x2 objective (Nikon UK Ltd Surrey, England), COHU High
Performance CCDCamera (Brian Reece Scientific Ltd, Berkshire, UK) it
was possible to visualise the radial swelling of individual particles in two
dimensions. Image analysis software (Image Pro Plus v.6.2, Media
Cybernetics, USA) captured a time sequence of 2D images of the swollen
particle at pre-determined time periods (t). The extent of radial particle
swelling was calculated by software measurements of the swollen area
and used to determine the normalised swollen area as follows:
Normalised = (Particle area at time t (pixels) - Particle area at t-O (pixels)
area of particle Particle area at t=O (pixels
at time (t)
Equation5.1
5.4.4 Preparation of drug solutions
Solutions of diclofenac Na and meclofenamate Na (30 and 60 mM) were
prepared in water in 100 ml volumetric flasks. 15 ml of the drug solution
was added using a pipette to a scintillation vial containing the appropriate
amount of Coomassie Blue dye. The vials were covered with aluminium
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foil to avoid exposure to light and minimise photochemical reactions (e.g.
photolytic oxidation). The solutions were stirred overnight to ensure an
even distribution of the dye.
In the imaging experiments. the Coomassie blue dye allowed the
differentiation of HPMC particles in the surrounding drug solution. The
dye provides a dark background. enabling easier image acquisition and
analysis and does not interact with HPMCparticles at this concentration
(Wong 2008).
5.4.5 Manufacture of hydrophilic matrix tablets
5.4.5.1 Sieving of HPMC
Fractionation of HPMC by sieving was carried out using the method
described in section 3.2.6.1.
5.4.5.2 Formulation preparation
Formulation preparation was undertaken as described in section 3.2.6.2.
The formulations of binary drug and HPMCmatrices are shown in table
5.1
5.4.5.3 Manufacture of HPMCmatrices
Manufacture of HPMCmatrices was undertaken using the detailed method
described in section 3.2.6.3 using a compression pressure of 180 MPa and
8 mm tablet punches (I Holland. Nottingham. UK).
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Matrix com~laon
PerCMtlp of drill (%) Drill (m.) HPMC(m.)
0 0 200
10 20 180
30 60 140
50 100 100
70 140 60
80 160 40
Table 5.1 The composition of the binary matrix tablets used in this study
Matrices weighed 200± 5mg, compressed to 180 MPa. Details of matrix manufacture are
described in 3.2.6.3
5.4.5.3 Matrix storage
Matrices were stored under the conditions described in section 3.2.6.4.
5.4.5.4 Sample cell geometry for confocal and video microscopy imaging
As a hydrophilic matrix hydrates, a gel layer is formed around the dry core
which expands as the level of polymer hydration increases. During this
expansion, a fixed imaging position is difficult to achieve as the movement
of the matrix may take the emerging gel layer out of the focal plane. To
overcome this limitation, the matrices were held in place using the "Fixed
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Optical Geometry" (FOG)Apparatus. Figure 5.4 is a schematic diagram of
the experimental geometry. It is designed to hold a matrix tablet in a
stationary position for imaging, in a similar manner to devices used in
other imaging studies (Colombo et al. 1999. Bettini et al. 2001).
To reduce the effect of the apparatus on water ingress during the initial
period of hydration. the Perspex discs were coated with Sigmacote (Sigma.
Poole. UK). a chlorinated organopolysiloxane. This made the Perspex
discs highly water repellent and prevented hydration media seeping
between the surface of the tablet and the Perspex disc. The apparatus and
the hydration media were maintained at 37 ±lQC throughout the
experiment by means of a water-jacketed beaker.
5.4.6 Experimental method for confocal imaging of matrix tablets
All confocal imaging was performed using a BioRad MRC-600 confocal
microscope [Biorad, Hemel Hempstead. UK) equipped with a 15 mW
Krypton Argo laser attached to a Nikon Optiphot upright microscope. The
excitatory laser line 488 nm (15 mW) was used for all experiments and
fluorescence emission was captured at 510 nm using a BHSfilter block.
The setting of the confocal microscope to standardise the background was
optimised during preliminary experiments at a pixel intensity of 5 (on a
scale of 0-255) and the gain was set to provide the brightest possible
image without excessive saturation. The confocal aperture was set at 2 as
optimised in the Bajwa (2006) work to produce sufficient fluorescent
detail. Capture of the single wavelength images was as a 512 x 768 pixel
array, with each pixel coded 0-255 for fluorescent intensity using a
continuous grey-scale false look-up table (LUT). To improve the signal to
noise ratio. images were the average of three scans (Kalman averaging).
The lens used was an x4/0.13NA air lens [Nikon, UK).
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Figure 5.4 Schematic diagram of the experimental geometry used during confocal
imaging (adapted from Bajwa et al. 2006)
Matrices were hydrated in either degassed water or 0.9% wIv NaCIsolution maintained
at 37"Cusing a geometry which allowed the tablets to be observed from above while
undergoing hydration at the radial surface.
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5.4.7Image analysis
Measurements of gel layer thickness from the confocal images were
carried out using Image Pro Plus, version 6.2 (Media Cybernetics,
Maryland, USA). A grid of 10 evenly spaced horizontal lines was
superimposed over the images in the same position and measurements
were taken along the grid lines between the defined boundaries and
averaged (n = 10) for each time interval. Experiments were performed in
triplicate.
5.4.8 Matrix tablet disintegration testing
Disintegration testing of HPMCmatrix tablets was undertaken using a four
station Erweka USP disintegration testing apparatus (Copley Scientific,
Nottingham, UK)using the method detailed in section 3.2.7.
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5.5 Results
The effect of dissolved diclofenac Na and meclofenamate Na on HPMC
particle swelling was investigated upon hydration in water and 0.9% wtv
NaCI. The underlying rationale for exploring swelling in both media was
the observation that the drug/HPMC interaction was influenced by NaCIin
solution (section 4.5.6).
5.5.1 The effect of drugs on HPMC particle swelling and
coalescence
Figure 5.5 shows the swelling of an individual particle of HPMCand figure
5.6 shows the coalescence of HPMCparticles in water. Distinctive features
can be seen in both experiments. In the case of individual particle
swelling, there was rapid expansion of the particle swollen area in the first
15 seconds of hydration. The swollen area of the particles was seen to
increase with time, with the exterior boundary of the swollen particle
becomingly progressively less distinct from the swelling medium.
In the polymer particle coalescence experiments (figure 5.6), the swelling
behaviour of individual particles was replicated but as the boundaries
between particles met, there was a gradual loss of a distinct interface as
hydration proceeded. Eventually, a continuous phase of swollen particles
was seen to form. Measurements were made in 30 mM and 60 mM drug
solutions (figure 5.7). It can be seen that the swelling was increased in a
concentration-dependent manner in meclofenamate Na solutions but was
suppressed in a in diclofenac Na solutions.
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Unhydrated HPMC particle
•
• 111
• •
f
., .. '..'
Periphery of swollen HPMC particle
Figure 5.5 Real-time observation of single HPMCparticle swelling using O.003M
Coomassie blue as a visualisation aid
(A) 0 minutes (8) 15 seconds post-hydration (C) 30 seconds post-hydration (D) 60
seconds post-hydration, (E) 3 minutes post-hydration, (F) Sminutes.
Scale bar 200 urn
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Figure 5.6 Real-time observation of HPMCparticle coalescence using O.003M
Coomassie blue as a visualisation aid
(A) 0 minutes (8) 15 seconds post-hydration CC) 30 seconds post-hydration (D) 60
seconds post-hydration, (E) 3 minutes post-hydration, (F) 5minutes post-hydration.
Scale bar 200 11m
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Figure 5.7 The swelling of individual HPMCparticles in O.003MCoomassie blue
solution as a function of drug concentration
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5.5.2 Early gel layer formation and growth in HPMC hydrophilic
matrices
Figure 5.8 shows a time series of fluorescent images of gel layer
development in water. The images obtained show the development of
three distinct regions as described by 8ajwa et al. (2006): 81- the intense
fluorescent boundary at the periphery of the matrix, 82- an intermediate
region which comprised of domains exhibiting little fluorescence, and 83-
a network of penetrating towards the dry core of the matrix (figure 5.9).
For a detailed interpretation of polymer hydration and behaviour in each
of the regions, the reader is directed to this paper. For the purposes of
this thesis, only the salient points will be considered.
In our experiments, the innermost network region (B3) was visible
immediately on contact of the matrix with the hydration medium. 8ajwa
et al. (2006) have suggested that this region may highlight the rapid
uptake of the hydration medium by capillary action into the pores of the
matrix. It also provided a measure of fluorophore penetration into the
tablet core. The highly fluorescent boundary at the periphery of the
matrix (B1) was a consistent feature throughout the time series. This
region is an area of intense fluorescence as a result of the molecular access
provided by high polymer hydration and where the polymer is
disentangling and dissolving. The outer edge of 81 provides a boundary
which, by superimposing the boundary of the dry tablet, can be utilised to
measure the radial gel layer swelling kinetics in the early stages of matrix
hydration.
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Figure 5.8 Fluorescence images of 100% w/w HPMCmatrices hydrating in water
The images are coded for fluorescence intensity from white (highest) to black (lowest) as
indicated by the wedge. The bright regions indicate areas of high fluorescence,
highlighting regions of polymer hydration where the fluorophore has penetrated and
interacted with the cellulose backbone. Matrices were hydrated for 15 minutes in
0.008% w/v Congo red maintained at 37°C ± lQC. Ex488/Em>SlO nm. Scale bar e 500
urn.
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Bl B2 B3
Figure 5.9 A confocal image of 100% HPMCtablet hydrating in water annotated
with the key regions
Region A is the hydration medium, region 8 is the fluorescent areas within the matrix and
region C is the core of the tablet Regions 81, 82 and 83 are sub-sections within the
fluorescent region (refer to text for explanation of the different regions).
Image taken after 5 minutes, hydrated in 0.008% Congo red at 37°C. Ex488/Em>S10 nm.
Scale bar = 500 urn.
143
Chapter 5
The intermediate fluorescent region 82 contributes significantly to the
matrix swelling. From the earliest time points, the 82 region is
characterised by non-fluorescent domains interconnected with strands of
fluorescence. The pattern is indicative of that observed in region 83, with
the fluorescent strands possibly outlining individual particles or groups of
HPMC particles. If this rapidly swelling region is compared to the position
of the original dry matrix then it can be seen that (i) swelling is originating
from very near to the matrix surface and (H) behind the boundary, the
pattern of fluorescence changes very little. This suggests that the surface
particles contribute disproportionately to matrix swelling in the early
formation of the gel layer. This finding reflects previous work from bead
tracking, which showed the outermost layer of a xant han hydrophilic
matrix also contributed disproportionately to gel layer formation (Adler et
al.1999).
5.5.2.1 The effect of polymer dilution on early gel layer formation and
growth in HPMC hydrophilic matrices
As a control for assessing the possible effects of the drugs, the influence of
reducing the level of HPMC in the hydrophilic matrices on the gel layer
formation was determined (figure 5.10). The level of polymer was
reduced by the addition of silicon dioxide (SiOz), a compound with very
low solubility (0.012g in 100 ml) and which was found to have limited
water uptake «1% over 4 weeks). It can be seen up to the very highest
Si02 content (80%w/w). the gel layer appeared to form normally,
suggesting that a polymer content of at least 30% w /w forms a functional
gel layer, with the 'classical features' described above for a 100% HPMC
matrix tablet.
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Figure 5.10 The effect of incorporating silicon dioxide in the matrix on the
evolution of the HPMCgel layer microstructure after I, 5 and 15 minutes.
The images are coded for fluorescence intensity fran: white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium maintained COntained
0.008% w]» Congo red at 37°C. Ex488>510 nm. Scale bar = 500 urn
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5.5.2.2 The effect of drugs on the swelling and gel layer formation in water
Figure 5.11 shows the effect of increasing the diclofenac Na content and
decreasing the HPMCcontent on the developing microstructure of the gel
layer. Figure 5.12 and figure 5.13 shows a focus on 50% and 80% w/w
diclofenac Na matrices and are annotated with the key features to provide
clearer illustration of the effect of the drug. Although there appeared to be
gel layer formation at all diclofenac Na contents, there was an overall
reduction in gel layer swelling and expansion with respect to dry core as
the level of diclofenac Na was increased within the matrix (figure 5.14).
The region B2 appeared to be most affected (figure 5.12 and figure 5.13)
in comparison with the matrices containing the same level of HPMCwith
silicon dioxide. This is the region where columnar swelling and growth
occurs, and the changes observed suggest that diclofenac Na was having a
reductive effect on particle swelling and growth. This assertion is
supported by the single particle work in section 5.5 which shows how
single particle swelling was suppressed by increasing concentration of
this drug.
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Figure 5.11 The effect of incorporating diclofenac Na in the matrix on the evolution
of the HPMCgel layer microstructure after 1, 5 and 15 minutes.
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium maintained contained
0.008% w]» Congo red at 37°C. Ex488>S10 nm. Scale bar = 500 11m
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Figure 5.12 The effect of incorporating 50% w[w diclofenac Na in the matrix on the
evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w /v
Congo red maintained at 37°C. Ex488>S10 nrn, Scale bar = 500 urn
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Figure 5.13 The effect of incorporating 80% w Iw diclofenac Na in the matrix on the
evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w Iv
Congo red maintained at 37°C. Ex488>510 nrn, Scale bar" 500 urn
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Figure 5.14 The effect of drug loading on the radial gel layer growth in HPMC
matrices containing diclofenac Na
Hydration in 0.008% w/v Congo red at 37°C. Gel layer thickness measured from dry
tablet boundary to the edge of region B1. Mean (n=3) ±1 SO
150
Chapter 5
Figure 5.15 shows the effect of increasing meclofenamate Na content on
the morphology of the HPMCgel layer when hydrated in water. As the
meclofenamate Na content was increased within the matrix, there was a
progressive change in the gel layer microstructure. This begins to occur
with 50% w/w meclofenamate content in the matrix (figure 5.16) and is
most clearly shown in the series of images of80% w/w meclofenamate Na
matrices in figure 5.17. The gel layer appeared increasingly more diffuse,
with less controlled swelling of individual HPMC particles. The highly
fluorescent region lost its contrast with the remainder of the gel layer with
the higher meclofenamate Na content. In addition, there was extensive
expansion with respect to the dry matrix boundary. The overall matrix gel
layer growth with respect to the dry matrix is shown in figure 5.18. In
contrast with diclofenac Na matrices, it showed an increase in the gel layer
growth with increasing meclofenamate Na content. This increased gel
layer growth with less HPMCcontent suggests a more expansive gel layer
but with less HPMCconcentration within the gel layer and consequently
less barrier function. This hypothesis was supported by images of the
receding matrix core behind the dry boundary line with higher
medofenamate Na content, suggesting enhanced erosion of the matrix
core.
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Figure 5.15 The effect of incorporating meclofenamate Na in the matrix on the
evolution of the HPMCgel layer microstructure after 1, 5 and 15 minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% wjv
Congo red maintained at 37°C. Ex488>S10 nm. Scale bar = 500 urn
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Figure 5.16 The effect of incorporating 50% w/w mecIofenamate Na in the matrix
on the evolution of the HPMC gel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes.
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w Iv
Congo red maintained at 37°C. Ex488>510 nm. Scale bar = 500 um
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Figure 5.17 The effect of incorporating 80% w/w meclofenamate Na in the matrix
on the evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes.
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w]»
Congo red maintained at 37°C. Ex488>510 nrn. Scale bar = 500 urn
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Figure 5.18 The effect of drug loading on the radial gel layer growth in HPMC
matrices containing the indicated meclofenamate Na content
Hydration in 0.008% wjv Congo red at 37°C. Gel layer thickness measured from dry
tablet boundary to the edge of region Bl. Mean (n=3) ±1 SD
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5.5.2.2 The effect of drugs on the swelling and gel layer formation in 0.9%
w/v NaCI
Figures 5.19 to 5.24 show the same experiments conducted in section
5.5.2.2 but with the matrices hydrating in 0.9% w/v NaCl. This allowed
direct correlation with the medium used in the dissolution studies of
Banks presented in chapter 2.
In figure 5.19, it can be seen that as the level of diclofenac Na was
increased within the matrix, there were changes apparent in early gel
layer microstructure. The 'classic' gel layer morphology (i.e. a clear Bl, B2
and B3 region) appeared to form in matrices containing up to 30% w/w
diclofenac Na. The matrices of 50% diclofenac Na content and above
showed disruption of gel layer formation. At 50% w/w diclofenac Na
(figure 5.20), this disruption occurred at the earliest time points, with
impaired hydration of HPMCparticles at the surface of the matrix that are
initially exposed to the hydration medium. As time proceeded, swelling
eventually recovered as time proceeded, although the region at the
boundary between the expanding matrix and the swelling medium was far
greater. This has been postulated as the region where the polymer is
highly plasticised by the hydration medium and begins to dissolve,
facilitating fluorophore access (Bajwa et al. 2006).
Matrices containing over 70% w/w diclofenac Na exhibited a mass of
discrete hydrated but non-swelling HPMC particles at the matrix
periphery. The focus on 80% w/w diclofenac Na shows this more clearly
in figure 5.21. The outward expansion of the matrix is clear evidence of
polymer swelling, as this would provide the driving force for matrix
growth. The images show little particle coalescence and formation of a
functional diffusion barrier. The measurements of radial gel layer growth
(figure 5.22) shows a loss of controlled radial swelling in 70% and 80%
w/w diclofenac Na matrices.
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Figure 5.19 The effect of incorporating diclofenac Na in the matrix on the evolution
of the HPMCgel layer microstructure after 1, 5 and 15 minutes hydration in 0.9%
w/vNaCI
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.9% w/v
Congo red maintained at 37°C. Ex488>s10 nm. Scale bar > 500 urn
157
Chapter 5
Large swelling of the
matrix in the first
minute of hydration
with respect to the
dry tablet boundary
compared with
control matrices
Some loss of a
clear intermediate
swelling region
with absence of
clear columnar
swelling and
growth
Some degree of
recovery towards
the end of the
hydration period,
although some
reduction in
individual particle
coalescence
Figure 5.20 The effect of incorporating 50% w/w dicIofenac Na in the matrix on the
evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes hydration in 0.9% w]» NaCI
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containined 0.008% w/v
Congo red maintained at 37°(. Ex488>510 nrn. Scale bar = 500 11m
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Figure 5.21 The effect of incorporating 80% wIw diclofenac Na in the matrix on the
evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes hydration in 0.9% w/v NaCI
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium contained 0.008% wIv
Congo red maintained at 37°C. Ex488>510 nm, Scale bar = 500 urn
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Figure 5.22 The effect of drug loading on the radial gel layer growth of HPMC
matrices containing the indicated percentages of diclofenac Na in 0.9% wIv NaCI
Hydration in 0.008% w/v Congo red and 0.9% NaCI at 37°C. Gel layer swelling measured
from dry tablet boundary to the edge of region B1. . Mean (n=3) ±1 SO
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Figure 5.23 shows the effect of increasing meclofenamate Na content on
the morphology and swelling of HPMC matrices hydration in 0.9 % w]»
NaCl. As with the matrices hydrated in water, there appeared to be
increased hydration of the HPMC particles within the gel layer with
increasing meciofenamate Na content In figure 5.24, it can be seen in that
the morphology has changed clearly from matrices containing silicon
dioxide and the same formulation hydrating in water. This may be a
consequence of the surface activity of meclofenamate Na acting as a
wetting agent for individual agent HPMC particles. However, when
hydrated in NaCl, there was a distinct, highly hydrated region at the
matrix periphery, overall matrix gel layer swelling was suppressed and
there was a reduction in recession of the matrix core. This was most
clearly shown when comparing the 80% w/w formulation shown in figure
5.25 with the same formulation hydrated in water depicted in figure 5.17.
Although swelling and expansion was greater than diclofenac matrices,
the general coherence of the gel layer appeared to improve with NaCI
present in the hydration medium. The measurements of gel layer growth
in figure 5.26 show that swelling was largely unaffected by increasing
meclofenamate Na when swelling in 0.9% NaCI, in contrast with the same
formulations swelling in water (figure 5.17) although clearly there are
profound changes in the gel layer morphology.
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Figure 5.23 The effect of incorporating rneclofenamate Na in the matrix on the
evolution of the HPMCgel layer microstructure after 1, 5 and 15 minutes hydration
in 0.9% w/v NaCI
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w/v
Congo red maintained at 37°C. Ex488>S10 nm. Scale bar = 500 11m
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hydrating in water
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control
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matrices
Figure 5.24 The effect of incorporating 50% wIw mecJofenamate Na in the matrix
on the evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes hydration in 0.9% w/v NaCI
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w Iv
Congo red maintained at 37°C. Ex488>slO nm. Scale bar = 500 urn
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Figure 5.25 The effect of incorporating 80% w/w meclofenamate Na in the matrix
on the evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes hydration in 0.9% w/v NaCI
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w Iv
Congo red maintained at 37°C. Ex488>510 nm. Scale bar = 500 urn
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Figure 5.26 The effect of drug loading on the radial gel layer growth of HPMC
matrices containing the indicated percentages of meclofenamate Na in 0.9% w tv
NaCI
Hydration in 0.008% w]» Congo red and 0.9% NaCl at 37°C. Swelling measured from dry
tablet boundary to the edge of region Bl. Mean (n=3) ±1 SD
165
Chapter 5
5.5.3 The effect of diclofenac Na and meclofenamate Na
incorporation on the disintegration of HPMC matrices
Table 5.2 shows the effect of diclofenac Na and meclofenamate Na content
on matrix disintegration when hydrated in water and in 0.9% w]» NaCl.
Up to 50% w/w drug content, all the matrices resisted disintegration for
the duration of the experimental period, irrespective of drug or type of
hydration medium. For these matrices, there appeared to be sufficient
HPMCcontent to overcome the burdens of internal drug and the external
electrolyte in the hydration medium. However, different behaviour was
seen at higher levels of drug content At 70% w[v«, matrices containing
dicIofenac Na remained intact in water but disintegrated in 0.9% NaCI
after 60 minutes. This trend was reversed for meclofenamate Na matrices,
with disintegration in water after 45 minutes but survival in 0.9% NaCIfor
the duration of the experimental period.
This difference in disintegration behaviour was even more apparent at
80% w/w drug loading. At this level, dicIofenac Na matrices failed in both
water (75 minutes) and saline (15 minutes). In contrast, medofenamate
Na matrices failed in both media but with increased durability with
respect to NaCI concentration (15 minutes and 75 minutes in water and
0.9% NaCIrespectively).
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Tablet content (%w/w) Disintegration times of Disintegration times of
matrices containing matrices containing
diclofenac Na (min) meclofenamate Na (min)
Drug HPMC Water O.9%NaCI Water 0.9% NaCI
0 100 >120 >120 >120 >120
10 90 >120 >120 >120 >120
30 70 >120 >120 >120 >120
SO SO >120 >120 >120 >120
70 30 >120 60 95 >120
80 20 75 20 15 75
Table 5.2 The disintegration times for HPMC containing diclofenac Na and
meclofenamate Na in 0.9% NaCIand water
Disintegration data obtained in 900 ml at 37°C, observations made from 4 tablets and
taken to the nearest minute
167
Chapter 5
5.5.3.1 The effect of increasing electrolyte challenge on the disintegration of
meclofenamate Na and diclofenac Na matrices
The earlier confocal images together with the results in table 5.1
suggested either synergistic or antagonistic effects between internal drugs
with external electrolytes in the hydration medium. This was further
explored by increasing the concentration of NaClin the hydration medium
and determining the effect on the disintegration times.
Figures 5.27-5.29 show the effect of increasing NaCl challenge on the
disintegration of formulations containing 10% w/w, 50% w/w and 80%
w/w mecIofenamate Na and diclofenac Na. At 10% w/w incorporation
(figure 5.27), there was little difference between the matrices, although
both disintegrated at a lower threshold concentrations in comparison
with a 100% HPMCmatrix at 0.7 MNaCI.
At drug loadings of 50% wlw, clearer differences were seen between the
drugs (figure 5.28). In the case of mecIofenamate Na matrices, the
disintegration threshold was not reached until 0.4M NaCI. Above this
concentration, matrices disintegrated rapidly. In diclofenac Na matrices,
the disintegration threshold was found to be between 0.256 M and 0.3 M
NaCI.
At the highest level of drug loading (80% w/w) even clearer differences
were apparent between the drugs (figure 5.29). Meclofenamate Na-
matrices failed in water but as NaCl was introduced into the swelling
medium, matrix integrity was maintained for the duration of the
experimental period. The matrices exceeded the disintegration threshold
of pure HPMC matrices (0.7 M). This suggests that mecIofenamate Na
afforded a protective effect to NaCIchallenge. In contrast, diclofenac Na-
containing matrices were found to disintegrate in all the swelling media,
irrespective of the concentration of NaCl.
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Figure 5.27 The effect of sodium chloride challenge on the disintegration times of
10% w jw meclofenamate Naand diclofenac NaHPMCmatrices
Disintegration determined using USPmethodology at 37°C. Tested conducted maximally
for 120 minutes. Mean (n=4)
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Figure 5,28 The effect of sodium chloride challenge on the disintegration times of
50% wjw mecJofenamate Na and diclofenac Na HPMCmatrices
Disintegration determined using USPmethodology at 37°C. Tested conducted maximally
for 120 minutes, Mean (n=4)
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5.6 Discussion
5.6.1 The effect of diclofenac Na on HPMC gel layer formation
In Chapter 4, it was shown that diclofenac Na progressively "salted-out"
HPMC from solution in a concentration dependent manner, making the
polymer less soluble but with minimal effect on the viscoelastic
properties. Investigations in this chapter suggest that these effects in
solution may manifest as changes in the structure and function of the gel
layer. When hydrated in water, diclofenac Na matrices exhibited little
change in their swelling properties or gel layer morphology, irrespective
of changes to the drug: polymer ratio. The rapid swelling of HPMC in
water appeared sufficient for as little as 20% wIw HPMCto overcome the
'salting out' effect of the drug, and patterns of disintegration and gel layer
formation were not significantly different from pure HPMCmatrices.
However, when the hydration medium was changed to 0.9% w[v NaCI
there were clear differences between the different formulations. Matrices
containing over 50% wIw drug exhibited a synergistic 'salting-out' of the
polymer, with the combined effects of drug in the matrix and NaCI in the
hydration medium resulting in matrix failure and disintegration. Confocal
images showed that the HPMC content in formulations containing high
drug content and hydrated in saline was insufficient to produce a coherent
gel layer. There was clear erosion of the gel layer, comprising of partially
swollen polymer particles. The polymer appeared to be excessively 'salted
out' and failed to form a coherent gel layer. As in water, a 50% polymer
level was sufficient to overcome the 'salting-out' effects of the drug in the
matrix and the 'salting-out' effect of the NaCIin solution.
This synergy was analogous to the 'salting out' effects of diclofenac Na and
NaCIon the cloud point of HPMCsolutions in which the combined effect of
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was greater when they were present in solution alone (chapter 4). Ford
(1999) has stated that a reduction in cloud point temperature is an
indication of decreased polymer solubility and a reduced capacity of the
polymer to imbibe water. Subsequently, this damages the ability of HPMC
to hydrate and form a protective gel layer at the matrix surface. The
evidence in this chapter supports this assertion. Rajabi-Siahboomi (1993)
also found that if a drug (dicJofenac Na) and dissolution medium
(phosphate) both salt out HPMCmatrix, rapid disintegration occurred.
Therefore, it appears that diclofenac Na can act synergistically with other
'salting-out' ions.
5.6.2 The effect of meclofenamate Na on HPMC gel layer
formation
In chapter 4 it was shown that meciofenamate Na possessed the
propensity to "salt in" the polymer above a threshold concentration of 40
mM. It was proposed that this resulted from drug association with the
polymer resulting in the formation of a pseudo poly(electrolyte) complex
in solution. In addition, this interaction appeared to be influenced by the
presence or absence of NaCIin solution.
The interaction between meciofenamate Na and HPMC resulted in a
matrix that gels and swells rapidly in water. However, disintegration
studies suggested that HPMC swelling and gelation with high
meciofenamate Na and low HPMCcontent was excessive for the purpose
of extending drug release. The matrices failed to form a sufficiently robust
gel layer and disintegration occurred rapidly.
It can postulated that in the presence of NaCl, the polymer became
dehydrated as the electrolyte competes with the polymer for water of
hydration (8ajwa et al. 2006. Liu et al. 2008). This appears to counteract
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swelling and gelation promoted by drug within the matrix, while
concurrently reducing the solubility of the drug through a common ion
effect. It was evident from the confocal images and measurements of gel
layer growth that swelling was sufficiently restricted in 0.9% w/v NaCIto
allow a more coherent gel layer to form and increased the resistance to
disintegration extended beyond the time seen for the same formulation in
water.
These results can be rationalised with reference to the interaction
mechanism proposed in chapter 4. It may be suggested that the gel layer
swelling is the result of a disparity in the phase behaviour of polymer
mixtures arising from the interactions between meclofenamate Na and
HPMCwithin the gel layer.
In simple terms, we can envisage that the gel layer can be viewed as a
ternary polymer/polymer/solvent mixture in which the polymers are (i)
HPMC, and (ii) HPMC associated with meclofenamate Na (the 'pseudo-
polyelectrolyte HPMC-MEC)with the solvent being either Ci)water or [ii]
0.9% w[v NaCl. The low entropy of mixing high molecular weight
polymers can, depending on the balance between the various monomer-
monomer solvent pair interactions, result in liquid-liquid phase
separation phenomena which may be understood in the context of the
Flory-Huggins theory of polymer mixtures (Flory 1953, Bergfeldt et al.
1996). In the case of swelling and gel layer formation in water, there are
good interactions between the HPMCand solvent and there is no entropic
drive for phase separation. The greater solubility of the pseudo
poly(electrolyte) results in a highly swollen but inadequate diffusion
barrier. When NaCI is added to the hydration medium, there are poorer
interactions between solvent and the two polymers within the gel layer
becoming phase concentrated in both HPMCand HPMC-MECseparated
from a solvent only phase. This phenomenon is referred to as 'complex
coacervation' (Flory 1953, Tostoguzov 2003). The coacervate of the
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HPMCand HPMC-MECwill have greater viscosity than a gel layer formed
from predominately HPMCalone since it is rich in polymer and deficient in
solvent.
The tendency of ternary polymer/polymer/solvent system to phase
separate is strongly dependent on the ionic environment (Albertsson
1995). In mixtures of polyelectrolyte/uncharged polymer, the addition of
salt reduces the problems with electro-neutrality and encourages
separation (Picullel et al. 1995). This may explain the apparent
mecIofenamate Na-mediated resistance to NaCI challenge in the
disintegration studies. The increases in NaCI in the swelling medium
provided the entropy drive for phase separation since this is a poorer
solvent for both HPMCand HPMC-MECand leads to the formation of a
'coacervate gel layer' which provides an efficient diffusion barrier.
5.7 Conclusions
This chapter has shown how the initial period of gel layer development
appears critical for achievement of a functional diffusion barrier and
prevention of matrix disintegration. There was a direct correlation
between a compromised gel layer, as a consequence of drug and
electrolyte effects on the solubility of HPMC, and the onset of matrix
disintegration.
This provides further evidence of the validity of the original hypothesis
developed in chapter 4 which attempted to explain the contrasting drug
release from hydrophilic matrices of diclofenac Na and meclofenamate Na
presented in chapter 2. The observed effects of drug addition in HPMC
solutions appear to manifest as changes in the gel layer structure and
functionality. The drug effects appear to be influenced by the presence or
absence of NaCI in the hydration medium, an effect that can be explained
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through the changes NaCl afforded to the drug/HPMC interactions in
solution.
The next chapter will investigate another experimental avenue arising
from analysis of the dissolution data; the role of incorporated diluents on
the early gel layer formation and functionality.
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Chapter 6
The effect of diluents on the early gel
layer formation and disintegration of
HPMC matrices
6.1lntroduction
Previously, the effect of diclofenac Na and meclofenamate Na on HPMC
solution properties (chapter 4) and gel layer formation (chapter 5) have
been investigated. However, drugs are rarely formulated with HPMCas
simple binary mixtures, and excipients are routinely included in matrix
tablets. Diluents or fillers are used to provide tablet bulk but their effects
on gel layer formation and drug release are often discounted as
insignificant in comparison with polymer, drug and formulation factors
(chapter 1). In the interpretation of the drug release results in chapter 2,
it was suggested that lactose may have a Significant role in modulating
drug-polymer interactions and subsequent drug release from HPMC
matrices. The aim of the current chapter is to explore the effect of diluents
on the behaviour of the HPMCgel layer in binary matrices in the absence
of drug.
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6.1.1 The effect of diluents on drug release from HPMC matrices
Several studies in the literature have considered the effects of diluents on
drug release. Rekhi et aJ (1999) have investigated the effect of
formulation variables on metoprolol tartrate release from HPMCmatrices.
Increasing the lactose content from 25 to 61% wlw resulted in increased
drug release rate. These findings supported the earlier studies of Lapidus
and Lordi (1968) and Ford et aJ (1987). It is believed that when the
soluble excipient content exceeded 50% wlw, the rapid dissolution of the
excipients led to the formation of a fragile and porous gel. As a result, the
drug diffusion and gel layer erosion increased.
Sako et aJ (2002) have found that HPMCmatrices containing lactose (a
moderately soluble filler) and poly(ethyleneglycol) 6000 (PEG 6000) (a
highly soluble filler) exhibited similar release rates to matrices that
contained an insoluble filler. The soluble component of the matrices was
50% wlw, hence conflicting with the findings of Ford et al (1987) who
stated that this level of filler should result in a more rapid drug release.
Levina and Rajabi-Siahboomi (2004) have examined the effects of lactose,
microcrystalline cellulose (MCC) and partially pre-gelatinised starch on
drug release from HPMCmatrices. It was found that the incorporation of
starch produced a significant reduction in the release of a freely and
slightly water soluble drugs in comparison with the other two diluents. It
was suggested that this may be the result of a synergistic interaction
between starch and HPMC resulting in the formation of a stronger gel
structure. No direct evidence for this effect was offered.
Williams et al. (2002) have investigated the effect of diluent type and
content on the release of alprazolam from HPMC matrices. They
investigated the effect of a wide variety of soluble excipients (lactose,
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sucrose and dextrose) and insoluble excipients (dibasic calcium
phosphate dihydrate (OCP), dicalcium phosphate anhydrous and calcium
sulphate dehydrate) on the drug release profiles of matrices containing
40% w/w HPMC. Insoluble excipients reduced in the rate of drug release
in comparison with the soluble excipients, with a mixture of lactose and
OCPproduced an intermediate drug release profile.
Lotfipour et al. (2004) have investigated the effects of lactose and DCPon
atenolol release from HPMCmatrices. An increase in filler concentration
resulted in an increase in drug release rate, irrespective of the filler type.
Release profiles showed that a decrease in the ratio of HPMC/filler from
3:1 to 1:3 resulted in increased in drug release rates. Low concentrations
of OCPhad little effect on the release rate. It was proposed that changing
the polymer/filler ratio increases the release rate by altering the
diffusivity of atenolol through the gel layer.
Huang et al. (2004) have optimised an extended release matrix of
propranolol for once daily administration, using a constrained mixture
experimental design with variable content of HPMC, lactose and MCC.
Both MCCand lactose increased drug release but the enhancement by
lactose was greater than MCC. The influence of lactose was more
significant in the later rather than the early stages of drug release.
lamzad et al. (2005) have investigated the influence of water-soluble and
insoluble excipients on front movement, erosion and release of
tetracycline hydrochloride from HPMCmatrices using texture analysis.
Matrices containing 30% w/w drug and lactose had a more pronounced
swelling front movement and drug release in comparison with the
matrices containing OCP,with lactose formulations having greater water
penetration but subsequently a weaker gel structure. For OCP
formulations, the gel strength was greater, suggesting less hydration.
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6.1.2 The choice of diluents for investigation
The rationale for the choice of diluents investigated in this chapter was as
follows. Lactose monohydrate was used in the formulation detailed in
chapter 2 and represents the 'classic' soluble filler material used in many
tablet formulations (Riepma et al. 1992, Lerk 1993, [elcic et al. 2007). Its
influence on drug release has been highlighted in the literature with little
evidence from imaging techniques.
The other diluents offered contrasting physicochemical properties. DCPis
used in tablet formulations both as an excipient and as a source of calcium
and phosphorus in nutritional supplements (Bryan and McAllister 1992,
Schmidt and Herzog 1993). DCPis insoluble and non-swelling and offers a
counterpoint to the behaviour oflactose.
The final diluent was MCCwhich, although sharing its insoluble nature
with DCP, offered an additional water-imbibing and wicking property.
MCC is purified, partially depolymerised cellulose that exists as white,
odourless, tasteless, crystalline powder composed of porous particles. It
is used in pharmaceuticals as a binder/diluent in oral tablet and capsule
formulations, in both wet granulation and direct compression applications
(Lerk et al. 1979, Liand Mei 2006).
Based on the above, the diluents selected for investigation in this chapter
were: (i) a-lactose monohydrate, (H) dibasic calcium phosphate dihydrate
and (iii) microcrystalline cellulose. The chemical structures of the
diluents are illustrated in table 6.1.
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A
OH
OH
0
B IICa2+ -0 j-O-
.2HzOOH
c
OH
OH
OH---r-.._
O~/~ _
OH
Table 6.1 The chemical structures of diluents used in this chapter
The excipients listed above are: (A) a-lactose monohydrate, (8) Dibasic calcium
phosphate dihydrate (DCP) and (C) Microcrystalline cellulose (MCC)
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6.2 Chapter Aims
The aims of this chapter are to:
- To determine the effects of lactose monohydrate on HPMC
solution properties, including cloud point, viscosity and
viscoelasticity
- To assess the affect of varying diluent content and type on
early gel layer formation and functionality using confocal
microscopy and disintegration testing
Achievement of these aims will provide insights into the drug release
behaviour presented in chapter 2, where it was proposed that lactose
played a key role in influencing drug release.
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6.3 Materials and Methods
6.3.1 Materials
6.3.1.1 HPMC
Asieve fraction of 63-90 11mHPMC(Methocel E4MCRPremium) was used
in matrix manufacture. Details of the source and batch number are
detailed in appendix 1.
6.3.1.2 Diluents
Lactose monohydrate, microcrystalline cellulose (Avicel PH102) and
dibasic calcium phosphate dihydrate were used as received. Details of the
source and batch number are detailed in appendix 1.
6.3.1.3 Water
Solutions were prepared using Maxima HPLC grade water (USF Elga,
Buckinghamshire, UK)with a maximum conductance of 18.2 Mn.cm.
6.3.2 Manufacture of 1% w/w HPMC solutions containing lactose
Manufacture of 1% wjw HPMC solutions containing lactose was
undertaken using the method described in section 3.2.1.
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6.3.3 Turbimetric determination of the sol:gel phase transition
temperature of lactose-containing HPMC solutions
Turbimetric determination of the sol:gel transition temperature of 1%
w/w HPMC solutions containing lactose was undertaken by the method
described in section 3.2.2.
6.3.4 Continous shear viscosity measurements
Continuous shear viscosity measurements of 1% w/w HPMC solutions
containing lactose were undertaken using the method described in section
3.2.3.
6.3.5 Oscillatory rheology
Oscillatory rheology of 1% w/w HPMCsolutions containing lactose were
undertaken using the method described in section 3.2.5.
6.3.6 Measurement of single HPMC particle swelling
Visualisation and measurement of single particle swelling in the presence
of lactose solutions was undertaken using the method described in section
5.4.3.
6.3.6.1 Preparation of lactose solutions containing Coomassle blue
Lactose solutions were prepared in 100 ml volumetric flasks using
distilled water. A 15 ml volume of Coomassie Blue O.003M solution was
then made using each of the lactose solutions. The vials were covered
with aluminium foil to avoid any exposure to light, in order to minimise
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any photochemical reactions (e.g photolytic oxidation). The solutions
were left stirring overnight to ensure an even distribution of the dye in the
solutions and to reduce the amount of precipitation occurring.
6.3.7 Matrix preparation
6.3.7.1 Preparation of HPMCsieve fractions
Fractionation of HPMCfor matrix manufacture was undertaken using the
sieving method described in section 3.2.6.1. The diluent powders were
used as received.
6.3.7.2 Formulation preparation
Mixtures were prepared in appropriate quantities for 50 g batches of each
formulation by mixing as described in section 3.2.6.2.
6.3.7.2 Matrix manufacture
Manufacture of HPMC matrices was undertaken using the method
described in section 3.2.6.3 on a Manesty F3 single punch tablet press
(Manesty, Liverpool, UK) using a compression pressure of 180 MPa and 8
mm flat-faced tablet punches (I Holland, Nottingham, UK). The matrix
compositions are shown in table 6.2.
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Matrix composition
Percentage of diluent (%)
Diluent (mg) HPMC (mg)
0 0 200
15 30 170
30 60 140
50 100 100
70 140 60
85 170 30
Table 6.2 The quantity of the diluents in each tablet formulation
Matrices weighed 200± Smg, compressed to 180 MPa. Details of matrix manufacture are
described in 3.2.6.3
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6.3.8 Confocal laser scanning microscopy (CLSM) imaging
Confocal imaging was undertaken by the method described in section
5.4.6. Image analysis of confocal images was undertaken using the
method described in section 5.4.7.
6.3.9 Tablet disintegration studies
Disintegration studies of matrix formulations containing diluents were
undertaken using the method described in section 3.2.7.
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6.4 Results
6.4.1 The effect of lactose on the cloud point temperature (CPT)
of HPMC solutions
Figure 6.1 shows the effect of lactose on the ePT of a 1% wjw HPMe
solution. The addition of lactose lowered the ePT of HPMe solutions, in a
manner that appears analogous to the 'salting out' behaviour of commonly
formulated soluble excipients such as NaCIwith other thermo-sensitive
polymers (Eeckman et al. 2001, Mori et al. 2004). There was a
concentration dependent reduction in cloud point, with a 10.1°C reduction
at the highest concentration of lactose tested (500 mM).
Incompatibilities between sugars and polymers have been reported
elsewhere in the literature (Levy and Schwartz, 1958, Kim et al. 1995,
Kawasaki et al. 1996 and Lee et al. 2003). It is known that low molecular
weight saccharides are strong water structure makers ("kosmotropes") at
high concentrations (Almond 2005, Giangiacomo 2006). The stabilisation
of water structure by addition of saccharides may lead to a decrease in
interactions between water and polymer chain in solution, enhancing the
potential for hydrophobic interactions between methoxyl-rich regions on
the HPMCchains. Therefore, it is reasonable that the cloud point of the
present polymer solutions decreased with increasing saccharide
concentration.
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Figure 6.1 The effect of lactose on the cloud point temperature of 1% wjw HPMC
solutions
CPTmeasured turbimetrically as a reduction of 50% in light transmission (Sarker 1979).
Mean (n=3) ± ISO.
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6.4.2 The effect of lactose on the solution continuous shear
viscosity of HPMC solutions
Figure 6.2 shows the effect of lactose on solution viscosity. Lactose
increased the viscosity of a 1% w/w HPMCsolution but not to the same
order of magnitude as observed with the addition of meclofenamate Na
(where viscosity was increased by two orders of magnitude) (chapter 4).
This increase in viscosity may be a result of the 'salting out 'by the lactose-
mediated effects on the sol:gel phase transition temperature. This
assertion is supported by literature findings that electrolytes can slightly
increase the viscosity of HPMCsolutions (Zatloukal and Sklubalova 2007).
6.4.3 The effect of lactose on the viscoelastic properties of HPMC
solutions
Figures 6.3 and 6.4 show the effect of lactose addition on the storage and
loss moduli of 1% w/w HPMCsolutions. There was a slight increase in
both moduli of the polymer solutions. This may be related to the water-
structuring effect of the saccharide and resulting increases in hydrophobic
interactions between polymer chains as the HPMCare brought closer to
their thermogelation temperature.
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Figure 6.2 The effect of lactose concentration on 1% wjw HPMC solution
continuous shear viscosity
Geometry = ep 2° /SOmm. Temperature = 20 ± 0.1°C. Mean (n =3) ± lSD
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6.4.4 The effect of lactose on the swelling of HPMC particles
Figure 6.5 shows a comparison between the swelling of HPMCparticles in
water and in a 0.5 M lactose solution. Qualitatively, it appeared that the
presence of lactose in the swelling medium suppressed the swelling and
coalescence of HPMCparticles compared with behaviour of the polymer
particles in water. In the lactose solution, there were distinct gaps in the
swollen particle bed, whereas in water a continuous phase of swollen
HPMC particles coalesced by the end of the experiment. The
measurement of individual particle swelling shown in figure 6.6 suggested
that lactose suppressed particle swelling in a concentration dependent
manner
This suppression of polymer particle swelling may be related to the
capability of lactose to lower HPMCcloud point which in turn would affect
gel layer functionality. Ford (1999) has stated that a reduction in cloud
point temperature is an indication of decreased polymer solubility and
capacity to imbibe water reducing particle swelling.
6.4.5 The effect of incorporated diluents on HPMC gel layer
morphology
The effect of diluent content in the matrix tablet from 15% to 85% w/w on
the microstructure of the HPMCgel layer was determined.
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Figure 6.5 Real-time observation of HPMCparticle swelling in water and O.SM
lactose solution
Hydrated times indicated in the left hand column. O.003MCoomassie blue as a
visualisation aid. Scale bar: 200 urn
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6.4.5.1 The effect of lactose content on gel layer morphology and swelling
Figure 6.7 shows the effect of increasing lactose content in the matrix on
the gel layer development in HPMCmatrices. It can be seen that low
lactose content (15-30% w/w) had negligible effect on swelling behaviour
and gel formation and microstructure were not distinguishable from that
of a 100% HPMCmatrix.
At high lactose contents (>50% w/w), gel layer swelling was increased
markedly and gel layer formation appeared to be disrupted. This first
appeared at 50% w/w lactose content (figure 6.8). The disruption
occurred during the first minute of hydration, with an initial burst of
particulate matter leaving the surface of the matrix, after which the gel
layer was seen to recover and form normally.
At the higher lactose loadings (70 and 85% w/w), it appeared that gel
layer disruption was significant in the early stages but beyond five
minutes a structure began to form, albeit highly swollen and apparently
diluted (figure 6.9). This may be a result of lactose diffusing out of the gel
layer at a faster rate in comparison with HPMCdissolution at the gel layer
periphery, resulting in sufficiently increased polymer concentration in the
gel layer to form a dilute structure. Figure 6.10 depicts the expansion of
the gel layer within these matrices with respect to the original matrix
dimensions and confirms that loss of controlled swelling occurs at the
lactose loadings of 70% and 85%. The high variability in measurements is
a consequence of material debris falling out of the confocal plane.
The finding that disruption of gel layer development only occurs at the
highest lactose content is in agreement with the findings of Ford et al.
(1987) who suggested that diluent effects only become apparent at levels
of incorporation above (>50% wjw).
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Figure 6.7 The effect of incorporating lactose in the matrix on the evolution of the
HPMC gel layer after 1, 5 and15 minutes hydration in water
Formulations contained the indicated percentages of diluent and HPMC. The images are
coded for fluorescence intensity from white (highest) to black (lowest) as indicated by
the wedge. Hydration medium containing 0.008% w]» Congo red maintained at 37°C.
Ex488>s10 nm. Scale bar= 500 11m.
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Burst of particulate
matter leaving the
matrix surface
Gradual recovery
of gel layer after
five minutes of
hydration
Gel layer formation
has fully recovered
and morphology is
similar to that seen
in 100% HPMC
matrices
Figure 6.8 The effect of incorporating 50% w/w lactose in the matrix on the
evolution of the HPMC gel layer microstructure after (A) 1, (B) 5 and (C) 15
minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w/v
Congo red maintained at 37°C. Ex488>S10 11m.Scale bar = SOO!J,m
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Figure 6.9 The effect of incorporating 85% w/w lactose in the matrix on the
evolution of the HPMC gel layer microstructure after (A) I, (B) 5 and (C) 15
minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% wIv
Congo red maintained at 37°(, Ex488>S10 nm. Scale bar e 500 urn
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6.4.5.2 The effect of DCPcontent on gel layer morphology and swelling
Figure 6.11 shows the effect of OCPcontent on gel layer morphology and
growth. At low OCP content, there was minimal effect on the gel layer
formation. However, when OCP content was increased to 85% wlw, a
major disruptive effect was observed with the matrices apparently
becoming incapable of forming a coherent gel layer.
OCPis an insoluble, non-swelling excipient and on a microscopic scale the
images show how HPMCparticles had to swell around insoluble areas of
OCP. This supports the findings of Bettini et al. (2001) who suggested the
presence of solid particles in the gel layer reduced the swelling and the
entanglement of polymer chains and as a result, the matrix became more
erodible. There is visual evidence of this occurring in the confocal images
of figure 6.12, with clear hydration of HPMCparticles around OCP in the
85% wIw OCP matrices. However, with increasing OCP content, the
particles were too physically separated to coalesce and form a continuous
gel layer. At lower OCPcontents, the physical separation afforded by OCP
did not prevent gel layer formation. The measurements of gel layer
swelling shown in figure 6.13 show a controlled swelling up to 70% w/w,
after which the gel layer was shown to grow in an uncontrolled manner.
These results may explain why similar release profiles have been noted in
the literature for DCPand lactose despite the differences in their solubility
(Ford et al. 1987, Williams et al. 2002). Gel layer porosity is increased
with increased incorporation of both these diluents by different
mechanisms; by movement of soluble particles increasing water
penetration in the case of lactose and physical separation of hydrated
HPMC particles in the case of DCP, up to the point where catastrophic
disintegration occurs.
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Figure 6.11 The effect of incorporating dicalclum diphosphate dihydrate in the
matrix on the evolution of the HPMCgel layer after 1, 5 and 15 minutes
Formulations contained the indicated percentages of diluent and HPMC. The images are
coded for fluorescence intensity from white (highest) to black (lowest) as indicated by
the wedge. Hydration medium containing 0.008% w/v Congo red maintained at 37°C.
Ex488>SlO nrn. Scale bar= SOD 11m.
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Figure 6.12 The effect of incorporating 85% w/w dibasic calcium diphosphate in
the matrix on the evolution of the HPMCgel layer microstructure after (A) I, (B) 5
and (C) 15 minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0.008% w Iv
Congo red maintained at 37°C. Ex488>510 nm. Scale bar = 500 urn
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Figure 6.13 The effect of diluent content on the radial gel layer growth of HPMC
matrices containing dicalcium phosphate dihydrate
Formulations contained the indicated percentages of DCPand HPMCto 100%. Hydration
in 0.008% w]» Congo red at 37°C. Swelling measured from dry tablet boundary to the
edge of region B1. Mean (n=3) ±1 SD
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6.4.5.3 The effect of MCC content on gel layer morphology and swelling
Figure 6.14 shows the effect of increasing MCCcontent on HPMCgel layer
development. In common with DCPand lactose, at low contents of MCC
(15-30% w/w) there was little effect on the microstructure or the swelling
of the gel layer. At higher contents (>30% w/w), MCChad a profound
effect on the swelling and gelation of the HPMCmatrix. A 'classical' gel
layer was not formed, and disintegration of the underlying matrix was
observed as hydration proceeded, with highly hydrated MCC particles
'crumbling' away from the matrix. This is most clearly shown in the
matrices containing 85% w/w MCCin figure 6.15. Gel layer swelling
kinetics (figure 6.16) showed that the thickness of the gel layer was
proportional to the MCCcontent in the matrix with some variability in
measurements as consequence of material debris falling out of the
confocal plane
The disintegration of the matrix at high MCCcontent, through the wicking
and imbibing of water of this diluent, would reduce the controlled release
functionality and would result in premature drug release.
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Figure 6.14 The effect of incorporating microcrystalline cellulose in the matrix of
the HPMCgel layer after I, S andlS minutes hydration in water
Formulations contained the indicated percentages of diluent and HPMC. The images are
coded for fluorescence intensity from white (highest) to black (lowest) as indicated by
the wedge. Hydration medium containing 0.008% w/v Congo red maintained at 37°C.
Ex488>S10 nm. Scale bar= 500 urn.
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Figure 6.15 The effect of incorporating 85% wjw microcrystalline cellulose in the
matrix on the evolution of the HPMCgel layer microstructure after (A) 1, (B) 5 and
(C) 15 minutes
The images are coded for fluorescence intensity from white (highest) to black (lowest).
Dotted line depicts the dry tablet boundary. Hydration medium containing 0,008% wIv
Congo red maintained at 37°C. Ex488>S10 nm. Scale bar = 500 urn
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Figure 6.16 The effect of diluent content on the radial gel layer growth of HPMC
matrices containing MCC
Formulations contained the indicated percentages of MCC and HPMC to 100%.
Hydration in 0.008% w/v Congo red at 37°C. Swelling measured from dry tablet
boundary to the edge of region B1. Mean (n=3) ±1 SD
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6.4.6 The effect of diluent content on matrix disintegration
Disintegration times of HPMCmatrices containing various levels of diluent
content are shown in table 6.3. In water, 100% wjw HPMC matrices
remained intact throughout the experimental period. Matrices with 15%
w/w diluent content did not disintegrate, irrespective of the diluent
employed. This was also the case for matrices containing 30% and 50%
w/w diluent and supports the confocal images that show little evidence of
gel layer disruption at these diluent contents. However, at 70% and 85%
w/w diluent content, matrices disintegrated faster in 0.9% NaCIw]» than
in water. In all cases, matrices, containing 85% w jw diluent, disintegrated
more rapidly than those containing 70% w jw.
6.4.8.1 The effect of diluent content on matrix disintegration in sodium
chloride solution
The influence of increasing NaCIconcentration in the swelling medium on
the disintegration of DCP, MCCand lactose matrices is shown in figures
6.17, 6.18 and 6.19 respectively. The incorporation of diluent in the
matrix reduced the disintegration thresholds of the matrices when
compared to 100% HPMCmatrices. This supported the confocal work
suggesting that all diluents disrupted gel layer formation at the higher
content.
MCCmatrices afforded the greatest resistance to electrolyte challenge,
whereas lactose matrices appeared to be the most susceptible. This
suggested a combined burden upon HPMC particle swelling and
coalescence provided by NaCl in the swelling medium and the 'salting out'
soluble diluent in the matrices.
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Tablet content (% Disintegration Disintegration Disintegration
w/w) times of matrices times of matrices times of matrices
containing MCC containing DCP containing lactose
(min) (min) (min)
Diluent HPMC Water 0.9% Water 0.9% Water 0.9%
NaCI NaCI NaCI
0 100 >120 >120 >120 >120 >120 >120
15 85 >120 >120 >120 >120 >120 >120
30 70 >120 >120 >120 >120 >120 >120
SO SO >120 >120 >120 >120 >120 >120
70 30 >120 35 >120 >120 30 4
85 15 10 6 5 1 1 1
Table 6.3 Disintegration times of HPMCmatrices containing different diluents in
0.9% w/v NaCland water
USP Standard methodology, 37°C, carried out maximally for 120 minutes. Mean (n=4) ±
1 SD.
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Figure 6.17 The effect of DCPincorporation on HPMCmatrix disintegration time
with respect to increasing sodium chloride concentration
USPStandard methodology. 37°C. carried out maximally for 120 minutes. Mean (n=4) ± 1
SD. (0.154 M = 0.9% NaCl)
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Figure 6.18 The effect of MCCincorporation on HPMCmatrix disintegration time
with respect to increasing sodium chloride concentration
USPStandard methodology. 37°C. carried out maximally for 120 minutes. Mean (n=4) ± 1
SD. (0.154 M = 0.9% NaCl)
211
Chapter6
120
Vi
100
I:
I 80III
Cl.!
E
'';:;
I: 60
0
;
IV
...
tI.O
40Cl.!
...
I:
'in
(5
20
0
0 lS 30
% w/w lactose incorporation
50
.0 M NaCI
• 0.154 M NaCi
00.5 M NaCI
00.7 M NaCI
II I I
70 85
Figure 6.19 The effect of increasing lactose content on HPMCmatrix disintegration
time with respect to increasing sodium chloride concentration
USP Standard methodology, 37°(, carried out maximally for 120 minutes. Mean (n=4) ± 1
SD. (0.154 M = 0.9% NaCl)
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6.5 Discussion
These results suggest that the physicochemical properties of diluents
influence early gel layer formation and disintegration. These changes
include alterations to the rate of swelling, disruption of coherent gel layer
formation and diffusion barrier resistance to NaCI challenge. This study
has provided novel imaging evidence to support previous literature
findings (e.g Ford et al. 1987, Levina and Rajabi-Siahboomi 2004 and
[amzad et al. 2005). The effects of each diluent on the gel layer formation
and matrix disintegration will now be discussed in more detail.
6.5.1 The effect of lactose
The effect of lactose on drug release rates from HPMC hydrophilic
matrices has been described previously (Levina and Rajabi-Siahboomi
2004, Iarnzad et al. 2005) in which an increase in lactose content results in
more rapid drug release. The key difference of lactose in comparison with
MCCand DCP is its high solubility, and consequently it exerts an osmotic
pressure on gel layer coherence. From the confocal images presented in
this chapter, it appears that lactose would influence drug release since the
gel layer porosity will be increased by the rapidly dissolving lactose,
resulting in an osmotic pressure increasing the hydration and dissolution
of the gel layer. This would effectively expand the volume of the gel layer,
and consequently lowering the concentration of HPMCacross the gel layer
and reducing its molecular tortuosity.
An additional influence that may be exerted by lactose is its capability of
'salt-out' HPMCin solution and reducing its sol:gel transition temperature.
The capability of saccharides to affect the behaviour of thermo-sensitive
polymers has been noted in the literature (Kim et al. 1995, Kawasaki et al.
1996, Kato et al. 2001, Lee et al. 2003). In this chapter, it has been seen
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that the individual particle swelling and coalescence appeared to be
affected by the content of lactose in the matrix, with a particulate gel layer
appearing to form when the lactose content in the matrix exceeded SO(
wIw. This acts as an additional explanation to the influence of lactose 0
HPMC gel layer swelling and functionality, particularly its affording c
lesser resistance to the 'salting out' NaCIin the hydration medium.
In summary, the effect of lactose on gel layer formation may be proposed
as being a combination of: (i) increasing the lactose content increases the
soluble material within the matrix, which increases diffusion pathways,
facilitating drug egress and water ingress, (ii) the osmotic potential of
lactose in solution (Whittier 1933) results in a driving force which leads to
increased water uptake and consequently greater gel layer hydration and
(iii) the water structuring effect of lactose leads to dehydration of the
hydrophobic regions of the polymer, with a consequential reduction in
HPMCparticle swelling and coalescence. It may also reduce the amount of
polymer available to contribute to the gel layer.
6.5.2 The effect of MCC
MCChas been found to influence the early gel layer formation (Ford et al.
1987, [arnzad et al. 2005). The fluorescence of MCCin the presence of
Congo red allowed it to be identified within the gel layer with the extent of
its appearance being directly related to the original level of incorporation.
Unlike lactose, the insoluble nature of MCCmeans that it does not affect
the solution properties of HPMC. This insolubility means that it did not
result in uncontrolled gel layer expansion up to the highest diluent
content investigated, possessing a different mechanism of disruption of
the gel layer formation.
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With low MCCcontent, the insoluble particles of MCCwill act as a physical
barrier to the diffusion pathways through the gel layer, both for the entry
of water and release of drugs. However, it was apparent that when MCC
content relative to HPMC exceeded a critical threshold, there was
impairment of effective barrier formation, resulting in underlying matrix
dislntegration as a result of MCCwicking and imbiding of water.
The disruption of gel layer formation by insoluble materials has been
noted in other papers investigating polymer particle erosion and its
effects on drug release (Zuleger and Lippold 2001, Zuleger et al. 2002,
Freichel and Lippold 2004). Zuleger and Lippold (2001) proposed that
polymer particle erosion processes were the result of insoluble fibres
contained in a hydrophilic matrix based on methylhydroxy ethylcellulose
(MHEC). These particles acted to impede the matrix swelling, weakened
the gel layer and lead to attrition of polymer material.
The apparent 'protective' effect of MCC in response to electrolyte
challenge is potentially a consequence of its disruption mechanism. When
a 'salting out' electrolyte such NaCIis present in the swelling medium, this
may reduce the swelling of MCCand hence counteract the mechanism by
which this filler would disrupt HPMCgel layer formation.
These results conflict with the findings of Cao et aJ. (2005) who found, that
increasing the level of MCCwithin a matrix formulation led to increased
drug release rates. However, these matrices were formulated with other
disintegrants, which would have led to a lowering of the threshold
described above and consequently immediate release.
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6.5.3 The effect of DCP
The insoluble and non-swelling filler DCP was found to influence the
morphology and swelling of the gel layer. This influence is unlikely to be
the result of a chemical interaction between HPMC and the insoluble
calcium salts since a study by Dorozhkin (2001) has confirmed no
interaction between calcium phosphate and HPMC used FTIR. X-ray
diffraction and SEM. From the confocal images, DCPappears to act as a
physical barrier to HPMCparticles coalescing. This effect appears to only
become significant in leading to matrix disintegration at high DCPloading
(85% w/w). Below this threshold (-50% w/w) there appeared to be little
difference between the morphology of the gel layers formed between the
three different fillers suggesting that a coherent gel layer forms, but with
the presence of insoluble material in it, increasing drug diffusion
pathways and slowing drug release. This confirms the findings of Ford et
al. (1987) who suggested that only at high (>50%) content levels do
differences between insoluble and soluble fillers manifest as changes in
drug release profiles and contradicts Alderman (1984) that as little as
10% insoluble solid may prevent HPMCmatrices extending drug release.
The caveat to this is that this applies to a binary system of DPCand HPMC
only, and as has been shown in the previous chapter, drugs can exert a
considerable influence on the development and properties of the gel layer.
6.6 Conclusions
The confocal images presented provide unprecedented microscopic
evidence to support the many literature reports of the effects of different
diluents on drug release from HPMCmatrices. This study confirms that
diluents may have significant effects on the early gel layer formation in
HPMC hydrophilic matrices with diluent solubility and physical nature
appearing to exert considerable influence on the emerging gel layer.
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Lactose appears to have a particularly detrimental effect compared with
DCPand MCC,which may be related to high solubility and its 'salting out'
capability. The presence of lactose within the matrix places an increased
burden upon gel layer formation capacity which was evidenced by
increased susceptibility to disintegration upon NaCI challenge. This
confirms the hypothesis rationalised in chapter 3 that lactose exerts a
considerable influence on drug release through effects on the gel layer.
The next stage is to investigate if the detrimental effect of lactose and the
relatively neutral effect of MCCmanifest as changes in gel layer properties
in matrices containing diclofenac Na and meclofenamate Na.
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Chapter 7
The combined effects of drugs and
diluents on early gel layer formation in
HPMC hydrophilic matrices
7.1 Chapter aims and objectives
This chapter aimed to build on the previous experimental findings by
examining the effects of drugs and diluents on gel layer formation when
they are co-formulated in HPMCmatrices.
Specifically the objectives were:
- To investigate the effects of drugs and diluents when formulated
concomitantly in hydrophilic matrices
- To study the early gel layer morphology of matrices containing
various ratios of drug:HPMCwith high and low diluent content
- To determine the influence of NaCI on the interactive effects of
drug and diluents on HPMChydrophilic matrix gel layer formation.
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7.2 Materials and Methods
7.2.1 Materials
7.2.1.1 HPMC
A sieve fraction of 63-90 11mHPMC(Methocel E4MCRPremium) was used
in matrix manufacture. Details of the source and batch number are
detailed in appendix 1.
7.2.1.2 Drugs
Diclofenac Na and meclofenamate Na were used as supplied. Details of the
source and batch number are detailed in appendix 1.
7.2.1.3 Diluents
Lactose and MCCwere used as supplied. Details of the source and batch
number are detailed in appendix 1.
7.2.1.4 Water
Solutions were prepared using Maxima HPLCgrade water. Details are in
appendix 1.
7.2.2 Turbimetric determination of the sol:gel phase transition
temperature
Turbimetric determinations of the sol:gel transition temperature of HPMC
solutions containing drugs and lactose were undertaken as described in
section 3.2.2.
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7.2.3 Manufacture of matrix tablets
Fractionation of HPMC by sieving was undertaken using the method
described in section 3.2.6.1. HPMCmatrices containing drugs and diluents
were manufactured using the method described in section 3.2.6.3.
The formulations investigated are detailed in table 7.1 and 7.2 for 19%
wjw and 59% wjw diluent containing matrices respectively.
7.2.3.1 Matrix storage
HPMC matrices were stored under the conditions described in section
3.2.6.4.
7.2.4 Confocal laser scanningmicroscopy imaging
Confocal laser scanning imaging was undertaken using the method as
described in section 5.4.6.
7.2.S Tablet disintegration studies
Disintegration studies were undertaken using the method as described in
as section 3.2.7.
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Drug "w/wdrug Diluent " w/w diluent "w/wHPMC
Meclofenamate Na 20 MCC 19 60
Meclofenamate Na 20 Lactose 19 60
Diclofenac Na 20 MCC 19 60
Diclofenac Na 20 Lactose 19 60
Meclofenamate Na 40 MCC 19 40
Meclofenamate Na 40 Lactose 19 40
Diclofenac Na 40 MCC 19 40
Diclofenac Na 40 Lactose 19 40
Meclofenamate Na SO MCC 19 30
Meclofenamate Na SO Lactose 19 30
Diclofenac Na SO MCC 19 30
Diclofenac Na SO Lactose 19 30
Meclofenamate Na 60 MCC 19 20
Meclofenamate Na 60 Lactose 19 20
Diclofenac Na 60 MCC 19 20
Diclofenac Na 60 Lactose 19 20
Table 7.1 Formulations to investigate drug effects in matrices containing 19% w/w
diluent
Matrices weighed 200 mg. compressed to 180 MPa. All matrices contained 10/0
magnesium stearate to aid tablet compression.
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Drug "w/wdrug Diluent " w/w diluent "w/wHPMC
Meclofenamate Na 10 MCC 59 30
Meclofenamate Na 10 Lactose 59 30
Diclofenac Na 10 MCC 59 30
Diclofenac Na 10 Lactose 59 30
Meclofenamate Na 20 MCC 59 20
Meclofenamate Na 20 Lactose 59 20
Diclofenac Na 20 MCC 59 20
Diclofenac Na 20 Lactose 59 20
Meclofenamate Na 30 MCC 59 10
Meclofenamate Na 30 Lactose 59 10
Diclofenac Na 30 MCC 59 10
Diclofenac Na 30 Lactose 59 10
Table 7.2 Formulations to investigate drug effects in matrices containing 59% w/w
diluent
Matrices weighed 200 rng, compressed to 180 MPa. All matrices contained 1%
magnesium stearate to aid tablet compression.
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7.3 Results
7.3.1 The effects of diclofenac Na and meclofenamate Na with
lactose on HPMC solution cloud point
The effect of drug addition on the CPT of an HPMC solution containing a
constant concentration of lactose (250 mM) is shown in figure 7.1. The
addition of diclofenac to an HPMC solution containing lactose led to a
greater 'salting-out effect' of the HPMC solution than drug alone.
Typically, there was a 6°C greater reduction in CPT upon diclofenac Na
addition in the presence of lactose than the CPT reduction with drug
alone. For solutions containing meclofenamate Na, the presence of lactose
lowered the CPT compared to HPMC solutions containing drug alone as
well as shifting the concentration at which an inflexion occurred in the
HPMC solutions CPT containing meclofenamate Na (40 mM to 30 mM).
7.3.2 The effects of drugs and diluents on HPMC gel layer
formation in water
7.3.2.1 The effects of drugs on gel layer formation in matrices containing
low levels of diluent
The influence of low diluent content (19% w/w) on gel layer formation
was determined in matrices containing variable contents of drug and
HPMC. The rationale for examining this diluent content was that the drug
release of diclofenac Na and meclofenamate Na presented in chapter 2
included formulations with this percentage or lower diluent content.
Water was used as the hydration medium to eliminate the influence of
ionic species on the drug-HPMC interactions
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Figure 7.1 The effect of drug and lactose on the cloud point temperature (CPT) of
1% HPMCsolutions
CPTmeasured turbimetrically as a reduction of 50% in light transmission (Sarkar 1979).
Mean (n=3) ± SO
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Figure 7.2 shows gel layer development in matrices containing 19% w/w
MCCand increasing meclofenamate Na content. The gel layer growth is
shown in figure 7.3. There was little difference between the matrix
morphologies except at the highest meclofenarnate Na content (60%
w/w). The measurements of gel layer growth show only an increase in gel
layer growth occurring for the formulation containing 60% w/w
meclofenamate Na. The behaviour was analogous to the drug and HPMC
matrices (chapter 5), in which increasing meclofenamate Na content
increased the swelling of HPMC in the gel layer, therefore low MCC
content did not appear to affect the influence of meclofenamate Na on
HPMCparticle swelling and coalescence.
Figure 7.4 shows the gel layer development of the matrices containing
19% w/w lactose and increasing meclofenamate Na content The gel layer
growth is shown figure 7.5. As with the MCCmatrices, increased gel layer
growth occurred with increasing meclofenamate content. The
replacement of drug with lactose improved matrix integrity in comparison
with binary mixtures of drug and HPMCalone. Lactose 'salts out' HPMCin
solution but had little effect on gel layer formation up to 50% w/w
content. The low lactose content apparently suppressed the effect of the
meclofenamate Na and the gel layer maintained integrity. The gel layer
growth shown in figure 7.5 supports this assertion, with a controlled
swelling curve, typical in formulations with maintained matrix integrity,
apparent for all meclofenamate Na contents.
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Figure 7.2 The effect of increasing meclofenamate Na content in matrices
containing low levels (19% wIw) of MCCon the evolution of the HPMCgel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w [v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 11m. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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Figure 7.3 The effect of meclofenamate Na content on the radial gel layer growth of
HPMCmatrices containing 19% w/w MCC
Hydration in 0.008% w/v Congo red at 37°(, Swelling measured from dry tablet
boundary to the edge of region Bl. Mean (n=3) ±1 SO
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Figure 7.4 The effect of increasing meclofenamate Na content in matrices
containing low levels (19% w/w) oflactose on the evolution ofHPMCgel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w/v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 11m. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w /w magnesium
stearate.
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Figure 7.5 The effect of medofenamate Na content on the radial gel layer growth of
HPMCmatrices containing 19% w[w lactose.
Hydration in 0.008% w/v Congo red at 37°C. Swelling measured from dry tablet
boundary to the edge of region 81. Mean [n=S] ±1 SD
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Figure 7.6 shows gel layer development in matrices containing 19% w/w
MCCand increasing contents of diclofenac Na. The gel layer growth is
shown in figure 7.7. Increasing the diclofenac Na content had a minimal
effect on both the morphology and swelling of the gel layer. As with
binary matrices of diclofenac Na and HPMC,a reduction in HPMCmatrix
content reduced the overall fluorescent intensity, particularly in the
untangling and dissolving region at the gel layer periphery. The gel layer
swelling suggested little difference between the formulations (figure 7.7).
Figure 7.8 shows gel layer development in matrices containing 19% w/w
lactose and increasing diclofenac Na content The gel layer growth is
shown in figure 7.9. As with the MCCformulations, there was little effect
on the overall swelling of the matrices supporting the assertions of Ford et
al. (1987) that there is little difference in the effect of incorporation of low
levels of soluble or insoluble diluents. However, there was an absence of
fluorescent particulate matter in the gel layer and the 'classical' features in
the immediate region were largely absent from the formulations as with
the binary matrices of diclofenac Na and HPMCinvestigated in chapter S.
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20% diclofenac
19% MCC
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Figure 7.6 The effect of increasing content of diclofenac Na in matrices containing
low levels (19% w jw) of MCCon the evolution of HPMCgel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1. 5 and 15 minutes. Hydration medium containing
0.008% w/v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar= 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w/w magnesium
stearate.
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Figure 7.7 The effect of diclofenac Na content on the radial gel layer growth of
HPMC matrices containing 19% wIw MCC
Hydration in 0.008% w[v Congo red at 37°C. Swelling measured from dry tablet
boundary to the edge of region 81. Mean (n=3) ±1 SD
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20% diclofenac,
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40% diclofenac,
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Figure 7.8 The effect of increasing content of diclofenac Na in matrices containing
low levels (19% wjw) of lactose on the evolution of HPMCgel layer microstructure
after 1, 5 and 15 minutes hydration
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w]» Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w/w magnesium
stearate.
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Figure 7.9 The effect of dicIofenac Na content on the radial gel layer growth of
HPMCmatrices containing 19% w[w lactose
Hydration in 0.008% w/v Congo red at 37°C. Swelling measured from dry tablet
boundary to the edge of region B1. Mean (n=3) ±1 SO
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7.3.2.2 The effect of drug content on gel layer formation in
matrices containing high levels of diluent
Figure 7.10 shows gel layer development in matrices containing 59% w/w
MCCand increasing meclofenamate Na content. There was gradual loss of
gel layer integrity as the meclofenamate Na content increased. With the
lowest meclofenamate Na content (10% w/w), there was sufficient HPMC
content to form a gel layer. As the drug loading increased, the internal
swelling pressure and matrix disintegration capacity afforded by MCC
resulted in disintegration of the more swollen and less concentrated
HPMC gel layer. It appears the decrease in HPMC content and the
association of meclofenamate Na with the HPMC to form a
poly(electrolyte) material led to greater macromolecule chain extension,
lowering the disintegration threshold of these matrices with respect to
MCC.
Figure 7.11 shows gel layer development in matrices containing 59% w/w
lactose and increasing meclofenamate Na content. At the lowest level of
meclofenamate Na (10% w/w) the gel layer possessed a similar
morphology to a high lactose: HPMCbinary matrix (chapter 6). Therefore,
the extent of the interaction between the drug and HPMC appeared
insufficient to alter the polymer solution properties. However, when
meclofenamate Na content was increased to 20% w/w, matrix integrity
improved, possibly resulting from lactose counter-acting the 'salting-in' of
meclofenamate Na. However, once the meclofenamate Na content was
increased to 30% w[w, the burden of soluble material appeared to exceed
the capacity of the remaining HPMCto form an adequate diffusion barrier
and the gel layer failed.
Figure 7.12 shows the gel layer development in matrices containing 59%
wIw MCC and increasing diclofenac Na content. There were clear
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differences between the gel layer in each of the formulations. As the
diclofenac Na content was increased there was an apparent decrease in
HPMC particle swelling and a reduction in image fluorescence. At the
lowest drug loading (10% w/w) the gel layer formed normally, but when
the drug content was increased to 20% w/w, the presence of MCC
appeared to exert a detrimental effect on gel layer development, with a
pronounced 'bursting' of the gel layer. This may be as a result of the
decreased HPMC content in the matrix unable to produce a sufficiently
viscous gel layer to negate the swelling forces exerted by the MCC. This
trend did not continue when drug content was increased to 30% w[v«.
The low levels of fluorescence from HPMCor the MCCsuggests that the
drug had suppressed matrix hydration almost completely and the
'bursting' effect evident at lower drug concentrations appeared to be
suppressed. Diclofenac Na 'salts out' HPMCand reduced its swelling but it
may also reduce the swelling of MCC,reducing the disintegration capacity
of MCCwithin the gel layer. The image and measurement of the matrix
swelling support this assertion.
Figure 7.13. shows the gel layer development in matrices containing 59%
w/w lactose and increasing diclofenac Na content. An increase in
dicIofenac Na content resulted in a progressive decrease in the matrix
swelling. The 10% wjw diclofenac Na matrix possessed the characteristic
morphology of highly loaded lactosejHPMC binary matrix, with the drug
appearing to exert little influence on the development of the gel layer. As
the drug content increased, there was a reduction in particle swelling and
gel layer growth, reduction in gel layer coherence, which allowed rapid
dissolution of lactose from the matrix, eliminating matrix expansion.
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10% Meclofenamate
59% MCC
30% HPMC
20% Meclofenamate
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Figure 7.10 The effect of increasing content of mecIofenamate Na in matrices
containing high levels (59% w/w) ofMCCon the evolution ofHPMC gel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w Iv Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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10% Meclofenamate
59% lactose
30% HPMC
20% Meclofenamate
59% Lactose
20% HPMC
30% Meclofenamate
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10% HPMC
Figure 7.11 The effect of increasing content of meclofenamate Na in matrices
containing high levels (59% w jw) of lactose on the evolution of HPMCgel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1. 5 and 15 minutes. Hydration medium containing
0.008% w]» Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w jw magnesium
stearate.
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10% Diclofenac
59% MCC
30% HPMC
20% Diclofenac
59% MCC
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Figure 7.12 The effect of increasing content of diclofenac Na in matrices containing
high levels (59% w Iw) of MCCon the evolution of HPMCgel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w Iv Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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10% Diclofenac
59% lactose
30% HPMC
20% Diclofenac
59% lactose
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Figure 7.13 The effect of increasing content of diclofenac Na in matrices containing
high levels (59% w Iw) of lactose on the evolution of HPMC gel layer
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w Iv Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 11m. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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7.3.3 The effects of drugs and diluents on HPMC gel layer
formation in 0.9% NaCI
In chapter 4, it was observed that the interaction between drugs and
HPMCwas influenced in the presence of NaCl. This appeared to manifest
as an effect on the gel layer of binary matrices containing drugs and HPMC
(chapter 5). This section aims to determine if NaCI also influences the
combined effects of drugs and diluents in HPMChydrophilic matrices.
7.3.3.1 The effects of drugs and NaCI on gel layer formation in matrices
containing low levels of diluent
Figure 7.14 shows the effect of 19% w/w MCC on the gel layer
development in hydrophilic matrices containing increasing
meclofenamate Na content hydrating in 0.9% NaCl. Unlike the behaviour
of the formulations in water, there were clear differences in the
morphology of the gel layers. Matrices with low meclofenamate Na
content (20% w/w), swelled rapidly and disintegrated. As the
meclofenamate Na loading increased, gel layer integrity improved,
correlating with extended release profiles of matrices with high
meclofenamate Na content presented in chapter 2. The presence of NaCI
salted the polymer out of solution, and increasing the viscosity of the gel
layer.
Figure 7.15 shows the effects of 19% w/w lactose content on the gel layer
development in matrices containing increasing meclofenamate Na
content. Increased swelling and gelation occurred in the lowest
meclofenamate content matrices and replacement of drug with lactose led
to an increase in matrix integrity. The lactose in the dosage form, coupled
with NaCl in the hydration medium, appeared to act synergistically to
suppress the effect of increasing meclofenamate Na matrix content.
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Figure 7.14 The effect of increasing content of meclofenamate Na in matrices
containing low levels (19% w/w) of MCCon the evolution of HPMCgel layer in
O.9%NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1. 5 and 15 minutes. Hydration medium containing
0.008% w/v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w/w magnesium
stearate.
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Figure 7.15 The effect of increasing content of mecJofenamate Na in matrices
containing low levels (19% wjw) of lactose on the evolution of the HPMCgel layer
in 0.9%NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w Iv Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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Figure 7.16. shows gel layer development in matrices containing 19%
w/w MCCand increasing contents of diclofenac Na, hydrating in NaCI.
The gel layer appeared to form normally at the lowest diclofenac Na
content As the drug content was increased, HPMChydration appeared to
decrease until there was clear disruption of particle swelling and
coalescence at 60% w [v«. The images resembled those of 80% w/w MCC
20% HPMC (chapter 6), which suggests that the combined 'salting out'
HPMCparticles by internal diclofenac Na and external NaCIhad lowered
the gel layer disintegration threshold with respect to MCC
Figure 7.17 shows gel layer development in matrices containing 19% w/w
lactose and increasing contents of diclofenac Na, hydrating in NaCl. All
matrices were observed to fail. The failure of diclofenac Na-HPMCbinary
matrices when hydrating in NaCI manifested in these matrices with the
lactose content appeared to act to synergistically to 'salt out' the HPMC
with internal drug and external electrolyte in the dissolution medium.
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Figure 7.16 The effect of increasing content of dicIofenac Na in matrices containing
low levels (19% wJw) of MCCon the evolution of HPMCgel layer in 0.9% NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1. 5 and 15 minutes. Hydration medium containing
0.008% w/v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 11m. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w/w magnesium
stearate.
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20% diclofenac
19% lactose
60% HPMC
40% diclofenac
19% lactose
40% HPMC
50% diclofenac
19% lactose
30% HPMC
60% diclofenac
19% lactose
20% HPMC
Figure 7.17 The effect of increasing content of diclofenac Na in matrices containing
low levels (19% wIw) of lactose on the evolution of HPMCgel layer in 0.9% NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% w Iv Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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7.3.3.2 The effects of drugs and NaCI on gel layer formation In matrices
containing high levels of diluent
Figure 7.18 shows gel layer development in matrices containing 59% w/w
MCC and increasing rneclofenarnate Na content, hydrating in NaCI.
Matrices containing 10% w/w drug and the highest (30% w/w) level of
HPMC failed to form a coherent gel layer but as drug content was
increased and HPMCcontent decreased, the hydration of HPMCparticles
improved, with the 30% w/w meclofenamate Na formulation forming a
coherent gel layer.
Figure 7.19 shows gel layer development in matrices containing 59% w/w
lactose and increasing meclofenamate Na content, hydrating in NaCI. The
combined burden of drug. diluent and electrolyte in the hydration medium
acted either antagonistically or synergistically. Matrices containing 10%
meclofenamate Na failed, whereas increasing meclofenamate Na from
20% to 30% led to more coherent gel layer formation. This may be the
result of the respective burdens placed on the HPMCparticles by the drug,
the diluent and NaCIwith the level of coherence appeared to increase with
respect to increasing meciofenamate Na content.
Figure 7.20 shows gel layer development in matrices containing 59% w/w
MCCand increasing diclofenac Na content, hydrating in NaCl. With the
lowest diclofenac Na content, there was a sufficient HPMCin the matrix to
form a coherent gel layer but as diclofenac Na content increased, there
was loss of gel layer integrity.
Figure 7.21 shows gel layer development in matrices containing 59% w/w
lactose and increasing diclofenac Na content, hydrating in NaCI. All
formulations failed to form a gel layer, irrespective of the diclofenac Na
content.
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10% meclofenamate
59% MCC
30% HPMC
20% meclofenamate
59% MCC
20%HPMC
30% meclofenamate
59% MCC
10% HPMC
Figure 7.18 The effect of increasing content of meclofenamate Na in matrices
containing high levels (59% wjw) of MCCon the evolution of HPMCgel layer in
0.9% NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1, 5 and 15 minutes. Hydration medium containing
0.008% wjv Congo red maintained at 37°(, Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 J-Im. Dotted
line depicts the dry tablet boundary
248
Chapter 7
10% meclofenamate
59% lactose
30% HPMC
20% meclofenamate
59% lactose
20% HPMC
30% meclofenamate
59% lactose
10% HPMC
Figure 7.19 The effect of increasing content of meclofenamate Na in matrices
containing high levels (59% WIw) of lactose on the evolution of HPMCgel layer in
0.9% NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1. 5 and 15 minutes. Hydration medium containing
0.008% wIv Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% wjw magnesium
stearate.
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10% diclofenac
59% MCC
30% HPMC
20% diclofenac
59% MCC
20% HPMC
30% diclofenac
59% MCC
10% HPMC
Figure 7.20 The effect of increasing content of dicJofenac Na in matrices containing
high levels (59% w/w) of MCCon the evolution of HPMCgel layer microstructure in
0.9% NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at L 5 and 15 minutes. Hydration medium containing
0.008% w [v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 urn, Dotted
line depicts the dry tablet boundary. All matrices contained 1% w /w magnesium
stearate.
250
Chapter 7
10% diclofenac
59% lactose
30% HPMC
20% diclofenac
59% lactose
20% HPMC
30% diclofenac
59% lactose
10% HPMC
Figure 7.21 The effect of increasing content of diclofenac Na in matrices containing
high levels (59% w/w) of lactose on the evolution ofHPMCgel layer in 0.9% NaCI
Confocal microscopy images of the radial edge of a hydration matrix showing the
development of the gel layer at 1. 5 and 15 minutes. Hydration medium containing
0.008% w [v Congo red maintained at 37°C. Images are coded for fluorescence intensity
on a linear greyscale from white (highest) to black (lowest). Scale bar = 500 11m. Dotted
line depicts the dry tablet boundary. All matrices contained 1% w Iw magnesium
stearate.
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7.3.4 The effect of drug and diluent content on the disintegration
behaviour of HPMC matrices
Tables 7.3 and 7.4 show the influence of MCC or lactose on the
disintegration behaviour of diclofenac Na matrices. In water, the majority
of matrices did not disintegrate. The exceptions were formulations with
high diclofenac content (60% wjw) and all high content lactose
formulations. However, in NaCI solutions, there were clear differences
between the formulations. In 0.154M NaCI,all matrices containing lactose
were found to fail, irrespective of the content. Matrices containing 19%
wjw MCCdid not disintegrate except at the highest content of diclofenac
Na (60% wjw). Higher content MCCmatrices failed, but showed greater
longevity in comparison with their lactose containing counterparts.
Similar disintegration behaviour was observed in 0.5 M NaCl, with all
formulation failing but with the MCCmatrices outlasting lactose. All
matrices failed rapidly in 0.7 and 1.0MNaCl.
Table 7.5 and 7.6 shows the influence of MCC or lactose on the
disintegration behaviour of meclofenamate Na matrices. In water,
matrices with a lower meclofenamate Na content did not fail within the
experimental period, whereas at higher drug contents with 19% w jw
diluent the matrices disintegrated, irrespective of the incorporated
diluent. In 0.154M NaCl, matrices with low drug content disintegrated,
but matrices with higher contents showed greater longevity. The
exception were matrices containing high meclofenamate Na and lactose,
which disintegrated rapidly, independent of the hydration medium. In
O.SM NaCI, only high meclofenamate Na content (>50% w/w) matrices
including low diluent content did not disintegrate, with MCCmatrices
outlasting lactose. At 0.7 and 1.0 M NaCI concentrations, only matrices
containing 50% w/w meclofenamate or greater did not disintegrate.
Other formulations were observed to fail rapidly.
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Formulation Disintegration times of matrices (min)
Water O.l54M O.SM O.7M 1.OM
NaCI NaCI NaCI NaCI
20% 19% 60% >120 >120 15 1 1
diclofenac MCC HPMC
20% 19% 60% >120 40 5 1 1
diclofenac lactose HPMC
40% 19% 40% >120 >120 5 1 1
diclofenac MCC HPMC
40% 19% 40% >120 30 5 1 1
diclofenac lactose HPMC
50% 19% 30% >120 >120 5 1 1
diclofenac MCC HPMC
50% 19% 30% >120 30 5 1 1
diclofenac lactose HPMC
60% 19% 20% >120 25 15 1 1
diclofenac MCC HPMC
60% 19% 20% 105 15 5 1 1
diclofenac lactose HPMC
Table 7.3 Disintegration times of matrices of diclofenac Na with low MCCand
lactose content in the presence of various concentrations of sodium chloride
DiSintegration data obtained in 900 ml at 37°C. observations made from 4 tablets and
taken to the nearest minute
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Formulation Dislntqratlon times of matrices (min)
Water O.l54M O.SM O.7M 1.0M
NaCI NaCI NaCI NaCi
10% 59% 30% >120 40 20 5 1
diclofenac MCC HPMC
10% 59% 30% 100 15 10 1 1
diclofenac lactose HPMC
20% 59% 20% >120 30 15 1 1
diclofenac MCC HPMC
20% 59% 20% 70 10 10 1 1
diclofenac lactose HPMC
30% 59% 10% >120 25 15 1 1
diclofenac MCC HPMC
30% 59% 10% 60 15 10 1 1
diclofenac lactose HPMC
Table 7.4 Disintegration times of matrices of diclofenac Na with high MCCand
lactose content in the presence of various concentrations of sodium chloride
Disintegration data obtained in 900 ml at 37°C, observations made from 4 tablets and
taken to the nearest minute
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Formulation Dlslnt.... atlon times of matrices (min)
Water 0.154 O.SM 0.7M 1.0M
MNaCI NaCI NaO NaCI
20% 19% 60% >120 2 2 1 1
meclofenamate MCC HPMC
20% 19% 60% >120 2 2 2 2
meclofenamate lactose HPMC
40% 19% 40% >120 >120 10 2 1
meclofenamate MCC HPMC
40% 19% 40% 100 >120 10 10 5
meclofenamate lactose HPMC
50% 19% 30% >120 >120 >120 >120 >120
meclofenamate MCC HPMC
50% 19% 30% 90 >120 >120 >120 >120
meclofenamate lactose HPMC
60% 19% 20% 35 100 >120 >120 >120
meclofenamate MCC HPMC
60% 19% 20% 35 100 >120 >120 >120
meclofenamate lactose HPMC
Table 7.5 Disintegration times of matrices of meclofenamate Na with low MeCand
lactose content in the presence of various concentrations of sodium chloride
Disintegration data obtained in 900 ml at 37°C, observations made from 4 tablets and
taken to the nearest minute
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Formulation Dislntelratlon times of mltrlces (min)
Water O.l54M O.SM O.7M 1.OM
NaCI NaCI NaO Nee
10% 59% 30% >120 1 1 1 1
meclofenamate MCC HPMC
10% 59% 30% >120 3 1 1 1
meclofenamate lactose HPMC
20% 59% 20% >120 >120 20 10 5
meclofenamate MCC HPMC
20% 59% 20% 80 >120 3 1 1
meclofenamate lactose HPMC
30% 59% 10% 90 >120 40 30 15
meclofenamate MCC HPMC
30% 59% 10% 10 15 15 10 5
meclofenamate lactose HPMC
Table 7.6 Disintegration times of matrices ofmeclofenamate Na with high MCCand
lactose content In the presence of various concentrations of sodium chloride
DiSintegration data obtained in 900 ml at 37°C. observations made from 4 tablets and
taken to the nearest minute
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7.4 Discussion
The combined effects of drugs and diluents in these hydrophilic matrices
appear to be a complex interplay between the solubility of the additives,
drug interactions with the polymer and influence of the external
electrolyte. To aid clarity, the results will be discussed in a separate
section pertaining to the individual diluents.
7.4.1 The influence of lactose on drug-polymer interactions
Lactose appeared to influence the effects of both drugs. Lactose and
diclofenac Na were found to both lower the CPT of HPMC and their
combined effect was greater than each species individually. When co-
formulated with diclofenac Na, both drug and diluent reduced HPMC
particle swelling and growth of the gel layer. The high solubility of lactose
exerts an osmotic pressure, and this led to matrix disintegration when
HPMCparticulate swelling and coalescence was impaired by the 'salting
out' effects of diclofenac Na and lactose. This was exacerbated when the
matrices were hydrated in NaC!. This correlates with the drug release
data presented in chapter 2, in which diclofenac Na matrices were found
to fail when in formulations containing high lactose content
When formulated with meclofenamate Na, the influence of lactose
appeared to be more complex. With low drug content, the drug is in
insufficient concentration in the gel layer to interact with HPMC and
change its properties. the most important of which will be an increase in
viscosity and molecular tortuosity. When formulated with high levels of
lactose. the soluble content in the matrices exceeds the extended release
capacity of HPMCand the matrices fail. This supports the findings of Ford
et al. (1987) that matrices cannot extend release when formulated with
excessive soluble material. However. at intermediate contents of
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meclofenamate Na, the interaction between the drug and HPMCresulted
in changes to HPMCviscosity and solubility as a result ofpoly(electrolyte)
formation. Whereas this did not provide a functional gel layer in binary
matrices, the 'salting out' capability of the formulated lactose helps to
stabilise the poly( electrolyte) gel layers. This stabilisation occurs to a
greater extent when the hydration medium contains sodium chloride.
7.4.2 The influence of MCC on drug-polymer interactions
The insoluble nature of MCC means that it cannot exert a water
restructuring effect within the gel layer. However, it possesses the ability
to wick and imbibe water, the extent of which appears to be influenced by
the formulated drug and composition of the swelling medium.
The low solubility but considerable water-imbibing properties of MCC
provide an explanation for its influence on the drug effects on HPMCgel
layer development. An increasing content of MCCin the matrix results in
an increase in insoluble but swellable particles within the gel layer. This
increases molecular tortuosity, resulting in elevated local drug
concentration within the gel layer. This is supported by previous reports
in the literature which have suggested that MCCacts to physically obstruct
drug release (Xu and Sunada 1995, Lee et al. 1999). Consequently, this
increases the potential for drug-HPMC interactions and the subsequent
changes to HPMCsolution properties resulting from these interactions. In
the case of meclofenamate, this is an enhancement of swelling of HPMC
particles, whereas in the case of diclofenac Na it increases the propensity
of the drug to decrease HPMC solubility and particle swelling. The
hypothesis holds if there is a sufficient ratio of HPMCin the hydrophilic
matrix in relation to the level of MCC so that a gel layer forms and
disintegration does not occur.
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Studies from the literature have shown that the presence of MCC in a
hydrophilic matrix formulation actually resulted in increases in drug
release rates (Cao et al. 2005) which is attributed to the disintegrant
characteristics of MCC. Other studies have noted that the drug release
rate is only increased with the addition of superdisintegrants such as Ac-
Di-Sol (croscarmellose sodium) and Explotab (sodium starch glycolate)
(Lee et al. 1999). Evidence in this chapter suggests that MCCmay exhibit
'superdisintegrant' characteristics in the highly swollen gel layer resulting
from the meclofenamate Na interaction with HPMC.
7.4.3 The pharmaceutical consequencesof the combined effects
of drugs and diluents on HPMC gel layer formation
Previous studies have shown the importance of drug effects (Hino and
Ford 2001. Mitchell et al. 1990), the level of polymer (Alderman 1984, Xu
and Sunada 1995, Ebube et al. 1997, Ebube and Jones, 2004, Lee et al.
1999) and the importance of incorporated diluent (Jamzad et al. 2005,
Williams et al. 2002, Levina and Rajabi-Siahboomi 2004) on the
mechanisms of drug release from HPMChydrophilic matrices.
All three factors may have combined importance depending on the drug-
polymer level, the choice and physicochemical properties of the diluent
and the interactive capability of the drug with HPMC. In meclofenamate
Na matrices, the effect of drug on the gel layer is counteracted by the
'salting-out' burden from incorporated lactose. The apparent protective
effect afforded by MCCmatrices in response to NaCIchallenge may be a
result of an absence of burden on the HPMC particle swelling. The
additional presence of a 'salting out' electrolyte in the hydration medium
affected not only the behaviour of the drug in solution (i.e. its solubility
and capability of forming self-associative structures) but also its
interaction with HPMC.
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These results support the assertion of Ford (1999) who made the explicit
link between effects on HPMCcloud point and extended release properties
of HPMChydrophilic matrices. It can be seen that this concept holds in the
formulations investigated in this chapter, with the combined effects on
CPT of incorporated drugs and diluents with external ionic species
appearing critical in determining if a HPMCbased hydrophilic matrix will
successfully extend release.
7.5 Conclusions
The combined influence of drugs and diluents on the HPMCmatrix gel
layer has been presented and discussed. Lactose and MCC exerted
different influences on the effects of diclofenac Na and meclofenamate Na
in HPMC matrices, which was dependent on the diluent content in the
HPMC matrix. The influence of NaCI was dependent on the soluble or
insoluble diluent content. Cloud point studies suggested that lactose acted
synergistically in 'salting-out' HPMCin the presence of diclofenac Na and
antagonise the effects of meclofenamate Na, manifested in changes in the
morphology and physical properties of the geJJayer.
The results support the hypothesis in chapter 2 and developed in chapter
6 that lactose plays a key role in influencing drug-mediated effects on
HPMCgel layer development and functionality. It supports the assertion
of Ford (Ford et al. 1987) that high levels of diluent are required in order
for their effects to be exerted but with the additional consideration of how
the drug effects on HPMC particle swelling and gel layer formation
interplay with the effects of diluents.
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Chapter 8
Conclusions and future Work
8.1 Summary
The principal aim of this thesis was to explore the critical processes in
drug release from HPMChydrophilic matrices. Specifically, the effects of
diclofenac Na, meclofenamate Na and diluents on HPMC solution
properties and gel layer formation have been investigated and related to
patterns of drug release in a previous thesis. The following sections
discuss the key findings of each chapter.
Chapter 2 Developing a hypothesis
In chapter 2, a hypothesis was developed from an interpretation of a
previous study, which was subsequently tested in the experimental work
in this thesis. The key aspects of the hypothesis were that:
• The differences in the release of dicIofenac Na and
meclofenamate Na from HPMCmatrices are a consequence of
drug surface activity and the capability of the drug to interact
with HPMC.
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• The incorporation of lactose in the matrix has a significant
role in influencing the effects of drug on gel layer formation and
release mechanisms
• The choice of 0.9% w/w sodium chloride as a dissolution
medium influences the interaction of drugs with HPMCand the
subsequent drug release.
The validity of this hypothesis was tested in the experimental work
undertaken in the subsequent chapters of this thesis.
Chapter 4 Investigating interactions between drugs and HPMC
Chapter 4 investigated the nature of the interactions between diclofenac
Na and meclofenamate Na with HPMC, using PGSE-NMR, SANS,
turbimetry, tensiometry and rheology. In summary it was found that:
• Diclofenac Na and meclofenamate Na possess surface
activity, while tensiometry suggested drug binding to HPMCin
bulk solution, with an apparent saturation concentration for
diclofenac Na but not meclofenamate Na.
• The interaction between polymer and drug examined using
PGSE-NMR and SANS showed association between
mecIofenamate Na and HPMCbut not diclofenac Na and HPMC.
• The addition of meclofenamate Na led to changes in the bulk
properties such as cloud point temperature, viscosity and
viscoelasticity. In contrast, diclofenac Na was found to have
little effect on HPMCbulk solution properties.
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• The interaction between meclofenamate Na and HPMCwas
influenced by sodium chloride, with the sodium chloride
addition to a drug-HPMC solution resulting in decreased
polymer solubility and altered viscoelastic properties at lower
drug concentrations.
This provided supporting evidence for the hypothesis described above
and developed in chapter 2 that drug surface activity and its interactive
potential with HPMCcan change alter HPMCsolution properties. A theory
was proposed detailing the phenomenon of association of drug with the
polymer conferring polymer solubility increases, changes in the
Viscoelastic properties and increases in viscosity. This provides a
mechanistic explanation for how increasing meclofenamate Na content in
a matrix results in decreased drug release rates and vice versa for
diclofenac Na matrices.
Chapter 5 Investigating the effects of drugs on the gel layer
In chapter 5, the effects of increasing the matrix content of meclofenamate
Na and diclofenac Na on the early development of the gel layer was
investigated using confocal laser scanning microscopy. It was found that:
• Drug effects on HPMC solution properties externalise in
HPMCmatrix gel layer morphology.
• In water, meclofenamate matrices swell rapidly in
comparison with diclofenac matrices, producing a highly
swollen, diffuse gel layer.
• When hydrated in sodium chloride, gel layer formation and
matrix integrity for matrices including mecIofenamate Na
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improved, whereas diclofenac matrices produced a mass of
discrete particles that disintegrated rapidly.
• Drug and HPMCmatrices possessed different disintegration
properties depending on formulated drug and the sodium
chloride concentration in the hydration medium.
• Meclofenamate Na matrices disintegrated more rapidly in
water than diclofenac Na matrices and this was reversed when
challenged by sodium chloride in the hydration medium.
• Meclofenamate Na matrices exhibited an increased
resistance to sodium chloride challenge beyond the
disintegration threshold of 100% HPMCmatrices. This may be
explained by the poly(electrolyte) properties conferred by
bound drug, resulting in a viscous gel layer that has improved
functionality as sodium chloride concentration is increased.
• The inability of diclofenac Na to interact with HPMC
resulted in an increased propensity for HPMC matrices to
disintegrate, as a result of salting out from the incorporated
drug and external electrolyte.
Chapter 6 Investigating the effects of diluents on the gel layer
In chapter 6, it was found that the physicochemical properties of the
diluent had significant effects on gel layer development
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• Lactose reduced the cloud point temperature of HPMC in
solution, but had minimal effect on the viscosity and viscoelastic
properties ofHPMC solutions.
• Lactose had little effect on gel layer formation at low matrix
contents, but resulted in a highly diffuse gel at higher lactose
contents. This suggested rapid diffusion of the soluble excipient
through the gel layer, with a contributory effect from the
capability of lactose to 'salt-out' HPMCfrom solution.
• MCCexerted little effect on early gel layer formation at low
matrix content «50% w/w) but at higher matrix contents
(>50% w/w) apparently led to failure of HPMC to form a
coherent gel layer, with a visible erosion and disintegration of
the underlying matrix.
• DCP disrupted early gel layer formation and led to matrix
failure at the highest content (85% w/w) but had minimal effect
at lower contents.
• Increasing diluent content and reducing HPMCcontent led
to an increased susceptibility to disintegration upon electrolyte
challenge, with lactose having the most detrimental effect and
MCCthe least.
This chapter provided evidence supporting the hypothesis that the
content and nature of the diluent can influence the early gel layer
formation.
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Chapter 7 Investigating the combined effects of drugs and
diluents on the gel layer
The final chapter considered the influence of drug effects on gel layer
formation by incorporated diluents (MCCand lactose). It was found that:
• Lactose antagonised the effects of meclofenamate at both
low (19%) and high (59% w/w) levels of incorporation within
the matrix.
• Lactose acted synergistically with diclofenac to 'salt out' the
HPMCand reduce the gel layer integrity.
• MCCwas found to have a relatively neutral effect on the
drug-mediated effects on the gel layer formation and
functionality
• NaCIwas found to influence the drug effects on the gel layer
formation. Diclofenac Na matrices were found to disintegrate
and fail to form a gel layer, whereas it appeared to promote
matrix integrity in tablets containing meclofenamate Na.
8.2 Overall Conclusions
It has been identified that drug surface activity and capability to interact
with HPMCcan affect the gel layer formation and that this would provide a
mechanistic explanation for drug release profiles presented in chapter 2 of
this thesis. It is proposed that a balance exists between the influences of
different species on the capability of HPMC particles to form an adequate
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gel layer, both internally from the incorporated drug and excipients, and
externally from ionic species present in the hydration medium.
Tailoring matrix formulations to overcome the potential effects of each
component may lead to the production of more robust future dosage
forms through informed choice of excipient and consideration of these
interactive effects.
8.3 Future work
Future work should be concerned with providing further insights into the
mechanisms and the potential for interactions in other hydrophilic matrix
formulations.
8.3.1Influence of other surface active drugs
Several important classes of drugs possess surface activity including (i)
beta-blockers, (ii) phenothiazides and (iii) local anaesthetics (Attwood
1995). The work in this thesis has shown that the effect of drugs on HPMC
hydrophilic matrix performance may be partially a result of surface
activity, subsequent association with the polymer. with consequent
changes to the properties of the gel layer. It would be of value to consider
classes of drugs possessing surface active, e.g. beta-blockers, in an attempt
to discern the importance of concomitant properties such as drug
solubility in the drug-polymer association.
8_3.2 Influence of HPMC grade
Other studies have noted no differences between the swelling of particles
and gel layer formation of different HPMCgrades (Mitchell et al. 1990.
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Rajabi-Siahboomi et al. 1993) although this has been disputed (Conti et al.
2006). It would be interesting to determine if a grades of HPMCwhich
were more susceptible to drug-mediated changes in its solution properties
promotes extended drug release in the example of a 'salting-in' drug such
as meclofenamate Na, whereas a choice of less susceptible grade would
help negate the 'salting out' effects of a drug such as diclofenac Na.
8.3.3 Behaviour of surface active drugswith other polymers and
polymer blends
The interaction between surface active drugs and polymers is unlikely to
be confined to hydrophilic matrices based on HPMC.Other polymers used
in hydrophilic matrix dosage forms including alginates, xanthan gum,
poly( ethylene oxide) and their hydrophobic equivalents, possess the basic
chemical structure to interact with surface active drugs and this may
influence their performance within pharmaceutical dosage forms.
Polymer blends are being increasingly investigated as the possible basis of
hydrophilic matrix dosage forms. Again, interactions between drugs and
blends of polymers may provide a fertile area for future work.
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Appendix 1
Materials
Material Manufacture Batch no
Congo red Sigma-Aldrich Company Ltd, Dorset, 126H2510
UK
Deuterium oxide Fluorochem, Derbyshire, UK X3191
Diclofenac sodium salt MP Biomedicals, Germany 7721E
HPMC (Methocel E4M Colorcon Ltd, Dartford, UK OD16012N32
CR Premium USP/EP)
Lactose (Lactopress) Borculo Ltd, S0410410034
Magnesium stearate Sigma-Aldrich Company Ltd, Dorset, S03492-325
UK
Meclofenamate Cayman Chemical Company 17116A
sodium
Sigmacote@ Sigma-Aldrich Company Ltd, Dorset, 103K4360
UK
Silicon dioxide Sigma-Aldrich Company Ltd, Dorset, 106261D
UK
Silicone Oil (low Sigma-Aldrich Company Ltd, Dorset, 448742/1
viscosity 100 mPa.s) UK 11904174
Sodium chloride Fisher Scientific, Loughborough, UK 0585645
Water (Maxima HPLC USF Elga, Buckinghamshire, UK
grade with a maximum
conductance of 18.2
MOcm·1)
Al
Appendix
Appendix 2
Moisture content of HPMC batch
Powdered HPMCabsorbs moisture and can contain significant equilibrium
moisture content varying between 2-10% wjw water (Doelker 1993). The
moisture content of the HPMC batch utilized throughout the study was
therefore monitored periodically at 3 month intervals using a MB45
Moisture Analyser (Ohaus Corporation, Florham Park, NJ). The water
content was found to be maintained between 3.5-4.5% wlw, as shown in
figure A.1.
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Figure A.1Moisture content (% w jw) of the HPMCbatch used in the thesis
Moisture content monitored periodically at 3 month intervals. Mean (n = 5) ±1 SD
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